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Summary
Phospholipase C zeta (PLCQ is a sperm specific isoform of phospholipase C. It 
has been shown to produce a long lasting series of calcium oscillations and 
triggers the activation of development when introduced into mammalian eggs. It 
is not known how PLC£ is regulated or if its effects are specific to eggs. Here 
Chinese Hamster Ovary (CHO) cells were transfected with cDNA encoding PLC£ 
tagged with enhanced yellow fluorescent protein (eYFP) or luciferase (LUC). 
Comparisons were made between these cells and cells transfected with the 
catalytically inactive PLC?, the corresponding reporter gene, or nontransfected 
cells. PLC^ exhibited variable levels of nuclear localisation in a manner that 
depended upon time after transfection. Analysis of resting intracellular calcium 
levels in transfected CHO cells produced no evidence that PLC? expression has 
a significant effect upon calcium homeostasis. The calcium response to ATP 
receptor stimulation also remained unchanged after PLC? expression. A lack of 
any clear effect on cell viability enabled the generation of a stably transfected 
PLC? cell line. Individual cells were estimated to be expressing PLC? within and 
above the range required to initiate calcium transients in eggs, and are therefore 
considered to be expressing at levels comparable with that of sperm. Despite the 
lack of effect on calcium in CHO cells, the injection of either cytosolic extracts, or 
whole cells, from the PLC£ transfected cell line were able to cause calcium 
oscillations in mouse eggs. Such an effect was not seen with control CHO cells. 
These data suggest that PLC? is inactive when expressed in CHO cells and yet 
active when subsequently introduced into an egg. The results imply that the 
enzymatic activity of PLC? may be reversibly inhibited in somatic cells, or else 
specifically stimulated by factors in the egg cytoplasm.
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CHAPTER 1 
INTRODUCTION
CHAPTER 1 INTRODUCTION 
1.1 Calcium (Ca2*) Signalling
1.1.1 A fundamental ionic messenger
Calcium is an ubiquitous intracellular messenger that regulates a wide range of 
cellular processes, including muscle contraction, neurotransmission, gene 
transcription, cellular proliferation, apoptosis and fertilization (Berridge et al., 
2003; Bootman et al., 2001a; Clapham, 1995; Jayaraman et a/., 1997). Resting 
cytosolic free Ca2+ levels are typically ~100nM (Berridge, 1997; Bootman et a/., 
2001a). This level can increase to more than 1-1 OpM in response to various 
stimuli such as depolarisation, mechanical deformation, hormonal activation or 
exposure to a Ca2+ ionophore (Bootman et al., 2001a). Elevation of the 
intracellular calcium, either via influx from the extracellular environment or 
release from intracellular stores acts as a trigger to switch “on” various cellular 
processes. The subsequent removal of cytosolic Ca2+ then acts to switch them 
“o ff. This simplistic theory is in fact dependent on a complex interplay between 
several channels, pumps and exchangers as illustrated in Figure 1.1 (Berridge et 
al., 2000).
1.1.2 Calcium Influx
Ca2+ influx occurs via Ca2+ entry channels located at the plasma membrane 
(PM). The various Ca2+entry channels are grouped according to their mechanism 
of activation (Bootman eta!., 2001a). Receptor-operated Ca2+ channels (ROCCs) 
are found primarily on the PM of nerve terminals and secretory cells.
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Figure 1.1 The Ca2+ signalling network
Figure based upon Berridge etal., (2003).
Calcium can enter the cell via activation of receptor; voltage or store operated Ca2+ channels 
(ROCCs, VOCCs, SOCCs) located on the plasma membrane (PM). (For simplicity only one Ca2+ 
channel type is indicated at the PM). External stimuli also give rise to the formation of second 
messengers that release stored Ca2+ from within the endoplasmic/sarcoplasmic reticulum 
(ER/SR) via the inositol-1,4,5-trisphosphate (lnsP3R) or the ryanodine receptor (RyR). The 
majority of Ca2+ within the cytoplasm remains bound to buffers (shown as yellow circles), while a 
small amount binds to effectors that activate various cellular processes that operate over a broad 
temporal spectrum (shown to the right of the figure). The intracellular effectors and buffers 
release Ca + prior to its removal from the cell via a range of exchangers and pumps. Ca2+ is 
extruded from the cell via the Na+/Ca2+ exchanger (NCX) and the plasma membrane Ca2+ 
ATPase (PMCA), or it can be sequestered back into the ER/SR via the sarco(endo)plasmic 
reticulum Ca2+ ATPase (SERCA). Mitochondria play a role in the sequestration of Ca via a 
uniporter, this Ca2+ is then released slowly into the cytoplasm through a mitochondrial NCX. The 
golgi apparatus has been shown to contribute to elevations in cytosolic Ca2+ levels through 
InsPaR activation present on the golgi membrane. The Golgi also has the ability to sequester Csr 
via the secretory pathway Ca2+ ATPase (SPCA) and a Ca2+ ATPase belonging to the SERCA  
family. Cell survival is dependant on Ca + homeostasis, whereby Ca2+ fluxes during the “off’ 
reactions (red arrows) exactly match those during the “on” reactions (green arrows).
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They are activated by an agonist binding to the extracellular domain of the 
channel. Acetylcholine is a commonly known agonist, responsible for the 
transmission of neuronal impulses at nerve terminals through the synaptic cleft 
(Alberts et a/., 1997; Bootman e ta l., 2001a).
Voltage operated Ca2+ channels (VOCCs) are largely present in excitable cells 
such as muscle and neuronal cells. Interestingly the Ca2+ increase observed at 
fertilisation in many types of oocytes is known to be due to activation of VOCCs, 
such as in the sea urchin (Chambers et al., 1979; David et al., 1988). 
Depolarisation of the PM activates these channels resulting in the influx of 
extracellular Ca2+. They are composed of five protein subunits (a1, a2, p, y, 6) 
with multiple isoforms, resulting in a number of different possible channel 
isoforms (Bootman et al., 2001a).
Store operated Ca2+ channels (SOCCs) are gated by a poorly understood 
mechanism triggered by the depletion of intracellular Ca2+ stores (Bootman et al., 
2001a). The most studied and best characterised SOCCs are the Ca2+ release- 
activated Ca2+ (CRAC) channels, which were first identified in human T cells and 
mast cells (Hoth et al., 1992; Lewis et al., 1989). The search for the genes that 
code for the CRAC channel lead to the discovery of two proteins, Orail and 
STIM1, which are now considered to play obligatory roles in the activation of 
SOCCs. Orail is a four transmembrane protein present in the PM with 
intracellular N- and C- termini. Stiml is a typel transmembrane protein located 
primarily on the ER. Upon store depletion Stiml have been shown to translocate 
into puncta that accumulate in ER regions closely associated with the PM (Liou
4
et al., 2005). The redistribution of Stiml is believed to be the initiator of SOC  
entry as puncta formation has been shown to preceed CRAC channel activation 
by 6-10s (Wu et al., 2006). Furthermore, live cell imaging has revealed that Stiml 
forms oligomers within 5s after store depletion prior to its translocation (Liou et 
al., 2007). Studies have shown that Stiml interacts functionally with Orail to 
activate SOC entry (Potier et al., 2008), however the precise mechanism by 
which Stim 1 conveys information regarding store depletion to Orail channels 
remains to be determined. Accumulating evidence indicates that STIM1 acts as a 
sensor of Ca2+ store content, while Orail is believed to be a pore-forming CRAC 
channel subunit (Gwack et al., 2007; Mignen et al., 2007). The C-type transient 
receptor potential class of ion channels (TRPCs) have also been suggested as 
candidates for forming SOCCs (Birnbaumer et al., 1996; Hardie et al., 1993; 
Selinger et al., 1993), however their activity is believed to be distinct from CRAC  
channels (Smyth et al., 2006).
1.1.3 Intracellular stores and Ca2+ releasing agents
1.1.3.1 Phosphoinositides and inositol 1,4,5-trisphosphate (lnsP3)
Phosphatidylinositol (PI) is a ubiquitous eukaryotic lipid whose phosphorylated 
derivatives (collectively known as phosphoinositides) have been implicated in a 
number of important cell signalling events including cell survival, cell division and 
membrane trafficking (Cullen et al., 2001). The structure of PI consists of a myo­
inositol headgroup connected to a diacylglycerol via a phosphodiester linkage 
(Figure 1.2). The 3, 4 and 5 hydroxyl groups of the inositol head group can be
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phosphorylated by a variety of kinases (Figure 1.3). To date, seven 
phosphoinositides have been identified; three phosphatidylinositol 
monophosphates [phosphatidylinositol 3-phosphate (Ptdlns3P), 
phosphatidylinositol 4-phosphate (Ptdlns4P) and phosphatidylinositol 5- 
phosphate (Ptdlns5P)], three phosphatidylinositol bisphosphates 
[(phosphatidylinositol 3,4-bisphosphate (Ptdlns3,4P2), phosphatidylinositol 3,5- 
bisphosphate (Ptdlns3,5P2) and phosphatidylinositol 4,5-bisphosphate 
(Ptdlns4,5P2)], and phosphatidylinositol 3,4,5 trisphosphate (Ptdlns3,4,5P3).
Myo-inositol head group
Phosphodiester linkage
Diacylglycerol
Figure 1.2 Phosphatidylinositol (PI)
The structure of Phosphoinositol (PI) contains a myo-inositol head group connected to a 
diacylglycerol via a phosphodiester linkage. In mammalian cells the fatty add moiety is typically 
stearoyi-arachidonyl. The inositol head group can be phosphorylated at one of three currently 
identified positions, 30H, 40H and 50H for a total of one, two or three times by a variety of 
kinases.
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The reversible production of phosphoinositides is catalyzed through the 
combined actions of a number of specific phosphatases and phosphoinositide 
kinases which have not been fully identified. In the canonical phosphoinositide 
pathway Ptdlns acts as a substrate for PI 4-Kinases, generating Ptlns(4)P which 
in turn acts as a substrate for PI 5-Kinases to produce Ptlns(4,5)P2. PI 5-Kinases 
are found at the PM, at focal adhesions, in the nucleus and the golgi. PI 4- 
Kinases are found in the cytosol, nucleus and associated with the ER, but are not 
strongly associated with the PM (Doughman et al., 2003). Ptlns(4,5)P2 is 
hydrolysed by activated phospholipase C (PLC) proteins resulting in the 
synthesis of two second messengers, diacylglycerol (DAG), which activates 
protein kinase C (PKC), and inositol-1,4,5-trisphosphate (InsPs). lnsP3 binds to 
lnsP3 receptors (InsPsR) stimulating Ca2+ release from the endoplasmic 
reticulum. The localisation of Ptlns(4,5)P2 in mammalian eggs is unknown. 
Experiments involving the glutathione S-transferase tagged PH domain of PLC61 
have revealed the distribution of Ptlns(4,5)P2 in somatic cells (Watt et al., 2002). 
Ptlns(4,5)P2 was labelled in the plasma membrane and also in intracellular 
membranes including Golgi, endosomes and ER, as well as electron dense 
structures within the nucleus. Mammalian sperm PLC activity has been shown to 
induce Ca2+ dependent lnsP3 formation in a cytoplasmic sea urchin egg 
preparation (Rice et al., 2000). This data suggests that the Ca2+ wave in both 
mammals and sea urchin eggs could be generated via Ca2+ induced lnsP3 made 
in the cytoplasm.
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Recent work has uncovered a role for Ptdlns(3)P and Ptdlns(3,5)P2 in the 
regulation of vesicular trafficking through the recruitment of Fab1p-YOPB- 
Vps27p-EEA1 (FYVE) domain-containing proteins (Wurmser et al., 1999). The 
sole function of Ptdlns(4)P was previously considered to be acting as a substrate 
for the generation of Ptdlns(3,4)P2 and Ptdlns(4,5)P2. However, recent studies 
have demonstrated a role in the recruitment of proteins that are involved in 
vesicular trafficking from the trans-Golgi network (TGN) to the plasma 
membrane, including adaptor-protein (AP)-1 (Wang et al., 2003) and the four 
phosphate adaptor protein (FAPP) 1 and 2 (Godi et al., 2004). Ptdlns(5)P was 
recently discovered to bind to the plant homeodomain (PHD) finger of inhibitor of 
growth protein-2 (ING2), a candidate tumor suppressor protein (Gozani et al., 
2003). Tandem PH domain containing protein-1 (TAPP-1) and TAPP-2 have 
been found to selectively bind Ptdlns(3,4)P2. The biological significance of this 
interaction remains elusive, however it suggests a more specific role other than 
simply a by-product of Ptdlns(3,4,5)P3 breakdown (Sasaki et al., 2007). 
Ptdlns(3,4,5)P3 is an important second messenger in numerous signalling 
pathways involved in the control of cell growth, survival, metabolism, motility and 
immune responses. Proteins that bind Ptdlns(3,4,5)P3 are diverse in nature and 
include adaptor molecules, protein kinases and exchange factors for the small G 
proteins Arf (Cantley, 2002; Stephens et al., 2005; Vanhaesebroeck et al., 2005).
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Figure 1.3 Phosphoinositide metabolism
The figure shows the main pathways of phosphoinositide synthesis in mammalian cells. The 
combined action of phosphoinositide kinases (PIxKs) and phosphatases (X-Pases) generates 
multiple phosphoinositides phosphorylated at the 3, 4 and 5 positions either alone or in 
combination. Some of the reactions have been established in vitro but not yet in vivo. For the 
sake of clarity, only the enzymatic activity (3-,4-, or 5- kinase/phosphatase) is indicated and in 
some cases the identification of the enzyme is mentioned (Types I, II and III PI 3-kinases). The 
figure also shows the turnover of Ptdlns(4,5)P2 by phospholipase C (PLC) to yield soluble inositol- 
1,4,5P3and membrane-embedded diacylglycerol (DAG). The canonical phosphoinositide pathway 
is highlighted in blue. (Adapted from (Payrastre eta!., 2001)
1.1.3.2. The inositol 1,4,5-trisphosphate receptor (lnsP3R)
The activation of Phospholipase C (PLC) by a variety of stimuli including ligand 
interaction with G protein linked receptors is a common mechanism for 
modulating the intracellular Ca2+ concentration [C a2+]j. Activation of PLC leads to 
the hydrolysis of the membrane lipid phosphatidylinositol 4,5 bisphosphate 
(PIP2), generating inositol 1,4,5 trisphosphate (lnsP3) and diacylglycerol (DAG) 
(Berridge, 1993; Putney et al., 1993). lnsP3 diffuses freely throughout the 
cytoplasm and binds to its receptor (lnsP3Rs), which is a ligand-gated C a2+
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release channel (Ferris et al., 1989; Maeda et a/., 1991). InsPaRs are situated 
primarily on the membrane of the endoplasmic/ sarcoplasmic reticulum (ER/SR) 
(Ferreri-Jacobia et al., 2005; Otsu etal., 1990; Ross etal., 1989). Conformational 
change upon activation of this receptor/channel complex induces Ca2+ release 
from the lumen of the intracellular store into the cytoplasm. Three InsPaR 
isoforms have been identified (InsPaR Type 1, 2 & 3), that are approximately 
70% homologous in their overall amino acid sequence (Mackrill et al., 1997). 
InsPaR isoforms are expressed in almost all mammalian cell types and their 
relative distribution is tissue type/function dependant (Vermassen et al., 2004). 
The Type 1 isoform is the most widely studied InsPaR subtype, and is expressed 
predominantly in cerebellar Purkinje neurons (Furuichi et al., 1993). Genetic 
knockout of the Type 1 isoform in the mouse has been shown to cause 
neurological defects (Matsumoto et al., 1996). The Type 1 isoform is also 
expressed in relatively high amounts in smooth muscles (Nixon et al., 1994) and 
is the predominant isoform found in oocytes (Kume et al., 1993). The role of Type 
1 InsPaRs in fertilization was demonstrated in hamster eggs using the InsPaR- 
specific function blocking antibody 18A10, which blocked the Ca2+ oscillations 
induced by InsPa at fertilization (Miyazaki et al., 1992). The Type 2 isoform is 
expressed primarily in cardiac myocytes (Perez et al., 1997), and genetic 
deletion of the mouse lnsPaR2 has been shown to abolish the arrhythmogenic 
effect of endothelin in this cell type (Li et al., 2005). The Type 3 isoform is 
expressed in the brain, kidney, gastrointestinal epithelium, and pancreatic islets 
(Blondel etal., 1993; Taylor et al., 1999).
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Each InsPaR comprises four subunits of approximately 300KDa (Bootman et al., 
2001a). Each InsPaR subunit has a ligand binding domain located towards the 
end of a large cytoplasmic NH2-terminus, six transmembrane (TM) spanning 
domains which contribute to the formation of the channel pore, and a relatively 
short COOH-terminus as illustrated in Figure 1.4 (Foskett et al., 2007). InsPaRs 
also contain another functionally distinct region termed the modulatory domain 
which is located between the pore domain and the InsPa binding domain. The 
modulatory domain contains binding sites for Ca2+ and ATP. In addition to InsPa, 
Ca2+ also regulates InsPaR activation (Berridge, 1997; Bootman et al., 1999). 
InsPaR function is stimulated by cytosolic Ca2+ concentrations of 0.5-1 pM, unlike 
concentrations >1pM which inhibit their opening (Bootman et al., 1999). Binding 
of Ca2+ to InsPaR Type 1 has been shown to induce structural changes in the 
receptor, indicating that Ca2+ regulates InsPaR gating activity through the 
rearrangement of functional domains (Hamada et al., 2002). In the presence of 
InsPa, ATP increases activity of InsPaRs by binding to high affinity binding sites 
located within the modulatory domain (Maes et al., 2000).
Phosphorylation and dephosphorylation modulates lnsP3R function (DeSouza et 
al., 2002; Jayaraman et al., 1996), and numerous consensus phosphorylation 
sites have been identified (Patel et al., 1999). InsPaRs are regulated by 
phosphorylation by numerous kinases, including protein kinase A (PKA), protein 
kinase G (PKG), protein kinase C (PKC), protein tyrosine kinases (PTKs) and 
CaMKII (Foskett et al., 2007; Patel et al., 1999; Thrower et al., 2001). A large 
number of protein interactions with the InsPaR have been described (for review
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see (Patterson et al., 2004), many of which involve allosteric modulation of 
channel gating which may contribute to the diversity of spatially and temporally 
distinct InsPaR signalling properties.
Figure 1.4 The Inositol 1,4,5- 
trisphosphate receptor (IP3R)
(From (Foskett et al., 2007) 
Schematic representation of three of 
the four subunits (in different colours) 
of a single tetrameric IP3R ligand 
gated Ca + channel. lnsP3 binds to 
the NH2-terminus which elicts a 
conformational change that activates 
the channel. Part of the loop 
connecting the 5th and 6 
transmembranes helices contributes 
to the formation of the channel pore 
which enables Ca2+ efflux from the 
lumen of the ER
T
1.1.3.2.1 lnsP3R Downregulation
One of the mechanisms by which cells adapt during long term exposure to an 
agonist is by down-regulation of cell surface receptors, characterised by a 
reduction in the cellular content of these proteins. It has been found that chronic 
stimulation of receptors linked to lnsP3 formation leads to a decrease in the 
number of lnsP3Rs and a decrease in sensitivity of the intracellular Ca2+ stores to 
lnsP3 (Wojcikiewicz et al., 1991; Wojcikiewicz et al., 1992). The large 
conformational changes that occur as a result of lnsP3 binding to its receptor 
appears to be the essential trigger for receptor degradation (Zhu et al., 1999). 
The precise proteolytic mechanism responsible for lnsP3R degradation has yet to
Endoplasmic 
reticulum
cytoplasm
C O O H '& y
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be identified, but has been proposed to involve the ubiquitin/ proteasome 
pathway (Oberdorf et al., 1999). Activation of Phosphoinositide C linked 
receptors has been shown to cause InsPaR ubiquitination in a range of cell types 
(Oberdorf ef al., 1999). The cystein protease and proteasomal inhibitor ALLN and 
the highly specific proteasome inhibitor Lactacystin prevented InsPaR 
downregulation induced by activation of these receptors (Bokkala et al., 1997). 
This suggests that lnsP3Rs can be degraded by the proteasome, a cytosolic 26S 
multi protein complex that recognises and degrades poly-ubiquitinated proteins. 
Downregulation of InsPaR has been shown to inhibit Ca2+ release in mouse eggs 
(Brind et al., 2000; Jellerette et al., 2000), and has been proposed to partly 
explain the cessation of Ca2+ oscillations 3-4 hours after fertilisation.
1.1.3.3 The Ryanodine Receptor
Another ligand gated Ca2+ release channel that is structurally and functionally 
similar to the InsPaR is the Ryanodine receptor (RyR). RyRs are the largest 
known ion channel with a total molecular mass of ~2.2MDa and around twice the 
conductance of InsPaRs (Franzini-Armstrong et al., 1997). They are present on 
the ER/SR membranes of muscle and non-muscle cells (Fleischer et al., 1989; 
Lai et al., 1988). Each subunit of its tetrameric protein structure is comprised of 
~5000 amino acids, -90%  of which constitutes a large cytoplasmic NH2-terminus 
that is essential for the regulation of the channel pore (Franzini-Armstrong et al., 
1997; Mackrill, 1999). The three RyR isoforms that have been identified (RyR1, 
RyR2 and RyR3) have different physiological functions which are reflected by
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their tissue specific expression. RyR1 is expressed primarily in skeletal muscle 
whilst RyR2 fulfils the same function in cardiac muscle and in brain cells 
(Berridge, 1997). RyR3 is expressed in the central nervous system and in
smooth muscle (Berridge, 1997; Liu et al., 2001). The RyR channels are
activated by low Ca2+ concentrations (1-1 OpM), reaching a broad maximum near 
100pM and inhibited by high Ca2+ concentrations (1-10mM) (Chen et al., 1997; 
Chu et al., 1993; Copello et al., 1997; Laver et al., 1995). Calcium induced 
calcium release (CICR) from RyR channels is stimulated by cyclic adenosine 
diphosphate ribose (cADPR). cADPR is produced from nicotinamide adenine 
dinudeotide (NAD) by ADP-ribosyl cyclase. It is unclear if cADPR acts a direct 
ligand for RyR channels, or whether it stimulates CICR by binding to an
accessory protein. The Ca2+ wave observed at fertilisation is generally
considered to be generated by InsPaRs. RyRs do not contribute to the fertilisation 
response in mouse eggs (Swann et al., 2001), however they appear to make a 
substantial contribution to the mechanisms underlying the fertilisation Ca2+ wave 
in fish and echinoderm eggs (Fluck et al., 1999; Galione et al., 1993). Ruthenium 
Red, a RyR antagonist, has been shown to reduce the propagation velocity of the 
Ca2+ wave in sea urchin eggs (Galione etal., 1993).
1.1.3.4 Nicotinic acid adenine dinucleotide phosphate (NAADP)
Nicotinic acid adenine dinucleotide phosphate (NAADP) has been identified an 
extremely potent Ca2+-mobilizing messenger (Genazzani et al., 1997; Lee et al., 
1995). Similar to cADPR, NAADP is also believed to be synthesized by members 
of the ADP-ribosyl cyclase family (Aarhus et al., 1995; Lee et al., 1991).
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However, a recent study involving sea urchin sperm suggests the presence of a 
new NAADP synthase (Vasudevan et al., 2008) which has raised questions 
regarding an already limited understanding of NAADP biosynthesis. Its Ca2+ 
releasing properties have been examined in a broad range of cell types from a 
variety of organisms including sea urchin and starfish oocytes (Chini et al., 1995; 
Churchill et al., 2002; Lee et al., 1995; Lim et al., 2001; Santella et al., 2000), 
heart cells (Bak et al., 2001) and pancreatic cells (Cancela et al., 1999; 
Yamasaki et al., 2004). Pharmacological experiments involving selective 
inhibitors of InsPaRs and RyRs suggests that NAADP activates a distinct Ca2+ 
mobilising mechanism, involving a receptor/channel complex that has yet to be 
identified (Galione et al., 2005). Recent evidence suggests that two-pore 
channels (TPCs) located within the endolysosomal system are involved in 
NAADP-induced Ca2+ mobilisation (Calcraft etal., 2009; Galione et al., 2009).
1.1.3.5 The Mitochondria as an intracellular Ca2+ store
Mitochondria may also be viewed as a Ca2+ store. If necessary, mitochondria can 
significantly buffer cytosolic Ca2+ increases (Bootman et al., 2001b). Ca2+ is 
sequestered by a low affinity uni porter that operates at high speed that is driven 
by the mitochondria’s membrane potential. Despite the low affinity of the 
uniporter, the mitochondria are able to modulate intracellular calcium due to their 
close proximity to other Ca2+ release sites which exposes them to increased local 
Ca2+concentration [Ca2+] (Csordas eta l., 1999). Increasing the [Ca2+] within the 
mitochondria activates enzymes involved in the citric acid cycle, leading to
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enhanced production of ATP (Bootman et al., 2001b). Calcium is released slowly 
from the mitochondria via the Na+ dependant exchanger, to then be dealt with by 
various pumps and exchangers which act to re set basal Ca2+ levels and ensure 
the replenishment of intracellular stores.
1.1.3.6 The Golgi apparatus as an intracellular Ca2+ store
The Golgi apparatus is involved in sorting and processing secretory and 
membrane proteins prior to them reaching their final destination within the cell. 
Golgi function is regulated by changes in Ca2+ levels either within the Golgi 
lumen or the adjacent cytoplasm (Burgoyne et al., 2003; Wuytack et al., 2003). 
The Golgi is recognized as a Ca2+ store containing both release and 
sequestration apparatus (Pinton et al., 1998). The production of InsP3 activates 
InsPaR located on the Golgi membrane resulting in Ca2+ release. The Golgi has 
been shown to act in unison with the ER to elevate cytoplasmic Ca2+ in response 
to agonist stimulation (Missiaen et al., 2004b). Ca2+ release from the Golgi has 
been shown to contribute to the shaping of intracellular Ca2+ signals (Missiaen et 
al., 2004b). Two types of Ca2+ ATPases are present on the Golgi membrane, 
one belonging to the secretory pathway calcium ATPase family (SPCA) and the 
other belonging to the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 
family (Van Baelen et al., 2004; Wuytack et al., 2003). Altering the expression/ 
activity of the Golgi calcium ATPases, thus affecting their ability to sequester 
Ca2+, has a profound effect on cellular function. Hailey-Hailey disease, an
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autosomal dominant blistering skin disorder, is caused by mutations in the gene 
encoding Golgi localised SPCA1, demonstrating its important role in maintaining 
Ca2+ homeostasis (Missiaen etal., 2004a; Sudbrak etal., 2000).
1.1.4 Removal of cytoplasmic Ca2+
The plasma membrane Ca2+-ATPase (PMCA) utilises the energy generated by 
ATP hydrolysis to pump Ca2+ from the cytosol to the extracellular environment 
(Berridge et al., 2003). Following a rise in cytoplasmic Ca2+, the Na+/ Ca2+ 
exchanger (NCX) rapidly extrudes Ca2+ from the cell in exchange for Na+ ions 
(Berridge et al., 2000). Another mechanism by which Ca2+ is removed from the 
cytosol is via the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) which 
pumps Ca2+ into the lumenal spaces of the internal stores upon which they are 
located. It is critical for cell survival that the fluxes that switch “on” the Ca2+ 
reactions are counteracted by those that switch them “ofF (Carafoli, 2002).
1.1.5 Ca2+ - Friend or Foe?
Ca2+ signals enable cells to function properly. However, it is vital that this cellular 
messenger is carefully regulated. Cells can tolerate a brief rise in cytosolic Ca2+, 
however a sustained increase would result in persistent activation of Ca2+ 
controlled processes which would ultimately lead to necrotic cell death (Berridge 
et al., 2000). Mitochondria act only as a temporary safety mechanism during 
periods of Ca2+ overload. Despite having a large capacity for Ca2+ uptake, the 
continuous pumping of Ca2+ into the mitochondrial matrix depletes the organelles 
energy reserve, thus depriving cells of the ATP necessary to remove Ca2+ out of
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the cytoplasm through the pumps (Carafoli, 2002). Defects involving one or more 
component of the complex pathway involved in the generation, processing and 
control of Ca2* signals have been implicated in a variety of disease states. 
Examples include cardiac and skeletal myopathies (Benkusky et a/., 2004; 
George et al., 2005; Pogwizd et al., 2001), liver, kidney and pancreatic 
dysfunction (Matsuda et al., 2001; Shibao etal., 2003; Vassilev et al., 2001) and 
neuropathology (Mattson etal., 1998; Tang etal., 2003; Verkhratsky, 2005).
1.1.6 Spatio Temporal aspects of Ca2+ Signals
Cells protect themselves against the potentially harmful effects of Ca2+ by 
creating low amplitude Ca2+ signals or, more typically, by presenting the signals 
in a pulsatile manner. The up stroke of each transient is generated by the “ON” 
reactions that introduce Ca2* into the cytoplasm, and the subsequent decline 
depends on the “OFF” reactions that pump Ca2+ out of the cell or back into the 
internal stores. Single transients that activate cellular processes such as muscle 
contraction and neurotransmitter release are generated in response to periodic 
stimulation (Berridge et al., 2003). In contrast, many tissues receive continuous 
stimulation over a prolonged period, during which the Ca2* signal is presented as 
brief transients that are produced rhythmically, giving rise to highly regular Ca2* 
oscillations whose frequencies vary with the degree of stimulation. Cytosolic Ca2* 
oscillations are a major feature of Ca2* signalling in a wide range of cellular 
processes including oocyte activation at fertilisation (Ozil et al., 1995), liver
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Figure 1.5 Temporal aspects of Ca2+ signalling
(Adapted from (Krebs et al., 2007) The majority of Ca2+ signals appear as brief transients that can 
be utilized to set up complex temporal patters of Ca2+ signalling. The up stoke of each transient is 
generated by the “ON” reactions (green arrow) that introduce Ca2+ into the cytoplasm. The “OFF" 
reactions (red arrow) which are responsible for the removal of Ca2+ from the cytoplasm, prevent a 
sustained increase in Ca2+ levels and consequently protects the cell. In some cells these 
transients are produced in response to periodic stimulation (yellow arrows). Many other tissues 
receive continuous stimulation over a prolonged period (yellow bar), giving rise to highly regular 
Ca2+ oscillations whose frequency depends on the level of stimulation.
metabolism (Robb-Gaspers et al., 1998), smooth muscle contraction (Filosa et 
al., 2004), and lymphocyte activation (Feske, 2007).
Cells utilise highly sophisticated mechanisms which enable them to interpret 
changes in frequency of the Ca2+ oscillations. Such frequency modulation enable 
cells to regulate specific responses such as exocytosis (Tse et al., 1993), 
mitochondrial ATP production (Hajnoczky et al., 1995) and the control
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ofdifferential gene transcription (Berridge et al., 2003). Cells have developed 
decoders that respond to the duration and frequency of the Ca2+ signal, 
examples of which include protein kinase C (PKC) (Oancea et al., 1998) and 
calmodulin dependent protein kinase II (CaM Kinase II) (De Koninck et al., 1998). 
In addition to this temporal aspect, Ca2* signals are also highly organized in 
space. Ca2* microdomains are formed within cells as a result of brief opening of 
either Ca2* entry channels in the PM or release channels in the ER/SR. The 
movement of Ca2* throughout the cell is restricted by its limited diffusion and 
cytosolic Ca2* buffering. These microdomains enable cells to perform highly 
localised signalling functions such as neurotransmitter release (Grosche et al., 
1999; Sharma et al., 2003; Simkus et al., 2002). These confined plumes of Ca2* 
have been categorized according to the channels that produce them. Brief 
opening of VOCCs in the PM produces a sparklet (Wang et al., 2001), and small 
groups of RyRs on the SR generate sparks (and syntillas) (Cheng et al., 1993; 
De Crescenzo et al., 2004), whereas the lnsP3Rs produce puffs. Ca2* sparks and 
puffs comprise the basic building blocks of global Ca2* signalling. lnsP3Rs and 
RyRs must be sufficiently sensitive enabling them to respond to the local Ca2* 
puff or spark produced by their neighbours. These channels contribute to the 
positive feedback process of Ca2*-induced Ca2* release (CICR), whereby the 
Ca2* signal is propagated throughout the cytoplasm as a regenerative wave 
(Berridge et al., 2000). Ca2* oscillations are generated by successive rounds of 
Ca2* release and diffusion from small groups of lnsP3Rs or RyRs located on the 
ER/SR. It has been proposed that Ca2* oscillations are terminated by inactivation
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of lnsP3Rs, allowing Ca2+ to be pumped back into the ER, thereby lowering the 
cytosolic calcium concentration before the lnsP3Rs are resensitised to deliver the 
next pulse of Ca2+ (Berridge, 2007; Oancea et al., 1996). A popular mechanism 
of Ca2+ oscillations involves positive and negative feedback loops of Ca2+ acting 
directly on the lnsP3R (De Young et al., 1992). At low Ca2+ concentrations the 
lnsP3R is stimulated by Ca2+, but at higher Ca2+ concentrations the lnsP3R is 
closed by Ca2+ (Bezprozvanny et al., 1991).
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Figure 1.6 Spatial aspects of Ca2+ signalling.
Localised Ca2+ signals that arise from either individual or small groups of ion channels are 
depicted in panel A. Voltage operated Ca2+ channels (VOCCs) in the plasma membrane (PM) 
give rise to sparklets, and ryanodine receptors (RyRs) on the sarcoplasmic reticulum (SR) 
produce sparks (and syntillas), whereas the inositol 1,4,5-trisphosphate receptor (lnsP3R) 
produce puffs. Panel B illustrates the regenerative Ca2+ waves created by the process of Ca2+- 
induced Ca2+ release (CICR), whereby lnsP3Rs and RyRs with increase sensitivity become 
activated by the diffussion of Ca2+ from a neighbouring puff/spark and respond by releasing 
further Ca +. The receptors are sensitive enough to pass the signal over long distances 
(represented by the gaps) along the ER/SR membrane.
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1.2. Calcium and Fertilisation
1.2.1 Mammalian Fertilisation
The fertilisation process relies on the fusion of two haploid gametes derived from 
genetically distinct individuals of the same species. Female and male gametes 
are morphologically distinct, and are generated by meiosis from germ cells 
contained within sexually differentiated organs. The male gametes 
(spermatozoa) are produced from spermatogonia within the testis, and female 
gametes (oocytes) are produced from oogonia within the ovaries (Kupker et al., 
1998). If the fertilizing sperm and the oocyte successfully locate and activate 
each other, the diploid zygote begins to divide by mitosis to form a multicellular 
organism (blastocyst), and ultimately an embryo (Florman et al., 2006).
The process of activation involves large changes in the metabolism of the two 
gametes that are initiated by signals that trigger changes in the intracellular Ca2+ 
concentration [Ca2+]j. An increase in intracellular Ca2+ within the oocyte is 
recognised as a general feature of the fertilization process (Carafoli et al., 2001; 
Santella et al., 2004). The increase in Ca2+ can occur as a single transient or as 
repetitive oscillations, depending on the animal species (Strieker, 1999). The 
importance of Ca2+ in the regulation of oocyte physiology at fertilisation has been 
well documented, and it is generally accepted that in mammals, activation of 
InsPaRs is responsible for the rise in Ca2+ (Runft et al., 2002; Williams, 2002). 
More recently, information has began to emerge highlighting the importance of 
Ca2+ in the activation of sperm prior to fertilisation (Darszon et al., 2005).
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1.2.2 Oogenesis
Oogenesis, or female gametogenesis, is the mechanism by which the female 
gamete forms, grows and matures (Figure 1.7). This process begins during the 
early stages of female embryonic development, whereby primordial germ cells 
(oogonia) migrate to the embryonic ovaries and undergo several mitotic divisions. 
Approximately 7 million germ cells are formed during the second to seventh 
month of gestation. The majority of oogonia die following this period of rapid 
cellular division, while the remaining oogonia enter the first meiotic division 
(Pinkerton et al., 1961). These latter cells, called the primary oocytes, are 
arrested during late prophase of the first meiotic division, at which point they are 
maintained until puberty (Edwards, 1965). Each primary oocyte is enveloped by a 
primordial follicle consisting of a single layer of epithelial granulosa (follicle) cells. 
With the onset of adolescence, groups of primary oocytes periodically resume 
meiosis when exposed to the correct hormonal stimulation. The primary follicle 
enters a stage of growth forming gravian follicles, during which the primary 
oocyte undergoes an increase in diameter from <20pm to 80pm or 120pm in 
mice and humans respectively (Grundzinskas et al., 1995). Growing oocytes 
develop a large nucleus termed the germinal vesicle (GV), and a thick 
oligosaccharide based extracellular coat, the zona pellucida (ZP), which 
surrounds the plasma membrane. During the growth of the follicle, there is an 
increase in the number of granulosa cells which form concentric layers around 
the oocyte. In addition to this an antrum (cavity) forms, which is filled with 
secretions derived from follicular cells and the oocyte become surrounded by
24
several layers of granulosa cells known as the cumulus oophorus. These cells 
remain associated with the oocyte during ovulation, secreting hormones that are 
important for sperm capacitation and the acrosome reaction (discussed later) 
(Tesarik et al., 1988) and act as a screen to remove abnormal sperm (Nottola et 
al., 1998). Graafian follicles migrate towards the periphery of the ovary in 
preparation for final maturation and release of the oocyte (Grundzinskas et al., 
1995). Shortly after the initial follicle growth, the pituitary gland begins secreting 
luteinizing hormone (LH). In response to LH, the cell enters the first meiotic 
division whereby the germinal vesicle is broken down, and the spindle apparatus 
forms resulting in the segregation of the homologous chromosomes. One set of 
chromosomes is retained by the oocyte, while the other is extruded in a small 
daughter cell refered to as the first polar body (Donahue, 1968; Wassarman et 
al., 1976). During the second meiotic cycle the oocyte is arrested in its second 
metaphase (Mil) and at this point it is released from the ovary. Only oocytes 
arrested in the Mil stage can be activated by sperm, and meiotic division is 
resumed in response to intracellular signals within the oocyte following activation. 
Fertilisation results in the extrusion of a second polar body, leading to 
degeneration of the 1st polar body, and pronuclear formation.
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Figure 1.7: Oogenesis and 
fertilisation
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(See text for details)
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1.2.3 Spermatogenesis
Spermatogenesis is the process by which male germ cells (spermatogonia) 
develop into mature spermatozoa within the testis (Figure 1.8). Spermatogonia 
lie on the basal lamina of the convoluted seminiferous tubules where they 
undergo mitosis. This acts to maintain the spermatogonia population and also 
produces the cells that begin differentiation (primary spermatocytes). These 
diploid cells (46XY) migrate through the junctions at the base of Sertoli cells 
towards the lumen of the seminiferous tubules and undergo two meiotic divisions. 
During the first division the diploid primary spermatocytes separate into two 
haploid cells (23X or 23Y) termed secondary spermatocytes. The cells quickly 
proceed through this stage and undergo a second meiotic division whereby the 
chromatids separate forming spermatids that contain 23 single half 
chromosomes. Spermatids undergo a period of morphological development in 
vesicles within the sertoli cells during which they aquire their distinctive shape 
(Figure 1.8). This shape comprises a sperm head containing the nucleus and 
acrosome, a midpiece abundant in mitochondria and a long tail, or flagellum, 
containing a central complex of microtubules which form the axoneme that is 
responsible for sperm motility (Kupker et al., 1998). These general characteristics 
are shared by the majority of mammalian species, though there are variations in 
the size and shape of the head, and in the lengths and relative amount of the 
different components of the flagellum (Roosen-Runge, 1977). Spermatozoa are 
extruded from the sertoli cells into the lumen of the seminiferous tubules before
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Figure 1.8 Spermatogenesis
Schematic representation of male gametogenesis (See text for details). The lower panel 
illustrates the characteristic shape of a single sperm cell. The head contains a large dense 
nucleus and a single large vesicle termed the acrosome. The midpiece contains numerous 
mitochondria which provide energy for sperm motility. The tail contains a complex of microtubules 
which form the axoneme, responsible for sperm motility. The tail is not shown to scale, and is 
typically 10-15 times larger than the remainder of the cell.
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being transported to an accessory storage organ, the epididymis, where they 
undergo a period of functional development resulting in mature, motile sperm 
cells that have fertilising ability (Clermont, 1972; Kupker et al., 1998). 
Spermatozoa are moved to the urethra during coitus, where they are met by 
secretions (including water, buffering salts, acid phosphatases, cholesterol and 
phospholipids) from various accessory glands prior to ejaculation. In humans the 
development of mature spermatozoa from spermatogonial stem cells takes 65 
days (Dym, 1994). Approximately 100 million sperm are made per day and each 
ejaculation releases 200 million sperm (Reijo etal., 1995).
1.2.3.1 Sperm Capacitation and Acrosome Reaction
Spermatozoa require a period of incubation in the female reproductive tract 
where they undergo a series of biochemical modifications, which gives them the 
ability to fertilize the egg (Austin, 1951; Austin et al., 1952). This process, termed 
sperm capacitation, is a complex physiological event that is accompanied by an 
increase in sperm respiration and motility. Numerous cellular events occur during 
capacitation including an increase in intracellular Ca2+ and cAMP concentrations 
(Breitbart et al., 1985), cholesterol efflux from the plasma membrane that 
increases membrane fluidity (Cross, 2004), and increased intracellular pH and 
tyrosine phosphorylation (Dorval et al., 2002; Galantino-Homer et al., 2004; 
Visconti etal., 1999). Tyrosine phosphorylation of several sperm proteins play an 
important role in sperm capacitation (Visconti et al., 1998), and it has been 
demonstrated for example that the inhibition of protein kinase A (PKA) can inhibit
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the capacitation of spermatozoa (Visconti et al., 1995). Reactive oxygen species 
(ROS) have been suggested to play an important role in capacitation-related 
phosphorylation of several proteins in human sperm (Aitken, 1989). Roles for 
Ca2+ and HCO3' have been suggested in the upregulation of adenyl cyclase in 
sperm (Visconti et al., 1998). There is no direct evidence for a specific ligand 
which induces capacitation, however a role for epidermal growth factor (EGF) 
has been suggested, since its receptor tyrosine kinase EGFR has been identified 
in the head of bovine sperm (Lax et al., 1994). Activation of EGFR results in 
tyrosine phosphorylation and activation of PLCy; both of which are essential to 
the process of capacitation (Spungin et al., 1995).
In order to reach the surface of the oocyte, the spermatozoa must penetrate both 
the cumulus matrix and the zona pellucida (ZP). The cumulus acts as a selective 
barrier, controlling the entry of sperm whose functional ability has been 
compromised, and only allows fully capacitated, acrosome intact sperm to reach 
the zona and the oocyte (Westphal et al., 1993). Numerous observation suggest 
that PH20, a glycosyl-phosphatidylinositol-linked protein (expressed on the 
plasma membrane in response to capacitation), may be involved in the cumulus- 
dispersing activity of the sperm (Lin et al., 1994). PH20 has hyaluronidase 
activity, which allows sperm with intact acrosomes to traverse the cumulus matrix 
(Myles et al., 1997). Once contact has been made with the ZP, capacitated 
sperm undergo the acrosome reaction. This Ca2+ dependent mechanism enables 
the outer acrosomal membrane and the overlying plasma membrane to come 
into close proximity, to fuse, to secrete the acrosomal content, and to trigger the
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opening of SOCCs in the plasma membrane. The release of the acrosomal 
contents, notably the enzymes hyaluronidase and acrosin, combined with 
vigorous sperm motility is required for the passage of the sperm through the zona 
(Talbot, 1985). This process enables the sperm to contact and fuse with the 
plasma membrane of the oocyte (Evans, 2002; Wassarman etal., 2001).
1.2.3.2 Calcium signalling in sperm
Recent data has shown that Ca2+ signalling plays a major role in the important 
sperm functions that occur after ejaculation. Intracellular Ca2+ regulates sperm 
chemotaxis (Eisenbach, 1999), motility and hyperactivation (Carlson et al., 2003; 
Suarez et al., 2003), acrosome reaction (Kirkman-Brown et al., 2002) and also 
plays a role in the process of capacitation. During fertilisation, the ability of the 
sperm to locate the egg is modulated by Ca2+ changes induced in the sperm by 
soluble components released by the outer layers of the egg. During chemotaxis, 
the swimming trajectory of sperm is dictated by Ca2+ spikes in the flagellum. 
Voltage gated Ca2+ channels as well as a cAMP-regulated Ca2+ transporter may 
be involved in the Ca2+ increase that gives rise to the asymmetry of flagellar 
movement (Cook et al., 1994; Nishigaki et al., 2004). The Ca2+ rise in the 
flagellum is followed by a Ca2+ rise in the sperm head, and the duration of the 
Ca2+ signal is regulated by two Ca2+ clearance mechanisms, a K+-dependent 
Na+/Ca2+ exchanger (NCKX) and a plasma membrane Ca2+-ATPase (PMCA) 
pump. Mammalian sperm display hyperactivated motility prior to fertilisation. 
Hyperactivation is characterised by an increase in flagellar bend amplitude and
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beat asymmetry, and is required for successful fertilisation as it increases the 
ability of the sperm to make contact with the egg and penetrate its extracellular 
coat. Recent data suggests that sperm hyperactivation may be regulated by the 
emptying of an lnsP3-dependent intracellular store (Ho et al., 2001). The PMCA 
pump (isoform 4) is located almost exclusively in the tail of the sperm and is 
essential for extruding Ca2+ during hyperactivated motility. Recently, Catsper, a 
novel family of sperm cation channels, has been described. Catspers are 
distributed in the principal piece of the sperm tail, and mediate Ca2+ influx 
required for hyperactivated movement (Kirichok et al., 2006). Immunolocalisation 
experiments have shown that the sperm acrosome appears to function as an 
InsPaR containing Ca2+ store activated by agonists linked to PLC. Mobilisation of 
acrosomal Ca2+ appears to play a direct role in activation of the acrosome 
reaction (De Bias etal., 2002; Herrick etal., 2005).
1.2.4. Calcium change at Fertilisation
One of the earliest and most important changes in the oocyte at fertilisation is a 
transient increase in Ca2+, resulting from its release from intracellular stores, 
which stimulates the entire program of development. The suggestion that a Ca2+ 
increase plays a role in fertilisation dates back to the early 1920s when it was 
demonstrated that egg activation could be induced by promoting Ca2+ entry from 
the extracellular medium by pricking the egg with a needle (Jaffe, 1985; Loeb, 
1921). One of the morphological changes that occur at egg activation includes 
the cortical reaction, where the content of the cortical granule is extruded into the
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extracellular space (Jaffe et al., 2001; Schuel, 1985). Experiments involving the 
use of the Ca2+ ionophore A23187 demonstrated that the triggering of the cortical 
reaction and activation of development is dependent upon the increase in 
intracellular Ca2+ (Steinhardt, 2006; Steinhardt et al., 1974a). The observation 
that sperm interaction induces an increase in Ca2+ at the sperm entry site that 
then propagates to the opposite side of the egg was originally documented in 
medaka fish by experiments using injected aequorin (Ridgway et al., 1977). It is 
now recognised that an increase in Ca2+ is a general feature of the fertilisation 
process, and is a crucial event in activation of plants, animals and non­
mammalian species (Digonnet et al., 1997; Jaffe, 1983; Zucker et al., 1978). 
Depending on the animal species, the increase may occur as a single Ca2+ 
transient or as a series of repetitive oscillations (Strieker, 1999). In mammalian 
eggs a long lasting series of Ca2+ oscillations of constant amplitude continue at 
regular intervals (approximately every 7-20 minutes) for several hours after 
sperm-oocyte fusion, and persist until pronuclear (PN) formation (Carroll, 2001; 
Kline etal., 1992; Marangos etal., 2003; Miyazaki et al., 1993) (Figure 1.9). The 
first transient is distinctively longer in duration and larger in amplitude (Swann et 
al., 1994). The Ca2+ oscillations induced by sperm at fertilisation are both 
necessary and sufficient for the completion of the numerous events of egg 
activation, including membrane hyperpolarisation, changes in the pattern of 
protein synthesis, pronuclear formation and meiotic resumption (Kline et al., 
1992; Ozil etal., 2005; Schultz etal., 1995).
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Figure 1.9 Ca2+ oscillations during 
mammalian egg activation
This figure shows a fluorescent trace of 
the long lasting series of Ca2+ oscillations 
that are initiated in a mouse egg by 
sperm. These oscillations persist until 
pronuclear (PN) formation. (Image 
courtesy of K.Swann)
1.3 The Sperm Factor
1.3.1 W hat signalling pathw ay is involved in the generation of Ca2+ 
oscillations during m am m alian fe rtilisa tion?
A large body of evidence implicates the lnsP3 signalling pathway as the source of 
Ca2+ release from the ER during mammalian fertilisation. Early observations in 
sea urchin eggs showed a substantial increase the levels of polyphosphoinositide 
at fertilisation (Turner et al., 1984), and lnsP3 generation was later found to 
coincide with the Ca2+ transient (Ciapa et al., 1992). The critical role of lnsP3 and 
the lnsP3Rs in the development of Ca2+ oscillations at fertilisation has been more 
recently illustrated in studies using mouse and hamster eggs, where Ca2+ 
oscillations are abolished by the microinjection of antibodies that inhibit lnsP3Rs 
(Miyazaki et al., 1992). Downregulation of lnsP3Rs has also been found to inhibit 
Ca2+ transients in mouse eggs (Brind et al., 2000; Jellerette et al., 2000), a 
mechanism that has been proposed to partly explain the cessation of Ca2+ 
oscillations 3-4 hours after fertilisation.
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Three main hypotheses have been proposed to explain the generation of Ca2+ 
oscillations in fertilised oocytes (Figure 1.10). All of which are consistent with the 
delay of several minutes observed between oocyte contact and the initiation of 
Ca2+ oscillations (Whitaker et a i, 1989). The conduit hypothesis, is an early 
hypothesis that involves a mechanism by which the sperm head, once fused with 
the oocyte, acts as a non-selective channel, allowing influx of extracellular Ca2+ 
via pores in the sperm membrane into the oocyte cytosol (Jaffe, 1991). The Ca2+ 
release from the ER was proposed to be a result of Ca2+ induced Ca2+ release 
(CICR). Injection of Ca2+ into fish and frog eggs has been shown to produce a 
Ca2+ wave (Nuccitelli, 1991), however this hypothesis fails to explain many 
features of Ca2+ changes in fertilised oocytes. It appears to be an unlikely 
mechanism for mammalian egg activation given the more recent observation that 
sperm is able to trigger repetitive Ca2+ transients in the absence of extracellular 
Ca2+ (Jones etal., 1998; Swann, 1996).
The contact/receptor hypothesis suggests that upon sperm-oocyte contact, 
receptor-ligand interaction on the PM of the oocyte leads to the generation of 
intracellular messengers that trigger a series of signalling events that initiate Ca2+ 
release from the ER (Foltz et a i, 1993; Schultz et a i, 1995). There are surface 
proteins that play a role in sperm-egg interactions, however there is no evidence 
to suggest that they are linked to intracellular signalling (Runft et a i, 2002). 
According to this hypothesis, the generation of the Ca2+ increase might occur 
through several different routes, all ultimately leading to the activation of 
Phospholipase C (PLC) (Ciapa et a i, 2000). Ambiguous results with a number of
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G-protein activators and inhibitors have significantly reduced the interest in 
conventional G-protein/PLC/lnsP3 involvement (Runft et al., 2002). In 
echinoderms, it has become apparent that Ca2+ release may be triggered by a 
tyrosine kinase receptor that acts via a PLCy-mediated pathway (Townley et al., 
2006).
The Content hypothesis has been proposed to explain the generation of Ca2+ 
oscillations at fertilisation (Swann, 1990; Swann et al., 1994). It describes a 
mechanism by which a soluble sperm factor is released into the egg, capable of 
activating the lnsP3 signalling pathway and the subsequent Ca2+ release from the 
ER. Injection of hamster sperm extracts into mammalian eggs produced a series 
of Ca2+ oscillations much like those seen during in vitro fertilisation (Strieker, 
1997; Swann, 1990; Swann et al., 1994). Further support for this hypothesis 
comes from the clinical technique, intra-cytoplasmic sperm injection (ICSI) 
(Palermo et al., 1992), which involves direct injection of intact sperm thus 
avoiding sperm-oocyte membrane contact. This technique has been shown to 
lead to normal activation and development of oocytes (Nakano et al., 1997; 
Tesarik et al., 1994). The sperm factor hypothesis appears to be consistent 
between species. Pig sperm extracts have been shown to generate Ca2+ 
oscillations in cow, mouse and hamster eggs (Swann, 1990; Wu et al., 1997). 
Furthermore, fish sperm extracts were also able to induce oscillations in mouse 
eggs (Coward eta!., 2003).
36
Figure 1.10 Main hypotheses for intracellular Ca2+ increase at fertilisation
Schematic diagram showing the three main hypotheses to explain how sperm initiates the 
elevation in Ca + release from the ER of the oocyte during mammalian fertilisation.
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1.3.2. The sperm factor is a novel phospholipase C isoform
Early candidates for the sperm factor included small molecules such as lnsP3 
(Tosti eta!., 1993), NAADP+ (Lim et al., 2001) and NO (Kuo etal., 2000). Despite 
having the ability to generate intracellular Ca2+ release in non-mammalian 
species, none of these were capable of elicting a long period of Ca2+ oscillations 
observed during in vitro fertilisation in mammalian oocytes (Swann, 1994). 
Studies utilising various fractionation techniques suggested that the sperm factor 
was a protein (Strieker, 1997; Swann, 1996; Wu et al., 1998), of ~30-100kDa in 
size (Parrington et al., 2002; Rice et al., 2000). Other potential candidates have 
included a 33kDa glucosamine-6-phosphate isomerase, termed Oscillin 
(Parrington et al., 1996), and a truncated form of the c-kit receptor (tr-kit) (Sette 
et al., 1997). None of these proteins however have been shown to be capable of 
generated fertilisation-like Ca2+ transients when injected into mammalian oocytes 
(Wolny et al., 1999; Wolosker et al., 1998; Wu et al., 1998). The identification of 
the sperm factor has involved the isolation and purification of sperm extracts. In 
vitro PLC assays revealed that these extracts possessed a PLC activity, at least 
100 times greater than that present in other tissues known to express PLC 
isoforms (Rice et al., 2000). PLC became an obvious candidate for the sperm 
factor, not only due to the fact that the PI pathway is responsible for Ca2+ release 
at fertilisation, but also as several PLC isoforms have been shown to be 
expressed in mammalian sperm (Fukami, 2002). Despite this, microinjection of 
recombinant proteins corresponding to most of the known isoforms expressed in 
sperm, including PLC(31, y1, y2 and 61 failed to mimic the Ca2+ oscillations
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observed at fertilisation (Jones et al., 2000; Parrington et al., 2002; Runft et al., 
2002), or only managed to initiate Ca2+ oscillations at non-physiological 
concentrations (Mehlmann et al., 2001). Recent analysis of a mouse testis 
expressed sequence tag (EST) database revealed a novel PLC sequence. This 
led to the production of a full length cDNA encoding sperm protein, termed PLC? 
(Saunders et al., 2002). PLC? was found to be smaller than the other PLC 
isoforms and its expression was found to be testis specific. Microinjection of 
complimentary RNA (cRNA) encoding mouse (Saunders et al., 2002), human 
and monkey (Cox et al., 2002) PLC? into mouse eggs produced fertilisation-like 
Ca2+ responses. Furthermore, these Ca2+ oscillations were abolished when PLC? 
was immunodepleted by an anti-PLC? antibody, from native sperm extracts 
(Saunders et al., 2002; Swann et al., 2004). The amount of PLC? required to 
initiate Ca2+ transients correlates with the approximate concentration of PLC? in a 
single sperm (20-50fg) (Saunders et al., 2002). Studies involving transgenic mice 
that generate RNAi to interfere with PLC? expression in testis have shown that 
levels of PLC? are half of those of normal mice, causing premature termination of 
Ca2+ oscillations during fertilisation (Knott etal., 2005).
1.3.2.1 The Phospholipase C family
Mammalian phospholipases are an essential group of enzymes that play a 
central role in phosphatidylinositol metabolism and lipid signalling pathways in a 
Ca2+ dependent manner. Fourteen isoforms of PLC have been identified so far, 
grouped into six subfamilies that differ in mode of activation, catalytic regulation,
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cellular localisation and membrane binding activity; p(1-4), y(1,2), 5(1-4), e, ? and 
n(1,2) (Cockcroft et al., 1992; Fukami, 2002; Hwang et al., 2005; Kelley et al., 
2001; Nakahara et al., 2005; Rhee, 2001; Rhee et al., 1997; Saunders et al., 
2002; Song et al., 2001). As described previously, these enzymes catalyse the 
hydrolysis of PIP2 to generate the second messengers lnsP3 and DAG. The 
presence of distinct regulatory domains in PLC isoforms causes them to be 
susceptible to different modes of activation and allow them to participate in 
different signalling pathways (Rhee, 2001). The domain organisation of the six 
subfamilies of PLC are illustrated in Figure 1.11.
1.3.2.2 PLC Domain Functions
All PLC isoforms except PLCe and PLC? possess a Pleckstrin Homology (PH) 
domain at the NH2 terminal. The PH domain comprises approximately 120 amino 
acids is proposed to be essential for plasma membrane association of many 
proteins involved in intracellular signalling. This membrane association was first 
described in PLC51 (Rhee, 2001). Membrane binding is also regulated in a 
negative feedback by lnsP3 , which binds to the PH domain, thus inactivating it 
(Williams, 1999). X-ray crystallography studies have indicated that the PH 
domains of all isoforms share a common architecture, consisting of a p-sandwich 
closed off at one end by a C-terminal a-helix (Ferguson et al., 1995). The EF- 
hand domain consists of four helix-loop-helix motifs that are divided into pair-wise 
lobes. The loop region that links the two perpendicularly positioned a-helices 
possesses Ca2+ binding residues (Kretsinger et al., 1973). EF hands always 
occur in pairs because one loop stabilises the other. The second lobe of the EF
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hand domain interacts with the conserved (C2) domain, and its removal renders 
the enzyme inactive, probably due to tertiary structure destabilisation (Emori et 
al., 1989; Nakashima et al., 1995). All PLC isoforms have two regions of high 
sequence homology consisting of two building blocks, the X and Y domains.
PLC delta (5)
PLC zeta (£)
PLC eta (n)
PLC beta (p) PH
PLC gamma (y)
,PH
PH
PLC epsilon (c)
PH ]— 0 0 0 ( ^ —1~^~]—[~^~1— —[ R A [—[ RA |
Figure 1.11 Domain topographies of the phospholipase C isoform families.
Schematic diagram of the domain organisation of the known PLC subfamilies, illustrating the 
plecktrin homology (PH) domains which target the PLC to membrane bound proteins, the EF- 
hands which bind Ca2\  the X and Y catalytic domains, and the PKC-homology type II (C2) 
domain which binds lipids. The Scr homology (SH) domains bind to phosphorylated tyrosine 
residues in target proteins. The ras exchanger motif (REM) and cell division cycle 25 (CDC25) 
domains catalyse guanosine diphosphate (GDP) to guanosine triphosphate (GTP), an activity that 
is regulated by Ras associating (RA) domains.
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X and Y are organised in eight repetitive beta sheet/alpha helix sequences, 
forming a distorted barrel (Ellis et al., 1998; Williams, 1999). The catalytic 
mechanism involves a two step acid/base catalysis of the inositol 1-phosphate- 
glycerol bond that links the inositol headgroup to the DAG lipid anchor (Ellis et 
al., 1998). There is an interruption strand between strands four and five of the 
catalytic domain, which forms a large loop, termed the X-Y linker sequence, 
which differs considerably between PLC isozymes. For example, in the PLC5 
group, the X-Y linker is relatively short (46 amino acids). Proteolysis of this 
negatively charged region results in activation of the enzyme, and it is thought to 
play an important regulatory function (Rebecchi et al., 2000; Williams, 1999). The 
PKC-homology type II (C2) domain is a protein structural motif, comprising -120  
amino acid residues, that is involved in targeting proteins to cell membranes. The 
secondary structure of the C2 domain comprises 8 p-sheets, forming an anti­
parallel beta-sandwich motif (Williams, 1999). Membrane binding is facilitated by 
Ca2+ in three Ca2+ binding regions (CBR) which induces a conformational change 
in the domain. Ca2+ bound to CBRs does not take part in catalysis directly, but 
stabilises interactions with anionic phospholipids (Stahelin etal., 2001).
1.3.2.3 plc ;
PLC? is a soluble protein of approximately 70KDa, the smallest of the PLC family 
identified to date, and is most closely related to PLC61 (Saunders et al., 2002). 
Mouse PLC? is comprised of a tandem pair of EF hands at the N-terminus,
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followed by the catalytic XY domain and a C2 domain in the C-terminus. 
However, unlike other PLC isozymes, PLC? lacks the pleckstrin homology (PH) 
domain. Despite this, PLC? is similar to PLC51 sharing 38% identity and 49%  
sequence homology in 647 of its residues (Miyazaki eta!., 2006). The expression 
of PLC? in mouse eggs following the microinjection of cRNA gives rise to a series 
of fertilisation like Ca2+ oscillations (Saunders et al., 2002). The amount of PLC? 
contained in a single sperm has been estimated to be around 20-50fg (Saunders 
et al., 2002). Tagging PLC? with Venus fluorescent protein, Myc epitope or 
luciferase has enabled the quantification of the amount of PLC? protein produced 
following the microinjection of cRNA. The expression of levels comparable to that 
contained in a single sperm was shown to be sufficient to cause Ca2+ oscillations 
equivalent to those seen at fertilisation (Nomikos et al., 2005; Saunders et al., 
2002; Yoda et al., 2004). Recombinant PLC? has also been found to generate 
Ca2+ oscillations when injected into mouse eggs, although a greater amount of 
protein is required (~300fg) (Kouchi et al., 2004). The mechanism of action of 
PLC? remains unknown. It is unclear how PLC? targets its membrane bound 
substrate, PIP2 or how the activity of this enzyme is regulated. PLC? appears to 
be in an active state upon entry into the oocyte, however it remains uncertain 
how this protein maintains itself within the sperm and whether its effects are 
specific to eggs. Recent studies suggest that PLC? expressed in cell lines can 
cause Ca2+ oscillations and alter phenotype (Coward et al., 2006; Kuroda et al., 
2006). The transient expression of PLC? tagged with eYFP was assessed in 
COS cells (derived from the kidney cell line of the African green monkey)(Coward
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et al., 2006). Images taken of COS cells displaying expression of PLC?-eYFP 
show the existence of two main patterns of fluorescence: either a grainy 
cytoplasmic distribution or a nuclear distribution. Kuroda et al. (2006) reported 
Ca2+ oscillations in somatic cells following the expression of PLC?. The results 
show that 24 hours after transfection, repetitive Ca2+ spikes at intervals of ~3 
minutes were observed in COS cells expressing venus tagged PLC?. No Ca2+ 
oscillations were observed in any of the cells expressing the inactive D210R 
mutant or in non-transfected COS cells. This study also reports the nuclear 
accumulation of PLC? in COS cells and its D210R mutant. In contrast to the 
observations of Coward et al.,(2006), the confocal images taken of cells 48 and 
72 hours after transfection suggest an increase in active import into the nucleolus 
over time, with no report of cells displaying any other patterns of distribution. It is 
suggested that the less marked nucleolar accumulation observed in cells 
expressing the D210R mutant could be due to its inability to induce Ca2+ 
oscillations. Broad ectopic expression of PLC? in transgenic mice appears to 
have no effect with the exception of ovarian abnormalities in females. This 
suggests that the activity of PLC? is restricted to oocytes when low level 
expression is forced ectopically in multiple tissues, however the expression levels 
were not quantified (Yoshida et al., 2007).
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1.4 Aims of this study
In this study, the expression of PLC? was examined in Chinese Hamster Ovary 
(CHO) cells in order to establish if it can trigger Ca2+ signals or compromise cell 
viability, and to determine if mammalian cell lines could otherwise be used for 
making recombinant PLC? protein. Chapter 3 describes the first specific aim of 
this thesis, which includes the optimisation of recombinant PLC? expression in 
CHO cells using different methods of nucleic acid delivery. This chapter also 
describes the cellular localisation of transiently expressed eYFP-PLC? and 
examines the effects of PLC?-LUC expression on intracellular Ca2+. Chapter 4 
describes a comprehensive analysis of the effects of PLC? expression on basal 
Ca2+ handling and receptor induced Ca2+ mobilisation. Chapter 5 describes the 
generation of a CHO cell line stably expressing PLC?, with the aim of obtaining 
relatively homogeneous cell populations where the vast majority of cells 
expressed the recombinant protein. This chapter also examines the activity of the 
PLC? produced by this cell line in eggs. Chapter 6 will summarise the overall 
results from chapters 3 to 5 and provide a general discussion of the findings in 
this thesis.
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CHAPTER 2 
MATERIALS AND METHODS
Chapter 2 Materials and Methods 
2.1 Materials
2.1.1 General laboratory reagents and chemicals
All chemicals and reagents were obtained from Sigma or Invitrogen unless 
otherwise stated. All reagents were dissolved in dH20  and stored at room 
temperature unless otherwise stated. All filter sterilisation was through 0.2pm 
filters (Satorius).
2.1.2 Bacterial cell culture reagents
All growth media and antibiotics were obtained from Sigma, sterile plastic and 
glassware were obtained from Fisher or Greiner. All glassware was washed in 
detergent free water and autoclaved (135°C, 90min) prior to use. Growth media 
were autoclaved under the same conditions prior to the addition of antibiotics. 
Aseptic technique was used in all protocols and surfaces were swabbed with 
70% (v/v) methanol before and after use.
Listed below are the reagents used for bacterial cell culture:
■ Luria Bertani (LB) medium: 1% (w/v) tryptone, 0.5% (w/v) yeast extract,
0.5% (w/v) NaCI. Autoclaved. Medium cooled to <50°C before antibiotic 
addition. Stored at 4°C.
■ LB-Agar medium: LB medium, 1.5% (w/v) agar. Autoclaved. Medium 
cooled to <50°C before antibiotic addition. Plates were freshly prepared 
before use.
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■ Ampicillin 100mg/ml stock: filter sterilised and stored at -20°C, used at a 
working concentration of 100pg/ml.
■ S.O.C. medium (Invitrogen) Stored at 4°C.
■ Bacterial cells: TOP10 chemically competent Escherichia coli (Invitrogen). 
Prepared by members of the WHRI laboratory using the CaCb treatment 
method (Hanahan, 1983). Stored in 100pl aliquots at -80*0 for up to 6 
months.
2.1.3 Molecular biology reagents
Listed below are the reagents used for molecular biology techniques:
■ Wizard® Plus SV Miniprep DNA Purification system (Promega) 
comprising:
o Cell Resuspension Solution
■ 50mM Tris-HCI, 10mM EDTA, 100pg/ml RNase A; pH 7.5 
o Cell Lysis Solution
■ 0.2M NaOH, 1% SDS (w/v) 
o Neutralisation Solution
■ 4.09M guanidine hydrochloride, 0.759M potassium acetate, 
2.12M glacial acetic acid; pH4.2
o Column Wash Solution
■ 60mM potassium acetate, 8.3M Tris-HCI, 40pM EDTA, 60% 
Ethanol; pH 7.5
■ Plasmid Maxi kit (Qiagen®) comprising:
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o Resuspension Buffer (Buffer P1)
■ 50mM Tris-CI, 10mM EDTA, 100|jg/ml Rnase A ; pH 8.0 
o Cell Lysis Buffer (Buffer P2)
■ 200mM NaOH, 1% SDS (w/v) 
o Neutralization Buffer (Buffer P3)
■ 3M potassium acetate; pH 5.5 
o Equilibration Buffer (Buffer QBT)
■ 750mM NaCI, 50mM MOPS pH 7.0, 15% isopropanol (v/v), 
0.15% Triton® X-100 (v/v)
o Column Wash Buffer (Buffer QC)
■ 1M NaCI, 50mM MOPS pH 7.0, 15% isopropanol (v/v) 
o Elution Buffer (Buffer QF)
■ 1.25M NaCI, 50mM Tris-CI pH 8.5, 15% isopropanol (v/v) 
Agarose powder (ultra pure, Eurogentec)
TAE Buffer, 1x: 40mM Tris, 20mM acetic acid, 1mM EDTA.
Ethidium bromide (EtBr), aqueous solution, 10mg/ml.
DNA loading buffer, 2 x stock: 50% (v/v) TAE Buffer 1x, 50% (v/v) 
glycerol, 0.25% (w/v) orange G.
DNA restriction enzymes: EcoRI and Ncol. Restriction enzymes and 
appropriate buffers were stored at -20°C.
Molecular weight DNA marker: Hyperladder I (10Kb), obtained from 
Invitrogen. Stored at -20°C.
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2.1.4 Plasmid vectors
2.1.4.1 pCR3 and pcDNA3.1
Vectors pCR3 and pcDNA3.1 (Invitrogen) contain a cytomegalovirus (CMV) 
promoter (Pcmv) that initiates transcription in mammalian cells. The vectors also 
contain the ampicillin resistance gene for selection in E.coli, and a T7 promoter 
upstream of the multiple cloning site for in vitro expression of recombinant 
proteins. These vectors were utilised in the production of the cDNA constructs 
used in this thesis (see methods section 2.2.1 for further details).
Figure 2.1 Mammalian expression vectors pCR3 and pcDNA3.1
PLC^-LUC was constructed in the mammalian expression vector pCR3 
(M.Nomikos). eYFP-PLC£ was constructed in the mammalian expression vector 
pcDNA3.1 (C.Saunders). See section 2.2.1 for further details. Expression was 
driven by a CMV promoter in all cDNA constructs. (Images from Invitrogen)
\
T7 Promoter Hind III Kpn I Sac r  BamH I Spe r  Xma III*
LGACCCAlAGCTTGGTAcfcGAGCTbdGATCCAbTAGTAAcbGC
'CTGGGTTCGAACCATGGCTCGAGCCTAGGTGATCATTGCCG
PC R  P ro d u ct
SP6 Promoter
Sites are not unique to 
the multiple cloning site
pcDNA3.1 (+/-)
5428/5427 bp
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2.1.5 Chinese Hamster Ovary (CHO) cell line culture reagents
The CHO cell line was derived from a biopsy of an ovary of an adult Chinese 
hamster by T.T.Puck in 1957 (Puck et al., 1958). They are adherent, and exhibit 
typical epithelial cell morphology. All growth media and reagents were supplied 
by Gibco/ Invitrogen and all chemicals were supplied by Sigma unless otherwise 
stated. Sterile culture flasks were supplied by Nunc (Fisher) or Greiner. Poly-D- 
lysine coated glass bottomed cell culture dishes were supplied by World 
precision instruments (WPI). Class I cell culture containment hoods were used 
for all procedures. Aseptic technique was used in all protocols and surfaces were 
swabbed with 70% ethanol before and after use.
Listed below are the reagents used for the culture of CHO cells:
■ F-12 Nutrient Mixture (Ham) supplemented with filter sterilised 10% (v/v) 
foetal bovine serum (FBS) and 100pg/ml penicillin/streptomycin 
(supplemented media referred to as complete F-12). Stored at 4°C and 
warmed to 37°C prior to use.
■ Trypsin-EDTA, 1x in hepes buffered salt solution (HBSS). Stored at -20°C.
■ Saline solution, NaCI 0.9% (w/v) supplied by Baxter Medical Supplies.
■ Cryopreservation medium: FBS containing 10% (v/v) dimethyl sulphoxide 
(DMSO), filter sterilized. Freshly prepared.
■ Phosphate buffered saline (PBS): 137mM NaCI, 2.7mM KCI, 4.3mM 
Na2 HP0 4 , 1.4mM KH2 P0 4 , pH adjusted to 7.4 using HCL. Filter sterilised.
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■ Trypan Blue™ reagent (Sigma-Aldrich), 0.4%. Used as an addition of 
100pl to a 0.5ml, 1 x 105 cell suspension in PBS pH 7.4.
2.1.6 DNA Transfection materials and reagents
Listed below are the materials and reagents used for the transfection of CHO 
cells and their subsequent analysis:
■ Lipofectamine™ 2000 Tranfection reagent. Used as per manufacturers 
instructions. Stored at 4°C (Invitrogen)
■ Hepes buffered saline (HBS) 2x: 280mM NaCI, 10mM KCI, 1.5mM 
Na2 HP0 4 , 10mM glucose, 50mM Hepes, pH adjusted to 7.5 filter sterilised 
and stored at -20°C.
■ Calcium Chloride, 2M stock. Filter sterilised and stored at -20°C.
■ Pesda microbubbles: Perfluorobutane gas (F2 Chemicals Ltd), 5% 
Glucose, 10% (w/v) BSA.
■ FITC-dextran (10KDa), 10mg/ml stock stored at -20°C. For cell 
sonoporation this was dilued in KRH buffer to obtain a final concentration 
of100pg/ml.
■ Propidium Iodide, 1 mg/ml stock stored at -20°C. Used at a working 
concentration of 20pg/ml.
■ Femtotip® microinjection capillaries (Eppendorf)
■ KCI Hepes Buffer: 100mM KCI, 20mM Hepes, pH adjusted to 7.2. Divalent 
metal ions were removed with the chelating resin Chelex 100 (Sigma). 
Filter sterilised and stored at 4°C.
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■ Cell extract buffer: KCI Hepes Buffer, 1mM EDTA, 200|jM PMSF. Freshly 
prepared.
■ Alexa Fluor® 594 10,000 MW Dextran conjugate was obtained from 
Invitrogen and dissolved in dH20  to obtain a stock concentration of
5mg/ml, which was stored at -20°C. For use, this was then diluted 1 in 2 in
KCL Hepes to obtain a working concentration of 2.5mg/ml
■ Leibovitz’s L-15 medium supplemented with 5% FBS and 100pg/ml
penicillin/streptomycin (all filter sterilised). Stored at 4°C and warmed to
37°C prior to use.
■ Luciferase assay buffer: 50mM Tris HCI, 5mM MgCI2, 1mM EDTA, 1mM 
ATP, 0.5mM DTT, 1 mg/ml BSA. Freshly prepared.
■ Digitonin, 10mM stock.
■ Luciferin, 2mM stock, stored at -20°C.
■ Flow cytometry Buffer: 1x PBS, 1mM EDTA, 5% (v/v) FBS. Filter 
sterilised, freshly prepared.
2.1.7 Calcium (Ca2+) imaging reagents
Listed below are the reagents used during Ca2+ imaging experiments:
■ Krebs-Ringer-Hepes (KRH) buffer: 120mM NaCI, 25mM Hepes, 4.8mM 
KCI, 1.2mM KH2 P0 4 , 1.2mM M gS04, 1.3mM CaCI2, pH adjusted to 7.4. 
Filter sterilised and stored at 4°C.
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■ Ca2+ free KRH buffer: 120mM NaCI, 25mM Hepes, 4.8mM KCI, 1.2mM
KH2 P0 4 , 1.2mM MgSO^ 1 mM EGTA, pH adjusted to 7.4. Filter sterilised
and stored at 4°C.
■ Calcium dyes:
o Oregon Green Bapta dextran (OGBD), 2mM stock. (Molecular
Probes, Invitrogen). Stored at -20°C. For experiments this was
injected at a pipette concentration of 0.5mM. 
o Fluo-3 and Fura Red™ acetoxymethyl (AM) esters were obtained 
from Molecular Probes (Invitrogen) and dissolved in a solution of 
20% pluronic acid in DMSO to obtain a stock concentration of 1mM, 
which could be stored at -20°C but were usually freshly prepared. 
For use in CHO cell experiments, this was then diluted in serum 
free F-12 medium to obtain a working concentration of 10pM. For 
egg experiments Fura Red AM was used at a working 
concentration of 4pM. 
o Fura PE3 acetoxymethyl (AM) ester was obtained from Sigma. For 
egg experiments this was used at a working concentration of 4pM.
■ Adenosine trisphosphate (ATP), 10mM stock solution freshly prepared 
and placed on ice. For use, this was then diluted in KRH to obtain a final 
concentration of 100pM.
■ lonomycin, 100pM stock, stored at -20°C. For use, this was then diluted in 
KRH to obtain a final concentration of 5pM.
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2.1.8 Statistical analysis
Numerical data was stored in spreadsheets and plotted in graphical form using 
Excel (Microsoft) and GraphPad Prism. Data was expressed as mean ± standard 
error of the mean (SEM), where SEM is defined as standard deviation / V (n-1) 
(n= number of observations). Unless stated all data in this thesis was derived 
from a minimum of three separate observations. Data sets of equal variance 
were analysed using One Way Analysis of Variance (ANOVA). In addition to the 
Bonferroni multiple comparisons post hoc test where applicable. Comparisons of 
two independent samples were analysed using an unpaired student’s f-test. Data 
were considered statistically significant if p<0.05 (p value is the probability that 
any particular outcome would have arisen by chance).
2.1.9 Health and safety
All reagents were handled and stored as recommended by manufacturer’s safety 
guidelines. All experiments were performed in accordance with COSHH 
regulations and local college regulations. All genetic manipulation was carried out 
in accordance with GMAG guidelines. All bacteria and mammalian cell culture 
waste was disinfected prior to disposal.
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2.2 Methods
2.2.1 DNA Constructs
All DNA constructs shown in this thesis were kindly provided by Michail Nomikos 
(Luciferase tagged) or Christopher Saunders (enhanced yellow fluorescent 
protein (eYFP) tagged). The ezymatically inactive eYFP-D210RPLC£ construct was 
derived from eYFP-PLC? in collaboration with Andreas Rossbach. Diagramatic 
structural details of the DNA constructs are shown below (Figure 2.2). In addition 
to the PLC<J constructs, pCR3-LUC and pcDNA3.1-eYFP were used as controls 
in this thesis. Restriction digests with ECORI (Luciferase tagged constructs) or 
Ncol (eYFP tagged constructs) were performed to ensure successful ligation, 
and to confirm the presence and correct orientation of the insert (See Chapter 3).
A)
LUC
pCR3
B)
eYFP
LUC
pCR3
Figure 2.2:
Luciferase and eYFP tagged 
DNA constructs
Schematic diagrams showing the 
structural details of (A) the 
pCR3-LUC and PLC^-LUC 
constructs (Courtesy of 
M.Nomikos), and (B) the 
pcDNA3.1-eYFP and eYFP- 
PLC£ constructs (Courtesy of 
C.Saunders)
eYFP
2.2.2. In vitro site-directed mutagenesis
The eYFP tagged D210RPLC? construct was created in collaboration with Andreas 
Rossbach using the eYFP-PLC£ construct (Christopher Saunders) and the 
method of in vitro site-directed mutagenesis (SDM). Mutagenesis of the aspartate 
residue at position 210 to arginine to produce D210RPLC? was performed using the 
Stratagene Quikchange XL SDM kit. This technique utilises a dsDNA vector with 
an insert of interest and two synthetic oligonucleotide primers, both containing 
the desired mutation. The primers (complementary to opposite strands of the 
construct) are extended during temperature cycling by DNA polymerase, 
generating a mutated plasmid. Dpn I endonuclease treatment digests the 
parental DNA, whilst the mutation-containing synthesised DNA remains intact. 
The thermocycling reaction, digest of parental DNA and transformation were set 
up according to the manufacturer’s instructions.
2.2.3 Plasmid DNA propagation
2.2.3.1 Bacterial Transformation
Bacterial transformation and subsequent isolation of plasmid DNA enables the 
production of large quantities of highly pure DNA suitable for eukaryotic cell 
transfection. Bacteria are an appropriate host as they replicate exogenous 
plasmid DNA with high fidelity independent of the bacterial genome, enabling it to 
be easily isolated.
Chemically competent bacterial cells (50pl) were inoculated with 100ng of 
plasmid DNA and incubated on ice for 15 minutes. The cells were subjected to a
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heat shock at 42°C for 30 seconds in a water bath before being transferred 
immediately to ice for 2 minutes. The cells were placed into a 15ml snap cap 
tube containing SOC media (500pl) which was then incubated for 1 hour at 37°C 
with gentle rotary agitation at 225rpm. Two unequal volumes of the cell 
suspension were plated onto LB-Agar plates containing ampicillin (this ensures 
different densities of colony growth, avoiding lawn growth ensuring successful 
isolation of individual colonies). Plates were incubated overnight at 37°C until 
colonies were visible.
2.2.3.2 Small scale plasmid isolation (plasmid DNA miniprep)
Typically between 5-10 colonies were selected and screened for the presence of 
the plasmid using the following method; The 3mls of LB media supplemented 
with 100mg/ml Ampicillin were inoculated with a single colony and incubated 
overnight at 37°C with gentle rotary agitation at 225rpm. Subsequently 1ml of 
each culture was pelleted (14,000xg for 1 minute) and DNA isolation was 
performed by the alkaline lysis method employed by the Wizard SV Miniprep 
plasmid purification kit (Promega). The remaining culture was reserved for large 
scale plasmid isolation (section 2.2.3.4). Briefly, bacterial pellets were 
resuspended in 250pl of Resuspension solution (containing RNase A), prior to 
being lysed during a 3 minute incubation with 250pl Lysis solution. A high salt 
environment was created by the addition of 350pl Neutralisation solution, which 
results in the precipitation of all cell debris via the precipitation of potassium 
dodecyl sulphate (KDS) (co-precipitated in insoluble salt-detergent complexes).
58
The precipitate was subsequently removed by centrifugation at 14,000xg for 
10min, and the cleared lysate was applied to a mini spin column containing a 
silica-gel DNA binding membrane. The column was centrifuged at 14,000xg for 
2min, then was washed twice with an 80% ethanol buffer. DNA was eluted from 
the column in 30pl 10mM Tris pH 8.5. Recombinant plasmids were then analysed 
as in section 2.2.3.3 before being prepared on a larger scale (section 2.2.3.4).
2.2.3.3 Analysis of recombinant plasmids
Recombinant plasmids were verified by restriction enzyme mapping. Isolated 
DNA was digested using the EcoRI (luciferase tagged constructs) or Ncol (eYFP 
tagged constructs) restriction enzyme for 2 hours at 37°C, and the resulting 
fragments were analysed via agarose gel electrophoresis. An agarose gel was 
prepared by dissolving 1% agarose (Eurogentec) in TAE (1x) buffer and heating 
in a microwave oven. The solution was cooled to <50°C before the addition of 
ethidium bromide (0.2pg/ml final concentration), and poured into a pre­
assembled gel tray (Bio-Rad). Once the gel was set, DNA samples in 30% (v/v) 
DNA loading buffer (1x) were loaded onto the gel alongside a DNA molecular 
weight marker (10Kb, Invitrogen). Electrophoresis was performed in a gel tank 
containing TAE (1x) with a constant voltage (typically 10v per cm of gel). The gel 
was visualized with UV transillumination and imaged using a gel documentation 
system (Bio-Rad) with Hamamatsu camera and Quantity One software. Typically 
95-100% of colonies showed the correct pattern of DNA restriction fragment.
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2.2.3.4 Large scale plasmid isolation (plasmid DNA maxi prep)
Large scale plasmid isolation (plasmid DNA maxi prep) was performed following 
observation of the correct restriction fragments. LB media (200ml, supplemented 
with 100mg/ml Ampicillin) was inoculated with 1ml of the mini prep transformant 
culture (see above) and grown overnight at 37°C with rotary agitation at 225rpm. 
Cultures were centrifuged (10,000xg, 10 minutes, 4°C, JLA16:250 fixed angle 
rotor, Avanti J-25, Beckman) and large scale plasmid isolation was carried out 
using the Qiagen Maxi Prep Kit which uses an ion-exchange resin method. 
Bacterial pellets were resuspended in 10ml of Buffer P1 (resuspension buffer, 
containing Rnase A), prior to the addition of 10ml of Buffer P2 (lysis buffer). 
Following a 5 minute incubation at room temperature, 10ml of Buffer P3 
(neutralisation buffer) was added, and the samples were placed on ice for 30 
minutes. The resulting precipitate was removed by centrifugation (20,000xg, 30 
minutes, 4°C, JA25:50 fixed angle rotor, Avanti J-25, Beckman), and the 
supernatant was applied to a Qiagen-tip 500 silica gel column, which had been 
equilibrated using Buffer QBT (equilibration buffer). The plasmid DNA was 
washed twice with 30ml of Buffer QC (column wash buffer), then eluted with 15ml 
of Buffer QF (elution buffer). Plasmid DNA was precipitated using isopropanol 
(0.7 volumes), and harvested via centrifugation (20,000xg, 30min, 4°C). The 
DNA pellet was washed with 5ml of 70% ethanol and further centrifuged 
(20,000xg, 10min, 4°C). The plasmid DNA was dissolved in 700pl 10mM Tris pH 
8.0. Plasmid DNA purity and concentration (pg/ml) was determined by UV 
spectrophotometry (Perkin-elmer MBA2000). Samples were diluted 1:50 and
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measured in duplicate at an absorbance of 260nm (A260). The DNA concentration 
was calculated using the following equation: A260 value of 1 = 50pg/ml of double 
stranded DNA. Plasmid purity was determined by measuring the ratio of 
A26o/A28o, with values £ 1.9 indicating high levels of purity. Plasmid DNA was then 
further analysed by restriction digest mapping and agarose gel elecrophoresis as 
described previously, before being stored at -20°C.
2.2.4 Chinese Hamster Ovary (CHO) cells
CHO cells were maintained in complete F-12 (cF-12) media (see section 2.1.5) in 
a humidified atmosphere of 5% CO 2 at 37°C. The culture media was changed 
every 2 days and cells were routinely passaged upon confluency (typically every 
3-4 days) using the following method. Adherent cells were washed with saline 
and detached from the culture flasks using trypsin-EDTA for 3 minutes at 37°C. 
cF-12 (5mls) was added to the cell suspension prior to the cells being pelleted by 
centrifugation (1,200xg for 3 minutes), and re-suspended in fresh cF-12 (6mls). 
Subsequently 20pl of this cell suspension was removed for haemocytometric 
analysis (Neubauer haemocytometer), a method used to determine the correct 
volume of cells required to obtain the optimum seeding density (Typically 2.5 -  5 
x105 cells per 75cm2 culture flask). In order to maintain cell stocks, cells (~5 x 
106) were detached and pelleted as described above, and re-suspended in 1ml 
of cryopreservation medium (see section 2.1.5). Cell suspensions were placed in 
sealed screw top cryo-vials (NUNC), and gradually cooled to -80°C using 
insulating tissue paper, before being placed in liquid nitrogen for long term
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storage. When required, cells were thawed rapidly by hand and gradually 
introduced to increasing volumes of pre-warmed cF-12 (to a maximum of 5ml) 
prior to centrifugation (1,200xg for 3min). Cells were re-suspended in cF-12, 
seeded into a 25cm2 culture flask, and culture media was changed after 4 hours.
2.2.5 DNA Transfection
2.2.5.1 Calcium Phosphate mediated transfection
CHO cells were seeded in 6 well plates or in Poly Lysine coated glass bottomed 
culture dishes (WPI) 24 hours prior to transfection, and at ~70-80% confluency 
were transfected with high purity (A260/A280 > 1 -9) plasmid DNA using the calcium 
phosphate precipitation method (Chen et al., 1987). Briefly, a mixture of plasmid 
DNA (2-8pg), 18.5pl of 2M CaCI2 and sterile dH20 (total volume of 150pl) was 
added dropwise (over a period of 30 seconds) to 150pl of pre-warmed 2x HBS 
with continuous mixing. Transfection complexes (125mM CaCh, 300pl final 
volume) were incubated at room temperature for no longer than 30 minutes. The 
mixture was vortexed briefly and added dropwise to the cells in cF-12 (3ml), 
before being mixed gently and incubated in a humidified atmosphere of 5% C 0 2 
at 37°C for 16-18 hours. Cells were washed twice with 0.9% w/v saline solution in 
order to remove precipitates, before incubation (humidified, 5% C02,37°C) in cF- 
12 for a further 6 hours.
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2.2.5.2 Lipid mediated transfection (Lipofectamine2000y Invitrogen)
CHO cells were seeded in 6 well plates or in Poly Lysine coated glass bottomed 
culture dishes (WPI) 24 hours prior to transfection, and at -80-90%  confluency 
were transfected with high purity (A260/A280 > 1.9) plasmid DNA using cationic 
lipid mediated transfection (Lipofectamine2000, Invitrogen). This method was 
carried out according to manufacturer’s instructions. Briefly, plasmid DNA (2-8pg) 
was diluted with F-12 medium (without FBS or antibiotics) to a total volume of 
250pl. Lipofectamine2000 reagent (10pl) was also diluted with F-12 medium 
(240pi) and both mixtures were incubated at room temperature for 5 minutes. 
Lipid and DNA complexes were then combined (drop wise over a period of 30 
seconds), prior to further incubation at room temperature for no longer than 20 
minutes. During this time, cells were washed twice with 0.9% w/v saline solution 
before addition of the tranfection complexes in 2mls of F-12 medium, followed by 
incubation (humidified, 5% C 02,37°C) for 6 hours. Transfection complexes were 
removed, and the cells were incubated in complete F-12 for a further 16-18hours 
prior to testing for transgene expression.
2.2.5.3 Sonoporation
Sonoporation of cells using ultrasound (US) has recently gained interest for its 
potential as an alternative means of non-viral gene delivery (Bao et al., 1997; 
Kim et al., 1996; Taniyama et al., 2002). Initial studies utilised devices operating 
at kilohertz (kHz) frequencies (Fechheimer et al., 1987), however due to 
excessive cell damage, applications using megahertz (MHz) frequencies now
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appear to be more prevalent (Huber et al., 2000; Liang et al., 2004). The 
application of US to a liquid causes the formation and implosion of vapour filled 
microbubbles, or cavities, in the solution. The energy release associated with this 
is believed to be sufficient to permeabilise adjacent cell membranes and lead to 
DNA delivery (Deng et al., 2004; Unger et al., 2001). This process is referred to 
as cavitation. Microbubble contrast agents (CA) are believed to lower the energy 
threshold for cavitation (Unger et al., 2001), and have been shown to enhance 
gene delivery for applications using higher frequency US (1-3MHz) both in vitro 
and in vivo (Bao et al., 1997; Lawrie et al., 2000; Taniyama et al., 2002). The 
ability of ultrasonic standing waves (USW) to suspend small particles and cells at 
MHz frequencies has been widely studied in recent years (Coakley, 1997; Lee et 
al., 2005). Cells and particles in suspension exposed to an USW experience a 
force driving them towards the pressure node plane (Khanna et al., 2003) as 
indicated schematically in the figure below. It has been noted that increasing the 
proximity between cavitating CA’s and cells increases the probability of cell 
sonoporation (Ward et al., 2000). Standing wave systems offer an advantage 
over travelling wave fields by encouraging this bubble cell interaction.
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A)
Half wavelength standing wave
B )
Quarter wavelength standing wave
Glass reflector
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node plane .
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Piezoelectric Transducer
Figure 2.3: Particle movement towards the nodal plane of an USW
Current applications of this technology have focused on using devices that 
concentrate particles or suspensions of cells near the centre of the fluid cavity 
(Figure 2.3A). However, using a different combination of layer geometries, it is 
possible to focus particles up against the glass reflector (Figure 2.3B) (Harris et 
al., 2004). This %A mechanism has been utilised in the design of the novel USW 
minichamber used in this thesis (see figure 2.4). This presented us with the 
ability to expose adherent cells to cavitating CA’s held in close proximity by an 
USW, thus enabling real time monitoring of the biological response to US 
exposure. The method of using USW fields has been examined in our laboratory 
for macromolecular uptake (Khanna et al., 2006) and DNA transfection 
(unpublished observations) of cells in suspension. During this thesis an attempt 
was made to optimize sonoporation in a 1/4 wavelength USW as a means of 
permeabilising and transfecting adherent cells, and to compare this with existing
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transfection methodologies. CHO cells were seeded on circular glass cover slips 
(manufacturer) 24 hours prior to ultrasound exposure (~70% confluency upon 
exposure). Growth media was replaced with KRH buffer plus 4mg/ml BSA, 
containing FITC-dextran 10KDa (100pg/ml) and 2-10% PESDA microbubbles. 
Cells were exposed to a 1.72MHz ultrasonic standing wave at 40-80V for various 
pulse lengths (2sec-1min). Cells were subsequently washed three times with 
KRH buffer, and incubated with propidium iodide (PI; 20pg/ml) for 5 minutes. 
Optimum parameters for FITC-dextran uptake were used for plasmid DNA 
transfection experiments. Cells were exposed to USW at 40V in KRH buffer 
containing 100ng-10pg of plasmid DNA and 5% PESDA microbubbles. 
Fluorescence images were captured on a Nikon Diaphot 200 microscope 
equipped with a cooled CCD camera.
Figure 2.4 Design of the USW Quarter wavelength minichamber
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2.2.5.3.1 Perfluorocarbon-exposed sonicated dextrose albumin (PESDA) 
microbubbles
Perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles 
were prepared by methods similar to those previously described (Porter et al., 
1995). Briefly, 5ml of perfluorobutane gas was hand agitated with a 3:1 mixture of 
5% glucose and 10% BSA. This mixture then underwent sonication (Jencons Ltd) 
at 20kHz for 80 seconds, prior to a 30 minute incubation on ice.
2.2.5.4 Microinjection
Microinjection involves injecting DNA directly into cells, or even the cell nucleus 
using a very fine needle. CHO cells were seeded in Poly Lysine coated glass 
bottomed culture dishes (WPI) 24 hours prior to transfection, and at -50-60 / 70- 
80% confluency were transfected with high purity (A260/A280 > 1.9) plasmid DNA 
as follows. Plasmid DNA (100ng) was mixed with filter sterilised KCL Hepes 
buffer (section 2.1.6) and 2.5mg/ml Alexa 594-dextran (10,000 Mw), to a final 
volume of 12pl, prior to centrifugation at 14,000xg for 1 hour at 4°C. Alexa 594 
was omitted from the injection solution for experiments involving the use of Fura 
Red. Microinjection was performed semi-automatically with a Femtojet 
(Eppendorf, Germany) attached to an InjectMan NI2 (Eppendorf) mounted on an 
Axiovert 200 inverted fluorescence microscope (Carl Zeiss). Femtotips 
(Eppendorf) with an inner diameter of 0.5pm and an outer diameter of 1.0pm 
were used for all injections. Injection capillaries were backfilled with 3pl of the 
injection solution using sterile microloaders (Ependorf). The injection angle was 
set at 45°, and each tip was used for the injection of 50-70 cells. The injection
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time remained constant at 0.1s (lowest possible setting), and a constant 
compensation pressure of 80hPa was applied to the capillary. Cells were 
transferred to complete L-15 medium (section 2.1.5), and typically 50-100 cells 
were injected per culture dish over a period of 30-45 minutes with an injection 
pressure of 90hPa at 37°C. The medium was exchanged immediately for pre- 
warmed complete F-12, and cells were transferred to an incubator (humidified, 
5% C02,37°C) prior to imaging transgene expression 3-48 hours later.
2.2.6 Measurement of luciferase expression and intracellular Ca2+ in CHO 
cells
For experiments involving luciferase tagged constructs, CHO cells were 
microinjected as described in section 2.2.5.4 with 100ng of plasmid DNA mixed 
with 0.5mM Oregon Green BABTA dextran (Molecular Probes) in KCL Hepes 
buffer. Cells were transferred to an incubator (humidified, 5% C02,37°C) for 3-48 
hours in complete F-12 medium before being incubated with 100pM luciferin. 
Cells were imaged on a Zeiss Axiovert 100 microscope equipped with a cooled 
intensified charge-coupled device (ICCD) camera (Photek Ltd, UK), encased 
within a purpose built dark box. An ICCD is a charge-coupled device (CCD) that 
is optically connected to an image intensifier that is mounted in front of the CCD. 
The ICCD camera is depicted in Figure 2.5. Image intensifies are comprised of 
three functional elements mounted in close proximity to one another in the 
following sequence: a photocathode, a microchannel plate (MCP) and a 
phosphor screen. Photons generated by the bioluminescent sample fall onto the 
photocathode and are converted to photoelectrons. The photoelectrons are
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accelerated towards the MCP which amplifies the signal by generating a cascade 
of secondary electrons. The multiplied electrons are accelerated towards the 
phosphor screen which finally converts them back to photons which are guided to 
the CCD by a fibre optic taper. Cells were monitored for luminescence by 
integrating light emission for 20 minutes before Ca2+ was monitored in the same 
cells for 1 hour with low level excitation light from a halogen lamp.
High voltage
CCD Camera
Optional GM10-50  
Gate Unit
Figure 2.5 Intensified charge-coupled device (ICCD) camera (Photek)
A) Schematic representation of the ICCD camera from Photek Ltd. Light is collected onto the front 
of the camera before being intensified and imaged as described above (section 2.2.6).
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2.2.7 Measurment of luminescence using a luminometer
Luminometers detect and measure light using an extremely sensitive 
photomultiplier tube (PMT). PMTs are comprised of a vacuum-tube containing a 
photocathode which converts the light to photoelectrons (made of a compound 
semiconductor, mostly consisting of alkali metals); one or more secondary- 
electron-emitting electrodes or dynodes which amplify the number of 
photoelectrons; and an anode which collects the secondary electrons and 
provides the electrical output signal. Due to the very large amplification provided 
by the secondary emission mechanism, PMTs are capable of multiplying the 
current produced by incident light by as much as 107 times. Experiments in this 
thesis were performed using a custom built luminometer equipped with an S20 
PMT cooled to -20°C using a peltier cooler (Figure 2.6). The S20 PMT contains a 
multialkali (Na-K-Sb-Cs) photocathode that has a high, wide spectral response in 
the ultraviolet and near infra red ranges of the elecromagnetic spectrum. 
Samples were placed into a 5ml tube and positioned in front of the PMT. The 
injection port located directly above the sample enables the addition small 
volumes of reagents to the sample using a pressure controlled 50pl Syringe 
(Hamilton Ltd, Carnforth, U.K.). The output signal is connected to a current to 
voltage converter and photon counter, and is received by a computer in the form 
of photons per second. CHO cells (-1 .5  x 106) transfected with luciferase tagged 
constructs were trypsinised and washed twice with 1x PBS, before being 
resuspended in luciferase assay buffer (section 2.1.6). Cells were lysed by the 
addition of 40pM digitonin and placed in the luminometer. Background light
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emmision was recorded for each sample before the addition of 100pM luciferin. 
Luciferase activity was measured for 10 minutes, and expressed as counts per 
second.
Syringe
Shutter
Cooled Housing 
(-20°C)Photocathode
HV supply 
(0.789kV)
PMT
Anode
Silver mirror Glass insulated window
Counter Timer
Computer
Amplifier and 
Discriminator
Figure 2.6 Luminometer
Schematic diagram of a custom built luminometer. The light emitted from the sample following the 
addition of lysis buffer is collected and amplified as described above (section 2.2.7).
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2.2.8 Confocal laser scanning microscopy (CLSM)
Confocal laser scanning microscopy (CLSM) offers several advantages over 
conventional fluorescence microscopy, including controllable depth of field and 
elimination of image degrading out of focus fluorescent light. The acquisition of 
time resolved confocal image series (known as time series) provides the 
possibility of visualizing and quantifying dynamic changes within living 
specimens, even in the range of microseconds. The Leica TCS SP5 (True 
confocal scanner equipped with 5 spectrophotometer channels) equipped with 
the Leica DMI 6000 inverted microscope (Figure 2.7) was used for experiments 
involving eYFP-tagged constructs, including live cell experiments and 
experiments using paraformaldehyde fixed cells. Cells were visualised using an 
oil immersion, 63x objective lens (numerical aperture = 1.23) and images were 
acquired at 512 x 512 pixel resolution. eYFP fluorescence (excitation and 
emission peaks at 514nm and 527nm respectively) was visualised using the 
488nm laser line from an argon laser (set at 20% source power), with the PMT 
set to detect emission at 510-540nm. Alexa-594 fluorescence (excitation and 
emission peaks at 594nm and 617nm respectively) was visualised using the 
561 nm He:Ne laser line at 20% power, with the PMT set to detect emission at 
600-630nm. Fluo 3 fluorescence (excitation and emission peaks at 506nm and 
526nm respectively) was visualised using the 488nm laser line from an argon 
laser (set at 20% source power), with the PMT set to detect emission at 510- 
540nm. Fura Red fluorescence (excitation and emission peaks at 488nm and 
597nm respectively) was visualised using the 488nm laser line from an argon
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laser (set at 20% source power), with the PMT set to detect emission at 580- 
610nm.
0 Visible range lasers I up to SI ©  Multi Function Port IMFP) © XI-emission port
0 ID laser ©  Tandem Scanner © Spectrophotometer prism
0 UV laser ©  Calibration target © PMT channel 1
© Visible range AOTF ©  Field rotation optics © PMT channel 2
IflEOM ©  Objective lens © PMT channel 3
© UVAOTF ©  Transmitted fight dedector © PMT channel 4 (optional FlIMi
© UV optics imaging ©  Reflected light NOD © PMT channel 5 (optional FUM'i
© A08S ©  Confocal detection pinhole
Acousto Optical Beam Splitter ©  Filter- and polarizer wheel
Figure 2.7 The Leica SP5 Confocal laser scanning microscope
The Leica SP5 uses an acousto-optical tunable filter (AOTF) to control the excitation laser light 
and an acousto-optical beam splitter (AOBS) instead of filter blocks to convey the excitation laser 
light to the sample and to reflect the emitted light from the sample to the scan head. The emitted 
light is passed through a pinhole that prevents the out of focus light from dectected by the 
photomultiplier tube (PMT). The PMT converts light into an electrical signal that is recorded by the 
computer equipped with Leica confocal software. Image taken from 
www. zmb. uzh.ch/resources/download/CLSM.pdf
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2.2.8.1 Intracellular Ca2+ imaging
For experiments involving eYFP tagged constructs, CHO cells were seeded in 
poly lysine coated glass bottomed culture dishes (WPI) 24 hours prior to 
transfection, and at -50 -60  / 70-80% confluency were transfected with high purity 
(A260/A280 > 1.9) plasmid DNA as described in section 2.2.5.4. Cells were 
visualized for intracellular Ca2+ between 3 to 48 hours after transfection using 
CLSM. Prior to imaging, cells were loaded with the Ca2+ indicator dye Fluo-3 AM 
/ Fura Red AM (10pM in 20% w/v pluronic acid) in un-supplemented F-12 
medium. The dye containing solution was added to each culture dish as a 200pl 
meniscus and incubated at 37°C and 5% CO2 for 90 minutes. Cells were then 
immersed in F-12 medium prior to imaging, for which they were washed and 
transferred to Krebs-Ringer-Hepes buffer. The Ca2+ dependent fluorescence of 
Fluo-3 / Fura Red was visualized using CLSM as described is section 2.2.8. 
Experiments were structured to analyze either the signal variability in the Ca2+ 
dependent Fluo-3 / Fura Red traces in the absence of any chemically induced 
response or to incorporate the addition of a known pharmacological modulator of 
intracellular Ca2+ (Chapter 4). For signal variability (SV) analysis data was 
acquired every 100ms for 30 second duration (300 frames/experiment) at 512 x 
512 pixel resolution. For the analysis of intracellular Ca2+ handling, cells were 
imaged for 100 frames before the addition of ATP (100pM) and for a further 500 
frames (1 minute in total). Cells in separate culture dishes were used per 
application of ATP to negate the effect of sequential ATP application in the same 
population of cells. Following an experimental series, 15-20 cells were selected
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per area (typically 4-6 areas per dish) and data acquired from regions of interest 
(ROIs) of ~40pm2 (>150 pixels). These were collected and analyzed using Leica 
software. Further analysis was carried out using Microsoft Excel, The Single 
Transient Analysis (STA) program (designed by Steven Barberini using MATLAB 
software), and GraphPad Prism. Chapter 4 describes the precise derivation of 
mathematical operations used to calculate signal variability in this thesis.
2.2.8.2 Preparation and Fluorescence analysis of fixed cells
Cells expressing eYFP-tagged constructs /  cells loaded with fluo 3 were fixed 
with freshly prepared paraformaldehyde (4% (w/v) in PBS) to preserve their 
fluorescence in order to examine the relationship between voltage and intensity/ 
signal variability during CLSM. Cells were washed twice with PBS (pH 7.4) and 
fixed using paraformaldehyde (4% (v/v)). Fixed cells were rehydrated with PBS 
(pH 7.4) for 2 hours, and rinsed briefly with in dH20 prior to being mounted in 
FluoSave™ (Calbiochem). Fixed cells were dried at room temperature for 30 
minutes and stored at 4°C. Fluorescence analysis of fixed cells was performed 
using confocal microscopy within 7 days.
2.2.9 Flow Cytometry and Fluorescence activated cell sorting (FACS)
Flow cytometry is a powerful technique that allows simultaneous multi parametric 
analysis of the physical and/or chemical characteristics of single particles, usually 
cells, as they flow in a fluid stream through an optical-to-electronic detection 
apparatus. The properties measured include a particle’s relative size, relative
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granularity or inner complexity (i.e. shape of the nucleus, the amount and type of 
the cytoplasmic granules or the membrane roughness), and relative fluorescence 
intensity. A beam of light (usually laser light of a single wavelength) is directed 
onto a hydro-dynamically-focused stream of fluid, and any suspended particle or 
cell from 0.2 - 150pm in size passing through the laser intercept scatters the light 
in some way. Any fluorescent molecules found within the cells or attached to the 
cells surface will be excited into emitting light at a longer wavelength than the 
light source. A number of detectors are aimed at the point where the laser 
intercepts the stream of fluid (see figure 2.8): one in line with the beam of light 
(Forward scatter or FSC) and several perpendicular to it (Side scatter or SSC) 
and one or more fluorescence detectors. FSC correlates with cell size and the 
extent of SSC depends on the cells granularity. The electronics system converts 
the detected light signals into electronic signals that can be processed by a 
computer. The data generated by flow cytometry can be plotted in a single 
dimension, to produce a histogram, in two-dimensional dot plots or even in three 
dimensions. Following lipid mediated transfection, CHO cells underwent selection 
for the eYFP-PLC? and CONT-eYFP plasmids using G418 (500pg/ml). A sample 
of cells was removed from the culture at 5 hours, and then daily for a period of 
two weeks. Cells were collected by trypsinisation, adjusted to a density of 1 x 106 
cells/ml in Flow buffer (section 2.1.6) and analysed for YFP expression on a BD 
FACSCalibur (San Diego, CA, USA), using 488nm Argon laser excitation and 
530nm emission band pass filter.
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Figure 2.8 Flow Cytometry Optics
Simplified Layout of the optical system of a typical two colour flow cytometer (as viewed from 
above). Cells are depicted passing through the line of the 488nm argon laser. Fluorescence 
emitted by a cell at 90° to the excitation line is captured by three separate detectors after 
negotiating a series of barriers and filters. Band pass (BP) filters are desinged to restrict 
transmission of wavelengths either above (long pass or LP) or below (short pass or SP) their 
designated limits. The 585/42 BP allows the passage of wavelenghts 21 nm either side of 585nm.
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Flow Cytometry data was analysed using Flow Jo flow cytometry analysis 
software.
Fluorescence activated cell sorting (FACS) is a specialised form of flow 
cytometry that allows heterogeneous mixtures of cells to be sorted into two or 
more containers, one cell at a time, based upon the specific light scattering and 
fluorescent characteristics of each cell (Figure 2.9). CHO cells that had 
previously undergone lipid mediated transfection and subsequent selection for 
the eYFP-PLC£ plasmid were cultured for 4 weeks before being subjected to 
FACS. Cells were collected by trypsinisation and adjusted to a density of 1 x 106 
cells/ml in flow buffer (section 2.1.6). Cell sorting was performed by the Central 
Biotechnology Services (CBS) facility at Cardiff University using a Beckman 
Coulter MoFlo high speed FACS machine (Dako-formerly Cytomation) with 
488nm Argon laser excitation and a 530/40nm emission bandpass filter. Cells 
were selected on the basis of cell viability and YFP fluorescence intensity and 
sorted at a rate of approximately 7000 cells per second.
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Figure 2.9 Fluorescence activated cell sorting (FACS)
Schematic diagram illustrating the basic principle of fluorescence activated cell sorting (FACS). 
FACS enables rapid separation of cells from a mixed population based upon preselected 
characteristics such as fluorescence emission, fluorescence intensity, cell size and cell viability. 
Following the hydrodynamic focussing of the sample, each cell is interogated with a beam of light. 
The computer determines how the cell will be sorted prior to it reaching the break off point. As the 
drop is created an electrical charge is applied to the stream and the newly formed drop will form 
with a charge. The charged droplets then fall through an electrostatic deflectin system that diverts 
droplets into containers based upon their charge. (SSC: side scatter, FSC: Forward scatter)
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2.2.10 Clonal selection of cells expressing eYFP-PLC?
Non-clonal G418 resistant CHO cells stably expressing eYFP-PLC? were 
collected by trypsinisation and adjusted to a density of 15, 5 and 1.5 cells/ml of 
cF-12 medium containing G418 (500pg/ml). The suspensions were transferred 
into flat bottomed 96 well plates (200pl/well). Single colony wells were assessed 
for YFP transgene expression by flow cytometry (section 2.2.9).
2.2.11 Preparation of cell extract for injection into mouse eggs
CHO cells (~ 2 x 107) stably transfected with eYFP tagged constructs were 
harvested by trypinisation and pelleted by centrifugation (1200 x g, for 3 
minutes). Cells were washed twice in 1x PBS and once in Cell extract buffer 
(section 2.1.6), then resuspended in a mimimal volume of Cell extract buffer 
(50% of pellet volume). Cells were lysed with 3 cycles of freeze-thaw using liquid 
nitrogen, before being subjected to ultracenrifugation (Beckman Optima TLX) at
100,000 xg for 1 hour at 4°C. The resulting supernatant was concentrated using 
a Microcon centrifugal filter device (10KD, Millipore) as per manufacturers 
instructions, snap frozen, and stored at -80°C.
2.2.12 Mouse Egg experiments
Mouse egg experiments were carried out in collaboration with Karl Swann and 
Yangsong Yu. Metaphase II eggs were collected from six week old female mice 
that had been stimulated to superovulate by injection of pregnant mare serum 
(PMS, Folligon) and human chorionic gonadotrophin (hCG, Folligon). Eggs were 
collected 14 hours post hCG administration and maintained in droplets of
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HKSOM (see table 2.1) under mineral oil at 37°C. Prior to experiments, eggs 
were washed with M2 medium (Sigma)
For cell extract injections, eggs were incubated with 4pM Fura Red AM for 20 
minutes. Injection needles were formed by pulling borosilicate glass capillaries 
(Harvard Apparatus Ltd, 1.5mm outer diameter and 0.86mm internal diameter) 
with an internal filament using a vertical pipette puller (Model P-30; Sutter 
Instruments). Injection needles were backfilled with ~1pl of cell extract (diluted 1 
in 5 with KCI hepes buffer) using sterile micropipettes (Ependorf). Eggs were 
microinjected using an inverted microscope (TE2000, Nikon) equipped with 
hydraulic manipulators and a pressure pulse system. The volume of solution 
injected was estimated by the diameter of cytoplasmic displacement caused by 
the injection; which was ~1-5% of the eggs volume.
For single CHO cell injections, eggs were incubated with 4pM Fura PE3 AM for 
30 minutes. CHO cells were harvested by trypsinisation (section 2.2.4) and 
resuspended in M2 medium. Injection needles were formed as described above 
ensuring an internal diameter slightly less than that of a single CHO cell. Single 
eggs were all injected with single cells using a Piezoinjector from Primetech 
(Japan).
Eggs were monitored for Ca2+ oscillatory activity in M2 medium using an 
epifluorescence microscope equipped with excitation and emission wheels and a 
cooled CCD camera (Photometries Ltd). Ca2+ was measured as a fluorescence 
excitation ratio of 350/380nm. Emission was measured with a 535nm bandpass 
filter of 40nm band width.
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CHAPTER 3 Optimising expression and monitoring Ca2+ in CHO cells
3.1 Introduction
3.1.1 Transfection methods
The process of introducing recombinant DNA into eukaryotic cells is defined as 
“transfection”, and is considered a powerful tool for investigating the function of a 
gene of interest. Essentially, transfection is a method that neutralises the issue of 
introducing negatively charged molecules into cells with a negatively charged 
membrane. Numerous transfection techniques have been established over the 
past few decades that can be broadly classified as either chemical reagents or 
physical methods.
Calcium phosphate co-precipitation became a popular chemical transfection 
technique following the systematic examination of this method in the early 1970s 
(Graham et al., 1973). The authors studied the effect of different cations, cationic 
and phosphate concentrations, and pH on the parameters of transfection. 
Calcium phosphate co-precipitation is widely used because the components are 
easily available and inexpensive, the protocol is easy to use and many different 
types of cultured cells can be transfected. A precipitate is produced by carefully 
mixing a buffered phosphate solution with a solution containing calcium chloride 
and DNA. The solution is dispersed onto the cultured cells and is taken up via 
endocytosis. Although early chemical transfection methods helped to establish 
transfection techniques, a number of alternative approaches now exist offering 
relatively higher efficiency, lower variability, and lower toxicity for a greater 
variety of cell types.
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By 1980, artificial liposomes were being used to deliver DNA into cells (Fraley et 
al., 1980). The development of synthetic cationic lipids by Feigner and 
colleagues was the next advancement in this technique commonly referred to as 
lipofection (Feigner et al., 1987). The cationic head group of the lipid compound 
associates with the negatively charged phosphates of the DNA molecules. 
Sufficient liposome is used so that the liposome/nucleic acid complex has an 
overall net positive charge. This positive charge is attracted to the negative 
charge on the surface of the cell and the complex is taken up via endocytosis. 
Many different types of liposomes are commercially available for use in the 
transfection of mammalian cells including the frequently cited lipofectamine 
reagents (Invitrogen).
Alternative transfection techniques are available that do not rely on complexing 
the DNA for transefection. These physical methods include microinjection, 
electroporation and biolistic particle delivery. Direct microinjection of DNA into 
cultured cells is an effective technique to deliver DNA into individual cells, 
requiring specialised injection equipment, considerable labour, and technical 
expertise (Capecchi, 1980). This method is generally efficient; 50-100% of cells 
injected express the delivered DNA, although it is not suitable for studies 
requiring a large number of transfected cells. This technique has been used to 
transfer DNA into embryonic stem cells that are used to produce transgenic 
organisms (Bockamp et al., 2002).
Electroporation is a popular physical method of transfection, often used for cell 
types that are particularly resilient to milder methods of gene transfer. This
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method was first reported for gene transfer studies in 1982 (Wong et al., 1982), 
and relies upon perturbation of the cell membrane by short pulses of high voltage 
which forms pores that allow the passage DNA into the cell (Shigekawa et al., 
1988). This technique requires the cells to be suspended in buffer, and even 
under optimal conditions approximately 50% of the cells die due to shock. Those 
that survive typically require 48 hours to recover and show efficient uptake of the 
DNA.
Another physical method of transfection is biolistic particle delivery, also referred 
to as particle bombardment or the “gene gun” approach (Yang et al., 1990; Ye et 
al., 1990). This method requires precipitation of the DNA onto gold particles, and 
relies upon high velocity delivery of these DNA/gold microcarriers to recipient 
cells. Initially used for DNA delivery into plants, this technique has since been 
used to deliver DNA into cultured cells as well as cells in vivo (Burkholder et al., 
1993; Klein et al., 1992; Ogura et al., 2005). As with other physical methods, this 
technique requires special equipment and is relatively costly.
Many novel methods have been developed for mammalian cell transfection, most 
of which claim improved efficiency, reduced toxicity or wider versatility. For 
example positively charged, highly branched molecules termed ‘dendrimers’ 
complex with negatively charged DNA and transfect cells in a manner similar to 
liposomes (Tang et al., 1996). They are reported to have decreased toxicity over 
their liposome counterparts. Also a method termed ‘magnetofection’ has been 
shown to enhance delivery in a variety of cell types (Plank et al., 2003), whereby 
DNA is complexed to magnetic particles, and a magnet is placed underneath the
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tissue culture dish in order to bring DNA complexes into contact with a cell 
monolayer.
Our laborartory has examined the ability of ultrasonic standing waves (USW) to 
induce macromolecular uptake (Khanna et al., 2006) and DNA transfection 
(unpublished observations) in cell suspensions by a process referred to as 
sonoporation (Discussed in Chapter 2, section 2.2.5.3). This chapter reports 
briefly on the suitability of this novel method for the transfection of adherent cells, 
and compares this technique with a selection of more established transfection 
methodologies.
3.1.2 Reporter genes
It is often desirable to measure the expression of a transgene following its 
transfection into a mammalian cell. The attachment or fusion of a reporter gene 
to the gene of interest is a method used frequently for this purpose. The two 
genes are under the same promoter and are transcribed into a single messenger 
RNA molecule, which is subsequently translated into protein. Many different 
reporter systems are in widespread use, and are typically chosen because the 
characteristics they confer on cells expressing them are easily identified and 
measured using established, convenient assays. Reporter genes can be useful 
in characterising gene expression in a number of ways, such as estimating 
transfection efficiency (percentage of cells transfected with a plasmid) or by 
acting as a surrogate for the subcellular localisation of another gene of interest.
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3.1.2.1 Green fluorescent protein and its derivatives
Green fluorescent protein (GFP) has gained wide-spread use as a tool to 
visualise spatial and temporal patterns of gene expression in living tissue. The 
cloning of GFP from the jellyfish Aequorea victoria (Prasher et al., 1992) and 
subsequent expression in nonjellyfish systems (Chaifie et al., 1994; Inouye et al., 
1994) presented a protein that has since been used as an intrinsic intracellular 
reporter of gene expression, protein localisation and cell linage in vivo (Cubitt et 
al., 1995; Gerdes et al., 1996; Niswender et al., 1995). Wild type (WT) GFP, 
when excited by blue light, emits a fluorescent and easily detectable green light 
(emission maximum at 508nm) with a spectral pattern similar to that of 
fluorescein. Its fluorescence is not dependant upon additional co-factors or 
substrates, making it useful in many cell types (Heim et al., 1994; Inouye et al., 
1994). In addition to this, GFP fluorescence is stable, species independent, and 
can be monitored non-invasively in living cells using fluorescence microscopy or 
flow cytometry (Chaifie et al., 1994; Inouye et al., 1994). Following the cloning 
and expression of W T GFP, genetic manipulations were performed in attempts to 
alter its fluorescent properties. A variant of GFP (enhanced GFP or eGFP) was 
developed, which contains chromophore mutations (S65T and F^L), resulting in a 
protein 35 times brighter than W T GFP with increased photostability and an 
augmented excitation peak that was shifted to 488nm (Cormack et al., 1996; 
Zhang et al., 1996). A broad range of fluorescent protein genetic variants have 
been developed that feature fluorescence emission spectral profiles spanning 
almost the entire visible light spectrum. The enhanced yellow fluorescent protein
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(eYFP) variant used in this thesis is structurally equivalent to GFP with five 
additional mutations (S65G, V68L, Q69K, S72A, and T203Y) that increase the 
emission wavelength to 527nm and the brightness (Grynkiewicz et al., 1985; 
Tsien, 1998). eYFP has been used previously as a reporter gene to study the 
expression of PLC£ in somatic cells (Coward et al., 2006).
3.1.2.2 Bioluminescence
Bioluminescence is a natural process in which living organisms convert chemical 
energy into visible light. Many different organisms, ranging from bacteria and 
fungi to beetles and fish are endowed with the ability to emit light (Campbell, 
1988; Wilson et al., 1998). The majority of bioluminescent insects are beetles 
belonging to the families of Elateridae (e.g. click beetles), Phengodidae (the 
railroad worm) and Lampyridae (the fireflies) (Campbell, 1988; Wilson et al., 
1998).
Fireflies exhibit there characteristic flashing light from an abdominal organ 
(lantern) as a signal between potential mates. Each species of firefly has a 
unique pattern of flashes to provide distinction from other species in the 
geographical area. Fireflies emit light ranging in colour from green to yellow (550- 
580nm) (Wood, 1995). The flashes of light are a result of an oxygen-dependent 
bioluminescent reaction that occurs between the luciferase enzyme and its 
substrate, luciferin.
The luciferase from the North American Firefly Photinus pyralis was the first to be 
cloned of all the beetle luciferases and has become the best characterised (de
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Wet et al., 1987; de W et et al., 1985). (From here onwards the generic term 
‘firefly luciferase’ or ‘luciferase’ will be used to refer specifically to the luciferase 
of the firefly P.pyralis).
Firefly luciferase has long been used in biology as an indicator for monitoring 
ATP since the discovery that ATP is required for the bioluminescent reaction 
(McElroy, 1947). The cloning an sequencing of the firefly luciferase gene (luc) 
(de Wet et al., 1987; de W et et al., 1985) and its successful expression in a 
variety of organisms has rapidly expanded the applicability of firefly luciferase as 
a reporter for gene expression and an indicator for molecular signals in vivo 
(Aflalo, 1991; Sala Newby et al., 1999). Luciferase assays are very sensitive, 
rapid and utilise readily available substrates from commercial sources, making 
them a widely used analytical tool.
As indicated in figure 3.1, luciferase (Luc) catalyses the oxidative decarboxylation 
of luciferin (LH2) in the presence of MgATP2'. Firstly, the carboxylate group of 
luciferin is activated by acylation with ATP, in the presence of Mg2+. The enzyme 
bound luciferyl adenylate (LH2-AMP) is oxidised by molecular oxygen, with the 
intermediate formation of a cyclic peroxide (dioxetanone) and a molecule of 
AMP. The dioxetanone is decarboxylated releasing energy to generate C 0 2 and 
an electronically excited state of oxyluciferin (*). Relaxation of oxyluciferin to the 
ground state is accompanied by the emission of light (Amax = 562nm) (Deluca, 
1976; Sala Newby etal., 1999; Wilson eta!., 1998; Wood, 1995).
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Figure 3.1 The firefly luciferase-luciferin 
bioluminescent reaction
Left: Picture of the North American firefly beetle 
reproduced from:
http://en. wikipedia. org/wiki/File:Photinus_pyralis_ 
Firefly_3.jpg
Firefly luciferase (Luc) catalyses the 
decarboxylation of luciferin (LH2) in the presence 
of ATP, 0 2 and Mg2+, producing a yellow-green 
light as described in the reaction sequence 
outlined below. (See text for details)
(1) Luc + LH2 + MgATP2 - Luc*LH 2-AM P + PPj + Mg 2+
(2) Luc*LH2-AMP + 0 2 Luc*oxyluciferin* + AMP + C02
(3) Luc-oxyluciferirV Luc*oxyluciferin + LIGHT
3.1.3 Monitoring intracellular Ca2+ using fluorescent indicators
For over two decades researchers have been using fluorescent Ca2+ indicators to 
study the regulation of intracellular Ca2+. A wide variety of Ca2+ indicators are 
currently available, with excitation and emission spectra ranging from UV to 
visible colours. The most commonly used indicators are chemical fluorescent 
probes whose optical properties change when they bind Ca2+. Fluorescent Ca2+ 
indicators were originally derived from BAPTA (a membrane permeable Ca2+ 
chelating agent), and most of the classical members of this group were created 
by Tsien and colleagues in the 1980s (Grynkiewicz et al., 1985; Minta et al.,
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1989; Tsien, 1980; Tsien, 1981; Tsien et al., 1982). They can be broadly divided 
into single and dual (ratiometric) wavelength indicators on the basis of their 
spectral changes in response to Ca2+ elevation. Single wavelength Ca2+ sensitive 
indicators such as Fluo-3 change their emission intensity upon binding Ca2+. 
However, the intensity of the emission is directly proportional to both the ambient 
Ca2+ and the indicator concentration, so careful calibration is required.
Ratiometric indicators, such as Fura-2 offer the advantage of eliminating 
artefacts that may arise due to indicator concentration. They are used to 
measure the ratio of fluorescent signals at two distinct wavelengths, which 
enables the precise quantification of changes in Ca2+ concentration. However, 
the majority of ratiometric indicators require UV excitation, which can damage 
cells and result in enhanced autofluorescence. In addition, the exclusive 
requirement for UV excitation may be limited by hardware and experimental 
considerations.
The majority of fluorescent indicators are cell impermeant. It is therefore 
necessary to adopt one of the many invasive or biochemical techniques that are 
available to introduce the indicator into the cytoplasm of the cell. Many of the 
fluorescent Ca2+ indicators are available as acetoxymethyl (AM) ester derivatives 
(Tsien, 1981; Tsien et al., 1982). The AM form of the indicators can passively 
diffuse across cell membranes, and undergo hydrolysis by endogenous 
esterases once they reach the cell cytoplasm. This results in cleavage of the AM 
group which restores the cell-impermeant properties of the indicator, thus 
preventing leakage from the cell. Due to the low aqueous solubility of the AM
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forms, some dispersing agents such as Pluronic F-127 are often used to facilitate 
cell loading (Takahashi et al., 1999). Not all fluorescent Ca2+ indicators are 
available as the cell-permeable ester form.
Several of the indicators experience the issue of compartmentalisation. This is 
overcome by linking the indicator to a dextran of >10,000 molecular weight. 
These indicator-dextran conjugates cannot cross the plasma membrane and 
therefore require some invasive techniques for introducing them into the cell (e.g. 
microinjection or scrape loading). Once inside the cell, the indicator is retained 
within the cytosol providing more precise estimations of the cytosolic ion 
concentration over extended periods of observation (Takahashi et al., 1999).
3.1.4 Previous studies involving the expression of PLC? in somatic cells
In April 2006, Coward et al. published a paper describing the in vivo gene 
transfer and expression of a recombinant form of PLC? in mouse sperm. As part 
of that study, the transient expression of PLC? tagged with eYFP was assessed 
in COS cells (derived from the kidney cell line of the African green monkey) and 
in Human Embryonic Kidney (HEK) 293 cells. Images taken of COS cells 
displaying expression of PLC^-eYFP show the existence of two main patterns of 
fluorescence: either a grainy cytoplasmic distribution or a nuclear distribution. 
Myc or Venus tagged PLC£ has also been shown to localise to the pronucleus 
(PN) of mouse zygotes and early embryos (Halet et al., 2002; Sone et al., 2005). 
Ca2+ oscillations stop at the time of PN formation (Jones et al., 1995), but 
continue without stopping with the prevention of PN formation by injection of a 
lectin, WGA (Marangos et al., 2003). The translocation of PLC? into the PN is
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therefore considered to play an important role in the cessation of Ca2+ 
oscillations at the interphase of a cell cycle (Halet et al., 2004; Kono et al., 1995; 
Marangos et al., 2003). Coward et al.,(2006) offer no explanation as to why 
PLC?-eYFP displays these two distinct patterns of localisation in COS cells, 
however suggest that this may be linked to cell cycle events. HEK 293 cells were 
transfected with the same PLC?-eYFP in order to confirm that this construct was 
generating a protein of the correct molecular weight. Immunoblotting revealed a 
protein band with an apparent molecular weight of ~100kDa, consistent with the 
addition of the eYFP protein (27kDa) to the mouse PLC? protein (74kDa).
In September 2006, Kuroda et al. reported on the role of the X/Y linker region 
and N-terminal EF-hand domain in nuclear translocation and Ca2+ oscillation- 
inducing activity of PLC?. This was the first study to demonstrate Ca2+ oscillations 
in somatic cells following the expression of PLC?. The results show that 24 hours 
after transfection using FuGENE6 (Roche Diagnostics), repetitive Ca2+ spikes at 
intervals of ~3 minutes were observed in 12/17 COS cells expressing venus 
tagged PLC?. No Ca2+ oscillations were observed in any of the 18 cells 
expressing the inactive D210R mutant or in non-transfected COS cells. This 
study also reports the nuclear accumulation of PLC? in COS cells and its D210R 
mutant. In contrast to the observations of Coward et al.,(2006), the confocal 
images taken of cells 48 and 72 hours after transfection suggest an increase in 
active import into the nucleolus over time, with no report of cells displaying any 
other patterns of distribution. It is suggested that the less marked nucleolar
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accumulation observed in cells expressing the D210R mutant could be due to its 
inability to induce Ca2+ oscillations.
In 2007, Yoshida et al. successfully induced broad ectopic PLC? expression in 
transgenic mice. Reverse transcription polymerase chain reaction (RT-PCR) and 
immunoblot analysis confirmed recombinant PLC? protein expression in a range 
of tissues, including heart, skeletal muscle, lung, liver, spleen, kidneys, testes 
and ovaries. Their experiments revealed that endogenous PLC£ expression 
initially had no effect, and the mice appeared healthy. Their oocytes matured 
normally and established Mil, but subsequently exhibited autonomous Ca2+ 
oscillations, second polar body extrusion, pronucleus formation and 
parthenogenetic development. Transgenic males remained largely 
asymptomatic; however females developed abdominal swellings caused by 
benign ovarian teratomas. Yoshida et a/.,(2007) conclude that the activity of 
PLC? is restricted to oocytes when low level expression is forced ectopically in 
multiple tissues, however the level of PLC£ in somatic tissues was not 
established. They suggest that the cellular machinery required to transduce PLC? 
signalling is restricted to the tissues in which PLC? is normally active. They 
propose that this may involve tissue specific accessory factors such as adaptors 
that bind PLC?.
In 2008, Ito et al. published a paper which reported the difference in Ca2+ 
oscillation inducing activity and nuclear translocation ability of PLC£ between 
mouse, rat, human and medaka fish. PLC? from all species was capable of 
inducing Ca2+ oscillations in mouse eggs with variable degrees of activity.
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Species differences were observed in nuclear translocation experiments 
involving mouse and rat eggs. Unlike mouse; rat, human and medaka PLC£ did 
not accumulate in the pronucleus (PN) of mouse eggs. Also, rat PLC? could not 
enter rat PN, whereas mouse could. Experiments involving the expression of 
PLC£ from these four animal species in COS cells also show apparent 
differences in their nuclear translocation ability. These differences however only 
partially reflect the observations reported in eggs. Mouse PLC? was strongly 
accumulated in the nucleoli of COS cells at 48 hours after transfection as had 
been reported previously (Kuroda et al., 2006). In contrast, rat PLC? displayed a 
cytoplasmic distribution with no obvious signs of nuclear translocation. Despite 
their absence from the mouse PN, nuclear translocation was observed for both 
human and medaka PLC^ in COS cells. Ito et al.,(2008) suggest that the nuclear 
translocation of human PLC? in COS cells may be due to the fact that human and 
monkey PLC? share identical nuclear localisation sequences (NLS). They also 
propose that the nuclear translocation observed with medaka PLC£ could be a 
result of diffusion due to its relatively smaller size.
These data all suggest that a systematic investigation of PLC? expression in 
somatic cells is warranted.
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3.1.5 Objectives
The most suitable transfection technique and conditions for a particular cell type 
must be systematically and empirically determined because inherent properties 
of the cell influence the success of any specific transfection method. The 
preliminary aim of this chapter was to determine the most appropriate 
transfection techniques for examining the effects of transient expression of PLC? 
in CHO cells, and for the eventual production of a stable cell line (Chapter 5). 
The advantages and disadvantages of a variety of commonly used transfection 
methods were compared together with a brief assessment of the applicability of 
the novel technique of sonoporation that has been used experimentally in our 
laboratory.
This chapter reports on the pattern of cellular localisation observed with eYFP- 
PLC£, and examines the effect of transient PLC£-LUC expression on Ca2+ 
homeostasis.
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3.2 Results
3.2.1 Restriction digests of the DNA constructs
The constructs shown in this thesis were prepared by Michail Nomikos, 
Christopher Saunders, or in collaboration with Andreas Rossbach. Diagrammatic 
structural details of the DNA constructs are shown in Chapter 2 (section 2.2.1). 
Restriction digests were used to confirm successful ligation, and to ensure that 
the plasmids had not undergone any deletions or spontaneous recombination 
with the bacterial DNA during propagation. Digests of the DNA constructs with 
restriction enzymes yields several fragments of different molecular weights which 
can be identified after agarose gel electrophoresis and act as a ‘fingerprint’ for 
the complete recombinant plasmid. Figure 3.2.1 shows the predicted DNA 
cleavage fragments for each construct.
For the luciferase tagged constructs, EcoRI cuts once in the multiple cloning site 
of the pCR3 vector and once at the 587 position of luciferase sequence, resulting 
in two bands for each construct. The predicted size of the bands after digestion 
for the luciferase tagged constructs are 6156 and 587bp for pCR3-LUC, and 
6156 and 2542bp for PLC?-LUC (Figure 3.2.1).
For the eYFP construct, Ncol cuts three times in the pcDNA3.1 vector backbone 
at positions 610, 2751 and 3486, and once at position 860 of the eYFP insert, 
resulting in 4 bands. The predicted sizes of the bands after digestion are 3347bp, 
1891 bp, 735bp and 250bp (Figure 3.2.1).
For the eYFP-PLC? and eYFP-D210RPLC? constructs, Ncol cuts three times in the 
pcDNA3.1 vector backbone at positions 610,4727 and 5462, and three times at
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LUC EcoRI 6156bp 587bp
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eYFP Ncol 3347bp 1891 bp 735bp 250bp
eYFP-PLCS Ncol 3347bp 1900bp 1485bp 735bp 482bp 250bp
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PLC£ Ncol
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Figure 3.2.1 Predicted restriction fragments of the DNA constructs
A) Construct maps illustrating the restriction digest sites of the specified enzymes (represented by 
the black arrows) and the subsequent restriction fragment sizes (base pairs). The luciferase 
(LUC) reporter is indicated in blue, the enhanced yellow fluorescent protein (eYFP) reporter is 
indicated in green and mouse PLC zeta (mPLCO is indicated in red.
B) Summary of the expected sizes of the cleavage fragments for each of the DNA constructs.
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positions 860, 2345 and 2827 of the eYFP-PLC^ insert, resuiting in 6 bands. The 
predicted sizes of the bands after digestion are 3347bp, 1900bp, 1485bp, 735bp, 
482bp and 250bp (Figure 3.2.1).
Figure 3.2.2 shows the characteristic band patterns observed following agarose 
gel electrophoresis. This data indicated that the DNA constructs had been 
generated in the correct orientation, and that they were not altered by DNA 
propagation. Base pair substitutions which resulted from site directed 
mutagenesis were verified by automated cycle sequencing. This confirmed that 
no other mutations apart from those intended were introduced into the cDNA 
sequence. It should be noted that the introduced mutation did not alter any of the 
restriction sites.
Band size 
(bp)
Mw
Marker
LUC PLC£- 
LUC
eYFP eYFP- eY F P - Mw
PLC? D210R M arker
PLC? Band size
(bp)
Figure 3.2.2 Restriction digest patterns of the DNA constructs
Figure 3.2.2 shows a 1% agarose gel demonstrating the characteristic restriction patterns 
obtained following enzymatic digestion of DNA maxi preps corresponding to positive clones of the 
constructs indicated above. Luciferase (LUC) and enhanced yellow fluorescent protein (eYFP) 
tagged constructs were digested using the EcoRI and Ncol restriction enzymes respectively. 
Molecular weight marker (Mw Marker = Hyperladder I).
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3.2.2 Expression of the DNA constructs in mouse eggs
cRNA corresponding to luciferase tagged constructs were prepared (by Michail 
Nomikos) and microinjected (by Karen Campbell) in mouse eggs (Nomikos et al., 
2005). The left panel of figure 3.3A shows that the eggs injected with cRNA 
encoding PLC?-LUC construct caused a series of Ca2+ oscillations in eggs that 
lasted several hours. At the end of the fluorescence recording interval, 
luminescence was measured from the same eggs (in the absence of 
fluorescence excitation) to confirm luciferase expression (Figure 3.3A right 
image).
cRNA corresponding to eYFP tagged constructs were prepared and 
microinjected (by Yuansong Yu) in mouse eggs. Figure 3.3B shows that the eggs 
injected with cRNA encoding eYFP-PLC? also caused a series of Ca2+ 
oscillations in eggs that lasted several hours.
The X and Y  domains of PLC? contain the active residues 178His (Histidine), 
210Asp (Aspratate) and 223His (Histidine) that have been shown to be involved 
in catalysis (Ellis et al., 1993; Ellis et al., 1998). These residues are conserved 
across all PLC families (Katan, 1998). DNA constructs containing the mutation of 
Aspartate at residue 210 in PLC? to an arginine residue (D210R-PLC?) have 
previously been injected into eggs and have failed to produce Ca2+ oscillations 
(Saunders et al., 2002). This suggests that 210Asp is essential for PLC? enzyme 
activity.
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Figure 3.3 Eggs injected with PLC^-LUC and eYFP-PLC^.
(A) Eggs were injected with OGBD and cRNA encoding PLC^-LUC. Left panel shows a 
representative fluorescence trace from a single egg showing the changes in intracellular Ca2+ 
levels that were measured continuously for 4 hours. The right panel shows an integrated image 
over 30 minutes of the luciferase luminescence signal from the same eggs from which Ca2+ 
measurments were taken. (Images courtesy of Karen Campbell) (Nomikos et al., 2005).
(B) Eggs were injected with Fura 2 dextran and cRNA encoding eYFP-PLC^. The red line 
represents the changes in intracellular Ca2+ levels from a single egg that was measured 
continuously for 2 hours. The green line represents the eYFP expression levels from the same 
egg. (Image courtesy of Yuansong Yu).
30 min
eYFP-PLCC
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3.2.3 Optimising plasmid DNA transfection in CHO cells using chemical 
methods
The performance of calcium phosphate co-precipitation and the cationic liposome 
formulation Lipofectamine™ 2000 (Invitrogen) for transfection of CHO cells was 
assessed using the eYFP-PLC? and PLC?-LUC DNA constructs (described in 
Chapter 2, section 2.2.5). To obtain the highest transfection efficiencies, 
experimental conditions were optimized by varying the DNA(pl) : transfection 
reagent (pi) ratios, and by ensuring that cells were greater than 90% confluent 
(as recommended by the manufacturer).
For CHO cells transfected with eYFP-PLC^, recombinant eYFP expression was 
assessed 24 hours after transfection by comparing the number of cells exhibiting 
eYFP fluorescence with the total number of cells present (Figure 3.4A). Four 
separate fields of view were analysed from 3 separate transfections for each 
experimental condition. These results show that when a fixed amount of 
transfection reagent is used, it is possible to increase the expression levels of 
recombinant eYFP in CHO cells by increasing the DNA concentration from 2pg to 
6pg (for Lipofectamine 2000) and 8pg (for calcium phosphate). An increase in 
the DNA concentration from 6pg to 8pg with Lipofectamine 2000 failed to 
enhance the levels of eYFP expression further. When comparing the eYFP 
expression levels obtained with both chemical transfection reagents, 
Lipofectamine 2000 resulted in superior transfection efficiencies for each of the 
DNA concentrations assessed. The expression levels of eYFP were increased 
significantly (p<0.05) by using Lipofectamine 2000, both for4pg and 6pg of DNA.
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Figure 3.4 Calcium phosphate and Lipofectamine 2000 transfections of CHO cells
CHO cells were transfected with either the eYFP-PLC^ (A) or PLC^-LUC (B) DNA construct using 
the standard calcium phosphate co-precipitation/ Lipofectamine 2000 protocol (as described in 
Chapter 2, section 2.2.5). For cells transfected with eYFP-PLC^ (A), the endogenous 
fluorescence of eYFP was used to determine the efficiency of plasmid transfection by comparison 
with the total number of cells present 24 hours after transfection. For cells transfected with PLC£- 
LUC (B), cells were harvested 24 hours after transfection and assayed for luciferase activity (as 
described in Chapter 2, section 2.2.7). Data are presented as mean ± S.E.M. (n=3). cps denotes 
luminescent counts per second. * = p<0.05.
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This data shows that Lipofectamine 2000 is more efficient for the transfection of 
eYFP-PLC? in CHO cells when compared with calcium phosphate co­
precipitation. The highest transfection efficiencies (~20-25%) were obtained with 
a DNA (p g ): Lipofectamine 2000 (pi) ratio of 3:5 (6pg:10pl).
For CHO cells transfected with PLC£-LUC, luciferase activity was assessed 24 
hours after transfection by the addition of 100pM luciferin to the cell lysate. The 
resultant bioluminescent reaction took place in a custom made luminometer (see 
chapter 2, section 2.2.7), the average signal (cps) was taken over 60 seconds 
and expressed as cps per 103 cells (Figure 3.4B). Three separate transfections 
were analysed for each experimental condition. These results show that when a 
fixed amount of transfection reagent is used, it is possible to increase the 
luciferase activity in CHO cells by increasing the DNA concentration from 2pg to 
6pg (for lipofectamine 2000) and 4pg (for calcium phosphate). An increase in the 
DNA concentration from 6pg to 8pg with lipofectamine 2000, and 4pg to 8pg with 
calcium phosphate failed to enhance the luciferase activity further. When 
comparing the levels of luciferase activity obtained with both chemical 
transfection reagents, lipofectamine 2000 resulted in higher cps for each of the 
DNA concentrations assessed. The average signal (cps) was increased 
significantly (p<0.05) by using Lipofectamine 2000, for 4pg, 6pg and 8pg of DNA. 
This data shows that Lipofectamine 2000 is more efficient for the transfection of 
PLC^-LUC in CHO cells when compared with calcium phosphate co-precipitation. 
The highest transfection efficiency, demonstrated by a luciferase activity of
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~25,000 cps/103 cells was obtained with a DNA (pg) : Lipofectamine 2000 (pi) 
ratio of 3:5 (6pg:10pl).
Despite the optimisation of DNA transfection with both calcium phosphate and 
Lipofectamine 2000, initial imaging experiments revealed that cells displaying 
reporter gene expression were unevenly distributed throughout the cell culture 
dish and often failed to lie within close proximity to one another. This had a 
noticeable effect on the cells numbers obtainable for transient gene expression 
analysis in single fields of view. Figure 3.5 is representative of the typical cell 
numbers expressing PLC^-LUC 24 hours following transfection with 
lipofectamine 2000. On average, -2 0  cells per field of view were observed using 
a x10 magnification objective (Figure 3.5A). This combined with the integration 
time required to identify the cells displaying luciferase expression made it 
increasingly difficult to locate more than 1 or 2 cells per field of view when using 
an objective of higher magnification power (x40 oil immersion) (Figure 3.5B). 
Although well suited to experiments involving the generation of stable cell lines, 
due to the total number of cells transfected in a single culture dish (Chapter 5), 
these chemical transfection techniques do not appear to be suitable for the 
analysis of transient gene expression in this instance, especially if experiments 
require the use of higher magnification objectives.
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Figure 3.5 Expression of PLC^-LUC in CHO cells following Lipofectamine 2000 
mediated transfection
CHO cells were imaged for PLC^-LUC expression 24 hours following lipofectamine 2000 
mediated transfection, in a buffer containing 100pM luciferin using the Photek imaging system (as 
described in Chapter 2, section 2.2.6). Figure 3.4A is representative of the typical number of cells 
showing luciferase expression (Left panel) when imaged using a x10 magnification objective. Also 
shown in the panel on the right is the Hoechst fluorescence image of the same cells, 
demonstrating the total number of cells in the field of view. Figure 3.4B is representative of the 
optimal number of cells showing luciferase expression (Left panel) when imaged using a x40 oil 
immersion objective. The panel on the right is the Fluo 3 fluorescence image of the same cells, 
demonstrating the total number of cells in the field of view.
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3.2.4 Optimising plasmid DNA transfection in CHO cells using physical 
methods
3.2.4.1 Sonoporation
Sonoporation has been used successfully in our laboratory to induce 
macromolecular uptake (Khanna et al., 2006) and DNA transfection (unpublished 
observations) of CHO cells in suspension. In order to establish the suitability of 
this relatively novel method for the transfection of adherent CHO cells, an 
analogous experimental design was employed.
Firstly, a new ultrasonic standing wave (USW) minichamber was designed in 
order to accommodate glass cover slips upon which CHO cells were grown 
(Chapter 2, figure 2.4). The optimum parameters were established by 
assessment of the levels of FITC-dextran uptake together with the levels of cell 
viability (determined by propidium iodide staining). Optimisation of this technique 
involved varying the voltage intensity (40-80V), the duration of the ultrasound 
pulse (2sec-1min), cell density (50-100% confluency) and contrast agent 
concentration (2-10%).
Initial permeabilisation experiments seemed promising, with isolated areas of the 
glass coverslip displaying reasonable levels of FITC-dextran uptake with 
relatively little effect on cell viability as illustrated in Figure 3.6. Despite the non- 
uniform nature of the macromolecular uptake across the cover slip, positively 
labelled cells appeared in distinct regions and displayed increased proximity 
when compared to that of chemical transfection methodologies. It should be 
noted however that the levels of FITC-dextran uptake shown in Figure 3.6 were
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not easily reproducible, and it is therefore unlikely that consistent transfection 
results could be achieved using this technique.
CHO cells were then exposed under these optimised experimental conditions 
(70% confluency, 40V, 2sec pulse length, 5% contrast agent) to a range of eYFP 
DNA concentrations (100ng-10pg). None of the DNA concentration tested 
resulted in transient eYFP expression in CHO cells when imaged over a 72 hour 
period following ultrasound exposure. This data suggests that further optimisation 
beyond the scope of this thesis is required to successfully transfect adherent 
CHO cells using the method of sonoporation.
Figure 3.6 Sonoporation induced macromolecular uptake by adherent CHO cells
This figure shows a fluorescence image of adherent CHO cells demonstrating the optimum levels 
of FITC-Dextran uptake (Green) obtainable following ultrasound exposure (1.72MHz, 40V) for 2 
seconds. Imaged using a x40 oil immersion objective. (The average cell count in a single area 
was -5 0  cells). Cell viability was assessed using propidium iodide (shown in red). These distinct 
areas of FITC-dextran loaded cells were not seen uniformely throughout the glass coverslip, and 
were not easily reproducible.
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3.2.4.2 Microinjection
Although less suitable for studies requiring large numbers of transfected cells, 
single cell microinjection permits the precise control of the amount, timing and 
location of delivery (Zhang et a/., 2008). This robust physical delivery method 
achieves high transduction efficiency in the majority of cell types, including 
cultured primary cells and oocytes.
The injection parameters that can be optimised when using the FemtoJet 
microinjector system include the injection pressure (Pi), injection time (Ti) and 
compensation pressure (Pc). The Pi is the pressure which is needed to drive the 
fluid from the capillary into the cells and together with the Ti determines the 
volume of the sample injected. It is crucial to use an optimal Pi; using a low Pi 
may result in inefficient injection while using higher Pi values risks damaging the 
internal structure of the cell. The Pc maintains a low positive pressure inside the 
capillary to prevent back filling of the needle, and is dependent upon the viscosity 
of the sample (Bartoli etal., 1997).
Microinjection into adherent CHO cells was carried out under phase contrast 
microscopy, initially using ranges of Pi (50-100 hPa), Pc (20-70 hPa) and Ti (0.1- 
0.5 secs). Determination of the most suitable microinjection conditions was 
carried out in two stages. Firstly, FITC-dextran was used as a marker of 
successful injection. This was followed by the assessment of cell viability using 
propidium iodide. Cells were injected under phase microscopy using a range of 
times and pressures to find the optimal Pi, Pc and Ti parameters that did not 
cause cell damage such as prolonged deformation or cell rupture. Having
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identified the optimal parameters, cDNA encoding eYFP was injected into the 
nuclei of CHO cells to verify that, under the microinjection conditions determined 
above, the cells remained viable and expression-competent.
Following extensive evaluation of specific microinjection protocols, optimal 
conditions for transfection efficiency and cell viability were determined at injection 
pressure (Pi) of 90 hPa, compensation pressure (Pc) of 80 hPa and an injection 
time (Ti) of 0.1 seconds. These conditions typically resulted in a transfection 
efficiency of >75% as depicted in Figure 3.7. Transfection efficiencies were 
determined by comparing the number of cells showing eYFP expression (Figure 
3.7A) with the total number of cells successfully injected (indicated by Alexa 594- 
dextran fluorescence, Figure 3.7B). It can be seen that the intensity of Alexa 594 
signal is not homogenous in all microinjected cells. The differences in signal 
could be an artefact of the heterogeneity of cell size and shape, but it is also 
possible that it is an indicator of the amount of sample injected into each of the 
cells. The levels of eYFP expression are also heterogeneous in all microinjected 
cells; however this does not appear to correlate with the intensity of the Alexa 
594 signal, which suggests that expression levels may be determined by factors 
other than the amount of cDNA delivered into the cell. Figure 3.7C shows that 
cells that have undergone microinjection have a slightly ruffled appearance 3 
hours after cDNA delivery. Despite this, the cells remain viable and are able to 
express recombinant eYFP for at least 48 hours.
Due to the precise control over the location of delivery using this technique, the 
number of cells available for fluorescence analysis in a single filed of view at
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higher magnification is greatly improved when compared to the other transfection 
methodologies assessed during this study. Figure 3.7 is representative of the 
typical number of cells expressing recombinant eYFP 3 hours following 
microinjection when viewed using a x63 oil immersion objective.
This data suggests that microinjection is a suitable transfection technique for the 
analysis of transient gene expression, enabling the imaging of very large 
numbers of cells (15-25 cells per experiment, n = 4-6).
A) B) C)
Figure 3.7 Microinjection of cDNA encoding eYFP into CHO cells
CHO cells imaged for eYFP expression (A) and Alexa 594-dextran fluorescence (B) using 
confocal microscopy (x63 magnification). (C) is a phase contrast image of the same field of view. 
Images were taken 3 hours after DNA microinjection.
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3.2.5 Cellular localisation of eYFP-PLC?
Previous studies have reported differing results in terms of the cellular 
localisation observed when expressing PLC£ in somatic cells. Coward et at., 
(2006) report two main patterns of distribution; either grainy cytoplasmic 
distribution or nuclear distribution, and suggest that this could be linked to cell 
cycle events. Others describe an active import into the nucleus of somatic cells, 
which is considered to be a time (Kuroda et al., 2006) or species (Ito et a/., 2008) 
dependent phenomenon. The lipid mediated transfection techniques employed in 
all of these studies have the disadvantage of being unable to permit the precise 
control of timing and amounts of exogenous material introduced into the cell. An 
optimised and well controlled microinjection strategy enables the control of these 
parameters, allowing a more defined time course analysis of the cellular 
translocation of recombinant expression.
DNA constructs encoding eYFP, eYFP-PLC? and eYFP-D210RPLC? were 
successfully microinjected into CHO cells, using the parameters described above 
(3.2.4.2). The use of Alexa-594 conjugated dye enabled the easy visual detection 
of microinjected cells without interference of the eYFP fluorescent signal. Injected 
cells were visualised using confocal microscopy 3, 5, 24 and 48 hours following 
the delivery of the DNA.
Figure 3.8 shows that high levels of recombinant eYFP expression were detected 
as early as three hours after DNA delivery and persisted for at least 2 days, for 
all of the DNA constructs examined. The expression of eYFP alone (Figure 3.8, 
top panel) showed that the fluorescent signal in the cells nucleus was
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comparable to that in the cytoplasm of 100% of the cells analysed. This pattern 
of localisation remained unchanged throughout all of the time points examined. 
This suggests that eYFP passively diffuses into the nucleus of somatic cells. 
eYFP was not accumulated in the nucleoli of CHO cells, as indicated by black 
spots in the nucleus.
eYFP-PLC? dislayed two distinct patterns of localisation over the duration of the 
time course experiment (Figure 3.8, bottom panel). At 3 and 5 hours following 
DNA delivery, 100% of cells showed a clear cytoplasmic distribution, with no sign 
of obvious nuclear translocation. In contrast to this, at 24 hours the majority of 
cells (-78% ) show noticeable nuclear translocation. Particularly, the fluorescence 
in the nucleoli was strikingly enhanced. At 48 hours, the majority of cells (-82% ) 
also showed obvious nuclear translocation, however at this later time point the 
eYFP signal in the nucleoplasm was comparible to that of the nucleoli. The cells 
that did not show obvious nuclear translocation at 24 and 48 hours maintained a 
clear cytoplasmic distribution identical to that observed at 3 and 5 hours. This 
data suggests that the nuclear import of PLC? is relatively slow, while PLC£ that 
entered the nucleoplasm is concentrated to nucleoli.
For eYFP-D210RPLC? (Figure 3.8, centre panel) the pattern of cellular localisation 
3 and 5 hours following DNA delivery was comparable to that of eYFP-PLC?, with 
100% of the cells showing a clear cytoplasmic distribution. Unlike eYFP-PLC?, 
eYFP-D210RPLC? did not show any obvious signs of nuclear accumulation at later 
time points (24/48 hours), and the majority of cells (>90%) maintained the same
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Figure 3.8 Cellular localisation of PLC£ and its inactive D210R mutant in CHO cells.
Confocal images acquired at the indicated time after microinjection of respective cDNA. Each image is representative of the pattern of 
localisation observed in the majority of cells at each time point. The number of cells displaying the indicated pattern of localisation is 
shown in white alongside the total number of cells analysed in each instance. Scale bar represents 10pm.
cytoplasmic localisation. The remaining cells displayed a less obvious 
cytoplasmic accumulation, whereby the fluorescent signal in the cytoplasm was 
comparable to that of the nucleus; however they showed no distinct pattern of 
nuclear translocation. This data suggests that the nuclear accumulation of PLC? 
may be linked to its activity in somatic cells, as the inactive D210R mutant fails to 
show any signs of nuclear translocation.
3.2.6 Ca2+ in CHO cells expressing PLC?-LUC
Calcium oscillations induced by PLC? expression have previously been reported 
in somatic cells (Kuroda et al., 2006). Here, CHO cells were injected with cDNA 
encoding LUC or PLC£-LUC together with the fluorescent indicator Oregon 
Green Bapta Dextran (OGBD) to measure Ca2+. The image in Figure 3.9 shows a 
group of cells that were both luminescent (representing recombinant expression) 
and fluorescent (used as a marker of successful microinjection in addition to 
measurement of intracellular Ca2+).
Intracellular Ca2+ was measured in cells 3, 5 and 24 hours following 
microinjection. The average luminescence recorded in single CHO cells 
expressing PLC?-LUC ranged from 1-10cps, whilst the luminescence in cells 
expressing LUC alone ranged from 1-15cps. The addition of 100pM ATP was 
used to assess the cells response to receptor induced Ca2+ mobilisation 
(Examined in more detail in Chapter 4). Figures 3.10 to 3.12 show examples of
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the Ca2+ changes observed in some, but not all cells at 3, 5 and 24 hours 
respectively. Table 3.1 summarises the results of these experiments, indicating
B)
Figure 3.9 Luminescence and Fluorescence in the same cells
The luminescence (A) and fluorescence (B) images are shown of a group of CHO cells that had 
been injected with cDNA encoding PLC^-LUC and OGBD.
the proportion of cells displaying Ca2+ oscillations, the frequency of the
oscillations and the proportion of cells presenting a response to the addition of
ATP.
Ca2+ oscillations were recorded in <40% of cells expressing PLC^-LUC at 3, 5 
and 24 hours following microinjection of cDNA. The centre panels of figures 3.10 
to 3.12 show representative traces of typical pattern of oscillations observed. 
Statistical analysis revealed no significant change in the frequency of the
oscillations between the individual time-points analysed (Table 3.1).
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Tables 3.1 shows that a comparable proportion of cells (-30-35% ) either 
expressing LUC alone or injected with OGBD also show Ca2+ oscillations at 3, 5 
and 24 hours. Figures 3.10 to 3.12 show representative traces of the typical 
pattern of oscillations observed in these cells. The frequencies of the Ca2+ 
oscillations recorded were also comparable to those observed in cells expressing 
PLC^-LUC. Statistical analysis revealed no significant changes in either the 
proportion of cells displaying Ca2+ oscillations or the frequencies at which they 
occur between cells expressing PLC?-LUC and either of the control groups (LUC 
and OGBD).
Table 3.1 shows that almost all cells (>99%) show a response to the addition of 
ATP (100pM). Examples of the typical Ca2+ changes observed as a result of this 
purinergic receptor stimulation are shown in figures 3.10 to 3.12. Statistical 
analysis revealed that the expression of PLC?-LUC did not alter the proportion of 
cells showing a response to ATP induced Ca2+ mobilisation.
This data suggests that the Ca2+ oscillations observed in CHO cells are not 
induced specifically by the expression of PLC^-LUC, and a more likely to be as a 
result of spontaneous Ca2+ activity within the somatic cell line. The expression of 
PLC^-LUC does not appear to affect receptor induced Ca2+ mobilising, 
suggesting that the cells Ca2+ signalling network remains unchanged. It is 
possible however that the expression of PLC? induces subtle changes in the Ca2+ 
homeostasis of somatic cells that are not apparent without more detailed analysis 
(See Chapter 4).
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Figure 3.10 Ca2+ changes observed in CHO cells 3 hours following microinjection
CHO cells were microinjected with the fluorescent Ca2+ indicator OGBD (0.5mM) together with 
cDNA encoding LUC (top panel) or PLC^-LUC (centre panel). Cells were also injected with 
OGBD alone (bottom panel). The traces are representative of typical Ca2+ changes observed in 
some, but not all cells within each experimental group. Cells were imaged for OGBD fluorescence 
for at least 30 minutes prior to the addition of ATP (100pM, red arrow).
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Figure 3.11 Ca2+ changes observed in CHO cells 5 hours following microinjection
CHO cells were microinjected with the fluorescent Ca2+ indicator OGBD (0.5mM) together with 
cDNA encoding LUC (top panel) or PLC^-LUC (centre panel). Cells were also injected with 
OGBD alone (bottom panel). The traces are representative of typical Ca2+ changes observed in 
some, but not all cells within each experimental group. Cells were imaged for OGBD fluorescence 
for at least 30 minutes prior to the addition of ATP (100pM, red arrow).
120
+
CM
CD
o
ATP
LUC
3
<
0oc
0o0
2>ou
0
O
ATP
PLC?-LUC
+
CM
CD
o
ATP
OGBD
10 min
Figure 3.12 Ca2+ changes observed in CHO cells 24 hours following microinjection
CHO cells were microinjected with the fluorescent Ca2+ indicator OGBD (0.5mM) together with 
cDNA encoding LUC (top panel) or PLC^-LUC (centre panel). Cells were also injected with 
OGBD alone (bottom panel). The traces are representative of typical Ca2+ changes observed in 
some, but not all cells within each experimental group. Cells were imaged for OGBD fluorescence 
for at least 30 minutes prior to the addition of ATP (100pM, red arrow).
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3 HOURS
5 HOURS
24 HOURS
Proportion of cells 
showing oscillations
(%)
Frequency
(Spikes/hour)
Proportion of cells 
responding to ATP
(%)
n number 
(total cells)
LUC 35.1 ± 3.6 6.9 ±0 .9 99.8 ±0.3 4(47)
PLC^-LUC 36.0 ± 3.0 7.9 ± 1.0 99.3 ±0 .5 4(45)
OGBD 31.9 ±3 .7 7.0 ± 0.7 100 3(18)
LUC 25.1 ± 8.6 6.0 ±0 .9 100 4(29)
PLCS-LUC 31.0 ±3 .2 5.7 ±0 .6 99.8 ±0 .3 4(50)
OGBD 31.1 ±5 .9 6.0 ±0 .9 100 3(13)
LUC 31.0 ±4 .8 5.9 ±0 .8 99.0 ± 0.4 4(22)
PLCS-LUC 33.4 ± 3.9 6.2 ±1 .0 99.0 ± 0.6 4(21)
OGBD 29.0 ± 2.4 6.5 ± 0.8 99.3 ±0 .3 3(14)
Table 3.1 Ca2+ changes in CHO cells expressing PLC^-LUC at 3, 5 and 24 hours 
following microinjection.
CHO cells were injected with OGBD and cDNA encoding LUC or PLC^-LUC. Cells were also 
injected with OGBD alone. Cells were imaged for OGBD fluorescence at 3, 5 and 24 hours 
following microinjection. Data is given as mean ± S.E.M. n= the number of experimental runs. 
The total number of cells analysed is shown in parentheses.
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3.2.7 Resting intracellular Ca2+ levels in cells expressing PLC£-LUC
Basal Ca2+ levels in cells expressing PLC?-LUC were calculated from OGBD 
fluorescence data using the following equation:
[Ca2+] = Kd (F - Fmin)/(Fmax - F)
(Grynkiewicz et a/., 1985)
Where Kd, the dissociation constant for the rate of Ca2+ dissociation from OGBD 
in the cell cytoplasm was taken from the published value of 430nM (Thomas et 
al., 2000). Fmaxand Fmm represent maximum and minimum fluorescence signals 
respectively, and F represents fluorescent signal at any time. Fmax was the peak 
fluorescence after the addition of ionomycin (5pM) (Figure 3.13). lonomycin is a 
pore forming ionophore which mobilises intracellular Ca2+, enabling the 
calibration of the Ca2+ dependent fluorescence of OGBD. Fmin was approximated 
to be zero since the fluorescence of OGBD is extremely low in the absence of 
Ca2+ (Molecular probes). Figure 3.14 shows that the expression of PLC^-LUC in 
CHO cells does not affect the resting intracellular Ca2+ levels when compared 
with cells expressing LUC or cells injected with OGBD. This data suggests that 
the expression of PLC? in somatic cells has no obvious effect on resting 
intracellular Ca2+or spontaneous Ca2+ oscillations.
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Figure 3.13. Determination of maximal (Fmax) Ca2+ dependent intracellular OGBD 
fluorescence.
Fmax was determined at the end of each experiment by the addition of the ionophore ionomycin 
(5pM). This value in conjuction with the initial fluorescence (F), were used to calculate the resting 
intracellular Ca2+ concentration.
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Figure 3.14 Resting intracellular Ca2+ levels in CHO cells expressing PLC^-LUC
Resting intracellular Ca2+ levels were calculated by the method detailed in section 3.2.7. 
Intracellular Ca2+ levels of cells expressing PLC^-LUC (red) were compared with that of cells 
expressing LUC alone (blue) and cells injected with OGBD only (green). Data are given as mean 
± S.E.M (n=>3, 5-10 cells per experiment).
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3.3 Discussion
3.3.1 Microinjection is a suitable technique for the study of transient PLC? 
expression in somatic cells
Many techniques have been used for introducing cDNA into somatic cells, 
including chemical transfection (either by commercial lipid or calcium phosphate 
mediated transfer) and physical methods such as microinjection, elecroporation 
or sonoporation. Physical transfection methodologies are often used when either 
lipid or chemical mediated transfection is not possible (e.g. for expression in 
primary cells) and are not always considered to be the optimal choice for use in 
cell lines for various reasons, depending on the nature of the study. For example, 
microinjection cannot practically be used for expression in large populations of 
cells such as when attempting to establish a stably transfected cell line.
Calcium phosphate and lipid mediated transfer using Lipofectamine 2000 were 
optimised in this study, and were shown to generate moderate levels of 
recombinant protein expression. These techniques offer the advantage of being 
rapid and simple to perform, generating large numbers of successfully 
transfected cells with minimal effort. However, such techniques fail to permit the 
precise control of the amount, timing and location of cDNA delivery.
High transfection efficiencies were routinely obtained with the use of 
microinjection once the optimised conditions had been established. This 
technique offers control over the timing of cDNA delivery which allows for more 
accurate time course analysis in transient expression studies. Also, the proximity 
of cells displaying recombinant protein expression was greatly improved which 
enabled the analysis of larger cell numbers.
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3.3.2 Cellular localisation of PLC? in somatic cells appears to be dependent 
upon time after transfection
Macromolecular transport between the nucleus and cytoplasm of eukaryotic cells 
occurs via large multi-protein structures termed nuclear pore complexes (NPCs) 
that are embedded in the nuclear envelope (Suntharalingam et al., 2003; Tran et 
a/., 2006). Passive diffusion of molecules < 40kDa through NPCs does occur, 
however most macro molecules require specific transport signal sequences to 
enter and exit the nucleus via the NPC (Lange et al., 2007). Many proteins 
contain predicted nuclear localisation signal (NLS) and nuclear export signal 
(NES) sequences which are required for entering and exiting the nucleus. These 
targeting signals consist of a weak consensus of three to four hydrophobic 
residues which are often identified by computer searches (Pemberton et al., 
2005).
The site or region of the PLC? molecule responsible for its nuclear translocation 
ability has been shown to include residues 374-381 in the X/Y linker region, in 
which the basic amino acids Arg376, Lys377, Arg378, Lys379 and Lys381 are 
considered essential (Kuroda et al., 2006). Nuclear accumulation of PLC£ in 
somatic cells was reported to be a slow process, demonstrated by increasing 
levels of PLC^-Venus in the nucleoplasm of COS cells between 48 and 72 hours 
following lipid mediated transfection (Kuroda et al., 2006). The results in this 
chapter demonstrate a more marked increase in nuclear localisation with time 
after transfection, with CHO cells showing no obvious nuclear accumulation until 
24 hours after cDNA delivery by microinjection. This data also suggests that the
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transport of PLC£ into the nucleus of somatic cells is a gradual process 
dependent upon time after transfection.
It must be noted however that not all cells display an obvious pattern of nuclear 
accumulation at 24 and 48 hours following microinjection. Approximately 20% of 
cells have a distinct cytoplasmic distribution identical to the pattern observed at 
earlier time points. (Coward et al., 2006) also reported this cytoplasmic pattern of 
distribution in somatic cells 48 hours following transfection of PLC?, and suggest 
that it may be linked to cell cycle events. This is an interesting theory that 
supports the proposal that the nuclear localisation of PLC? observed in mouse 
zygotes and early embryos (Halet et al., 2004; Sone et al., 2005; Yoda et al., 
2004) may explain the cell cycle dependent regulation of Ca2+ oscillations after 
fertilisation (Halet etal., 2004; Sone eta l., 2005).
PLC61 has a nuclear import signal at a lysine-rich sequence in the C terminus of 
the X domain (Okada et al., 2002); however it is not accumulated to the PN 
(Yoda et al., 2004) or the nucleus (Yamaga et al., 1999). Nuclear import and 
export is balanced due to the existence of an export signal at a leucine rich 
sequence in EF1 (Kuroda et al., 2006; Yamaga et al., 1999). Kuroda et al., 
(2006) propose that I31-C43 in EF1 of PLC£ may correspond to the export signal 
sequence of PLC61, however this has not been experimentally verified. Should 
PLC£ contain a nuclear export signal, then differences in the rate of nuclear 
import and export may account for the two distinct patterns of cellular localisation 
observed.
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3.3.3 PLC£ expression has no obvious effect on intracellular Ca2+ 
homeostasis in somatic cells
PLC? expression has been reported to induce Ca2+ oscillations in -70%  of COS 
cells 24 hours following transfection, whilst the expression of D210R was without 
effect (Kuroda et al., 2006). This observation was made from a relatively small 
experimental group, with less than 20 cells in each category. In contrast to this, 
the results of this chapter suggest that the expression of PLC? has no effect on 
the cellular Ca2+ homeostasis of somatic cells. The oscillations recorded in cells 
expressing PLC£ were found to be present in a comparable proportion of cells in 
both control groups (i.e. cells expressing LUC alone, and cells injected with 
OGBD). Statistical analysis revealed no differences in the frequency of the 
oscillations observed, either between experimental groups or between each of 
the time points examined. CHO cells expressing PLC? also retained a response 
to receptor induced Ca2+ mobilisation, and resting Ca2+ levels were unaffected. It 
is possible that the oscillations observed are induced by the method of 
microinjection, or they could be due to spontaneous Ca2+ activity within this cell 
type. Calcium signalling is believed to play a crucial role in driving cells through 
different stages of the cell-division cycle (Kao et al., 1990; Poenie et al., 1985). 
For example, a surge in Ca2+ controls the nuclear envelope breakdown and exit 
from mitosis in eggs (Steinhardt et al., 1988). Changes in intracellular Ca2+ have 
also been shown to characterise the metaphase-anaphase transition (Poenie et 
al., 1986; Ratan et al., 1986) and G1/S phase transition (Russa et al., 2009) in 
some somatic cells, however the significance of these Ca2+ changes in the cell
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cycle remains to be determined. There is no evidence to suggest that the 
oscillations observed in this study are a direct result of PLC£ expression. These 
results show that PLC£ appears to have no obvious effect on intracellular Ca2+ 
homeostasis in somatic cells, irrespective of its cellular localisation, which 
suggests that its activity is specific to oocytes.
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CHAPTER 4 
INVESTIGATING THE EFFECTS OF PLC? 
EXPRESSION ON RECEPTOR INDUCED Ca2+ 
MOBILISATION AND HOMEOSTASIS
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CHAPTER 4 INVESTIGATING THE EFFECTS OF PLC? EXPRESSION ON 
RECEPTOR INDUCED Ca2+ MOBILISATION AND HOMEOSTASIS 
4.1 Introduction
4.1.1 Analysis of agonist induced Ca2+ transients
This study investigates the intracellular Ca2+ ([Ca2+]j) changes induced by 
adenosine triphosphate (ATP) in CHO cells expressing PLC£. [Ca2+]i was 
measured with the fluorescent Ca2+ indicator Fluo 3 in single cells (Chapter 2, 
section 2.2.8.1). The proposal is that a change in agonist-induced Ca2+ release 
will be evident if there is any major alteration of the lnsP3 signalling pathway.
In addition to its important role in cellular metabolism, ATP has also been shown 
to act as an extracellular signalling molecule (Burnstock, 1990; Dubyak et al., 
1993). ATP acts on many receptors including P2-purinergic receptors which have 
been classified into two main subtypes on the basis of their agonist and 
antagonist selectivity, and their molecular structure (for reviews see (Fredholm et 
al., 2000; Khakh, 2001; von Kugelgen et al., 2000). P2X receptors are ligand- 
gated ion channels which conduct Na+ and Ca2+ from the extracellular medium. 
To date, seven separate genes coding for P2X subunits have been identified and 
named as P2X1 through to P2X7 (Gever et al., 2006; North, 2002). P2X receptor 
subunits are comprised of two transmembrane spanning domains connected by 
a large extracellular loop, with intracellular carboxyl and amino termini. ATP 
binds to the extracellular loop of the P2X receptor, resulting in a conformational 
change in the structure of the ion channel that causes the opening of the ion- 
permeable pore allowing cations to enter the cell. In contrast, P2Y receptors are
131
G-protein coupled receptors (GPCRs), with a structure comprising seven 
transmembrane helices. To date, eight mammalian P2Y-receptors have been 
identified that have been subdivided into the five G(q)-coupled subtypes (P2Y1 , 
P2Y2 , P2Y4 , P2Y6 , P2Y11), and three G(ircoupled subtypes (P2Y12, P2Y13, P2Y14) 
linking them with phosphoinositide and adenylate cyclase metabolism 
respectively (von Kugelgen, 2006). The G(P) protein is a heterotrimeric G protein 
subunit that activates phospholipase C (PLC). PLC hydrolyses PIP2 resulting in 
the formation of two second messengers, DAG and lnsP3 (Berridge, 1993; 
Putney et al., 1993). DAG activates protein kinase C (PKC), and lnsP3 binds to 
InsPsR on the ER which leads to Ca2+ release (Ferris et al., 1989; Maeda et al., 
1991). With prolonged P2Y receptor activation, there is an associated Ca2+ influx 
in response to Ca2+ store depletion which is referred to as capacitative Ca2+ entry 
(CCE).
It has been shown that CHO cells endogenously express P2Y1 , P2Y2 and P2X7 
receptors (Iredale et al., 1993; Marcet et al., 2003; Marcet et al., 2004; Michel et 
al., 1998). In populations of CHO cells, the addition of ATP results in a rapid 
increase in intracellular Ca2+ followed by a slowly declining secondary (plateau­
like) phase. Omission of Ca2+, and inclusion of a non-specific calcium channel 
antagonist, such as Ni2+ in the extracellular medium, has been shown to prevent 
this secondary phase, suggesting that Ca2+ influx forms part of the overall 
response (Burnstock, 1990).
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Plasma m em brane
Figure 4.1 Signalling pathways of P2-purinergic receptors activated by ATP
Adenosine triphosphate (ATP) acts on two types of P2-purinergic receptors, one of which (P2X) is 
a ligand gated ion channel, and the other (P2Y) is a G-protein coupled receptor linked to the 
phosphoinositide signalling pathway via the Gq alpha subunit. Gq activates phospholipase C 
(PLC) which hydrolyses phosphatidylinositol 4,5-bisphosphate (PIP2) to form second messengers 
diacyl glycerol (DAG) and inositol-1,4 ,5-triphosphate (lnsP3). lnsP3 activates lnsP3 receptors 
(lnsP3R) on the endoplasmic reticulum (ER) which opens calcium (Ca2+) channels allowing 
mobilisation of Ca2+ into the cytosol.
4.1.2 Objective
In light of the involvement of lnsP3Rs in the Ca2+ cycling observed at fertilisation, 
this chapter investigated whether the expression of PLC? in CHO cells alters 
agonist-induced lnsP3R-dependent Ca2+ handling. This chapter also investigated 
whether PLC? expression induces subtle changes in basal cellular Ca2+ handling 
in this cell type. The methods implemented in this analysis are described in detail 
in section 4.2.
4.2 Method Development
4.2.1 Investigating the Ca2+ entry component of the ATP-induced transient 
in CHO cells.
The CHO cell line used in the present study was found to respond to ATP as had 
been shown previously (Burnstock, 1990), with the omission of extracellular Ca2+ 
resulting in a characteristically different response which clearly lacked the 
secondary phase, whilst the initial rapid increase in intracellular Ca2+ remained 
intact (Figure 4.2). This is a clear demonstration that the primary response 
following the addition of ATP is mediated solely by Ca2+ release from the ER, 
whilst the persistent elevation is underpinned by Ca2+ influx. This suggests that 
the Ca2+ response investigated in this thesis involves the combined action of P2Y 
purinergic receptors and capacitative calcium entry.
6O-1
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Figure 4.2 The ATP-induced transient in CHO cells
The effect of extracellular Ca2+ on the intracellular Ca2+ response elicted by ATP (100pM). CHO 
cells were loaded with the Ca2+ indicator Fluo 3 prior to imaging. Under control conditions (1.3mM 
extracellular Ca2+, represented by the blue line) the initial rapid increase in intracellular Ca2+ was 
followed by a slowly declining secondary plateau phase. However the omission of calcium from 
the extracellular medium (represented by the red line) resulted in a characteristically different 
response which clearly lacked the secondary plateau. Each of the traces shown is representative 
of 99% of the responses (n = 4,18-20 cells per experiment).
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4.2.2 Analysis methods implemented in the assessment of Ca2+ handling
The following characteristics of the Ca2+ responses in CHO cells were quantified 
in order to assess whether the expression of PLC? alters cellular lnsP3R- 
dependent Ca2+ handling. These parameters are illustrated and defined in figure 
4.3.
I. The amplitude of the Ca2+ release: This represents the magnitude of the 
change in Fluo 3 fluorescence following ATP addition, and was expressed as F- 
Fo/Fo, where F is the maximum fluorescence observed and Fo is the resting Fluo 
3 fluorescence determined in resting cells.
II. Rate of Ca2+ release: This is represented by a change in Fluo 3 fluorescence 
as a function of time (dF/dt), and was expressed as the relative increase in 
fluorescence over time, from basal to peak fluorescence.
III. The proportion of cells that did not exhibit ATP-induced Ca2+ release was 
analysed. These cells are referred to as being non-responsive.
IV. Basal cellular Ca2+ handling was examined using a form of noise analysis 
termed signal variability (SV) (Section 4.2.3).
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I. Amplitude of the 
Ca + release 
= F- Fo/Fq
A
Time
ti t2
Rate of Ca 
release
= (F-F0) / (t2-ti)
t
Non-responsive cells
IV. Signal Variability (SV) 
analysis of basal Ca2+ 
= sum of point to point 
differences from t3 to U 
(Section 4.2.3)
Figure 4.3 Schematic representations of the ATP-induced Ca2+ transient analysis 
parameters
I., II. and IV represent typical Ca2+ transients induced by the addition of ATP (100pM) in CHO 
cells loaded with fluo 3. The equations for the parameters measured are detailed alongside each 
figure. F = maximum fluorescence; F0 = basal fluorescence; U= time of agonist addition; t2 = time 
at which maximum fluorescence occurs. t3 to tt = 30 second time period used to calculate basal 
Ca2+ signal variability (SV). III. represents a typical trace of a cell that did not exhibit agonist- 
induced Ca2+ release. The black arrow corresponds to the time of the agonist addition.
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4.2.3 Analysis of basal cellular Ca2+ handling
This chapter examines the effect of PLC£ expression on basal cellular Ca2+ 
handling using a form of ‘noise analysis’ termed signal variability (SV). George 
and colleagues recently developed this novel calculation which quantifies subtle 
changes in cellular Ca2+ cycling that can be used to determine cell-to-cell signal 
variability, in addition to agonist-induced changes within the same cell (George et 
al., 2006). Commonly used indices of variability including standard deviation 
(SD), variance (SD2) and coefficient of variance (CoV = SD/mean) are all 
intrinsically linked to a constant mean signal level. Because of the drift in signal 
frequently observed in our CLSM experiments, these tools are not reliable 
measures of signal variability. The applicability of SV to cellular Ca2+ analysis has 
been extensively characterised (George et al., 2006) and its utility in signal noise 
analysis over and above SD, Variance and CoV have been shown (Fry, 2008). 
SV is calculated by the sum of point to point differences in Ca2+ dependent 
fluorescence signals and as such is not influenced by the small drift in the 
fluorescence signal frequently observed in CLSM experiments. SV is defined in 
figure 4.4.
As a pre requisite for this analysis, this chapter also examines the relationships 
between SV, mean fluorescence intensity and PMT voltage settings. This 
highlights the issues faced when comparing basal Ca2+ homeostasis between 
different cells exhibiting a broad range of fluorescence intensities.
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Figure 4.4 Definition of Signal Variability (SV)
Signal Variability is the sum of the moduli of the differences between successive intensity values.
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4.2.4 The use of fluo-3 to measure changes in intracellular Ca2+
The Ca2+ indicator fluo-3 was initially chosen to determine changes in 
intracellular Ca2+ in CHO cells expressing eYFP tagged constructs. This indicator 
was used due to its large dynamic range, low compartmentalisation tendency 
and appropriate apparent Ca2+ binding affinity (Thomas et al., 2000). Despite 
these desirable properties, fluo-3 has an almost identical excitation/emission 
profile to eYFP (Figure 4.5) and as a result it is not possible to easily distinguish 
between their respective fluorescences. These data are entirely consistent with 
that obtained in cells using a lambda scanning protocol and confocal microscopy 
(data not shown).
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Figure 4.5 Fluorescence emission spectra of enhanced yellow fluorescent protein 
(eYFP) and fluo-3.
The green line represents the emission spectra for eYFP and the dark blue line represents the 
emission spectra for fluo 3. The vertical light blue line indicates the position of the 488nm laser 
line. Spectra generated using Molecular Probe’s Fluorescence Spectra Viewer (Invitrogen). 
http://probes.invitrogen.com/servlets/spectraviewer
139
This posed two potential problems: 1) Cells expressing the eYFP tagged 
constructs may not be easily identified by their fluorescence when loaded with 
fluo-3, and 2) Changes in the intensity of fluorescence emitted in the 510-540nm 
region may not be solely due to Ca2+ dependent changes in fluo-3 if the eYFP 
fluorescence was altered by the addition of the agonist or Ca2+ itself. However, 
cells expressing eYFP tagged constructs were easily identified due to the 
fluorescence intensity of eYFP being significantly higher than that of fluo-3 
(Figure 4.6A). Additionally, the fluorescence intensity of eYFP remains unaltered 
following ATP induced Ca2+ mobilisation from the intracellular stores (Figure 
4.6B). This suggests that the fluorescence changes observed upon agonist 
addition to fluo-3 loaded cells expressing eYFP tagged constructs are due 
exclusively to changes in the fluorescence of fluo-3.
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Figure 4.6 eYFP Fluorescence is independent of ATP-induced Ca2+ release
A) Typical eYFP fluorescence intensity 3 hours following microinjection of DNA constructs is 
significantly higher than the fluorescence intensity exhibited by cells loaded with the Ca2+ 
indicator fluo-3. Data were acquired from regions of interest (ROI) representing single resting 
(non-stimulated) cells, of approximately 40pm2. Data are shown as mean ± S.E.M (n=4, the 
number of cells analysed is shown in the parentheses). ***=p<0.001. B) The amplitude of the 
change in eYFP fluorescence (F/F0) is given as the maximum fluorescence determined following 
ATP addition (F) expressed as a percentage of the eYFP fluorescence measured in resting cells 
(F0, 100%). Data represent mean values ± S.E.M  (n=4, the number of cells analysed is shown in 
the parentheses).
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4.2.5 Heterogeneity of eYFP expression
CHO cells display heterogeneous levels of eYFP fluorescence intensities during 
transient expression following microinjection, presumably as a result of varying 
levels of DNA delivery between cells (figure 4.7). In order to assess the 
association between fluorescence intensity and signal variability (SV), regions of 
interest (~40pm2 , >150 pixels) from 4 separate experiments were selected. The 
average fluorescence intensities per pixel were obtained at a photomultiplier tube 
(PMT) voltage setting of 1000V using a laser power of 20%. The relationship 
between fluorescence intensity and SV for each region of interest ROI is outlined 
in the scatter plot in figure 4.7(c). The fluorescence signal becomes increasingly 
saturated at fluorescence intensities above 120 (mean pixel value) due to an 8- 
bit image resolution that results in 28 (or 256) levels of intensity for each pixel. 
The signal from a defined ROI which typically comprises >150 pixels is 
intrinsically linked to sub-saturation pixels. As pixels within the ROI progressively 
saturate, the SV will appear to decrease. Therefore, two options presented 
themselves: either to set a threshold of fluorescence intensity above which data 
would be eliminated, or to adjust the PMT voltage setting thus enabling cells 
exhibiting higher levels of expression to be included in the analysis. Eliminating 
the data would have sacrificed a large number of data points and would also 
have prevented the examination of cells displaying higher levels of PLC? 
expression, hence this option was ruled out.
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Figure 4.7 Heterogeneity of eYFP expression following microinjection
a) eYFP expression in CHO cells 24 hours after DNA microinjection. Bar represents 20pm.
b) Bar chart representing actual eYFP fluorescence intensities across the transient phase of 
expression. Images were acquired at PM T voltage settings ranging 750V-1000V, and single cell 
fluorescence intensities were corrected post acquisition using the Boltzman equation in figure 4.8. 
Data is presented as mean ± SEM (n=4, number of cells analysed is shown in parentheses). 
*=p<0.05, **=p<0.01
c) Scatter Plot of data obtained from CHO cells expressing eYFP at 24 hours post DNA 
microinjection. All images were acquired at a PMT setting of 1000V. Each dot represents the 
signal variability (SV) and fluorescence intensity (arbitary units) of a single region of interest (ROI) 
(n=4)
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4.2.6 Understanding the effect of PMT voltage on fluorescent signals
Due to the correlation between signal variability and relative fluorescence 
intensity shown in figure 4.7 (c) (discussed further in section 4.2.7), It was 
important to assess the association between both of these parameters at 
different PMT voltage settings. Regions of interest (~40pm2) from 4 separate 
experiments were selected. The mean fluorescence intensities per pixel were 
obtained at PMT voltages ranging from 500-1250V in 100V increments, using a 
laser power of 20%. The relationship between PMT voltage, fluorescence 
intensity and SV for each ROI was plotted for fluo3 and eYFP (see figure 4.8).
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Figure 4.8 The dependency of fluorescence intensity and signal variability (SV) on 
PMT voltage settings.
PMT voltage plotted against (a) relative fluorescence intensity and (b) signal variability (SV) for 
fluo-3 and eYFP. (n = 4 for all traces, >74 ROI in each instance). The data was fitted to a 
Boltzman equation yielding the non-linear regression shown above each trace. The Boltzman 
sigmoidal equation is defined as Y=bottom+(top-bottom)/(1+exp((V50-X)/slope)).
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4.2.7 Correction of fluorescence signal intensity and signal variability (SV) 
for PMT Voltage
Given the dependency of fluorescence signal intensity and signal variability on 
voltage (Figure 4.8), experimental data would need correcting using the 
equations given in Figure 4.8. The linear portion of the relationship between 
voltage and fluorescence intensity /  SV for eYFP exists between -800V  and 
1100V. Due to the heterogeneity of eYFP expression, experiments were 
performed at PMT settings spanning this voltage range (Figure 4.9). The gradual 
decrease in PMT settings from 3-24 hours reflects the incremental increase in 
eYFP expression, such that a fluorescence signal intensity of approximately 120 
could be achieved at lower voltage settings. Upon data analysis, differences in 
voltage settings between experimental groups were found to create an artefact in 
the basal cellular Ca2+ handling data. Consequently, the experimental protocol 
employed during the investigation of cells expressing eYFP tagged constructs 
meant that fluorescent signals required correction post-aquisition. All SV and 
fluorescence intensities values were corrected to a PMT setting of 1000V using 
the equations outlined in figure 4.8.
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Figure 4.9 Photom ultiplier Tube (PM T) voltage settings used for Ca2+ imaging 
experiments on cells expressing eYFP-tagged constructs
CHO cells expressing eYFP tagged constructs and loaded with the Ca indicator fluo 3 were 
imaged at PMT voltage settings spanning the 800V-1100V range. Wild type (WT) CHO cells 
loaded with fluo 3 were imaged at -1 1 0 0 V  in all instances. Data is expressed as mean ± SEM 
(n=4, >360 cells in each experimental group. *=p<0.05, **=p<0.01, ***=p<0.001 when compared 
to WT CHO cells)
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4.2.8 Understanding the relationship between fluorescence intensity and 
SV
Initial analysis of Ca2+ signalling revealed a striking and expected correlation 
between signal variability (SV) and relative fluorescence intensity (Figure 4.10). 
Log transformation of fluorescence intensity produced a linear association 
between these parameters, enabling direct comparisons to be made between 
mean SV of different experimental groups. Due to this linear relationship, all 
comparisons of mean SV will be considered alongside relative fluorescence 
intensity values for the same experiments.
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Figure 4.10 Correlation between signal variability (SV) and mean fluorescence 
intensity
Scatter plot of data obtained from fluo-3 loaded CHO cells expressing eYFP showing the 
relationship between signal variability (SV) and mean fluorescence intensity (n=8, >600 cells). 
The rise in the intensity of the fluorescent signal is associated with an increase in SV (a). Log 
transformation of fluorescence intensity reveals a linear association with an r  value of = 0.8136 
and a p value of <0.001. Note that the data displayed here bears the typical profile of 
fluorescence intensities below 120 units as described in figure 4.7c.
0.8136
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4.3 Results
4.3.1 Microinjection of CHO cells does not alter cellular Ca2+ handling
Although the data presented in Chapter 3 suggests that under optimised 
conditions, microinjection was well tolerated by CHO cells, the microinjection 
procedure itself may modulate some aspects of cellular phenotype and 
signalling. Consequently, control experiments were performed to assess whether 
any changes in Ca2+ handling were attributable to microinjection. CHO cells 
microinjected with the buffer used for all microinjection experiments (KCI Hepes 
containing 2.5mg/ml Alexa 594) were compared with wild type CHO cells. Cells 
were loaded with fluo-3 AM and imaged for Ca2+ dependent fluo-3 fluorescence 
in KRH buffer using CLSM at 3, 5, 24 and 48 hours following microinjection. The 
average fluorescence intensities per pixel were obtained at a photomultiplier tube 
(PMT) setting of 1000V, using a laser power of 20%. Data were acquired from 
regions of interest (ROI) of ~40pm 2 representing global Ca2+ environments. 
Analysis revealed that the microinjection procedure did not alter the amplitude or 
temporal characteristics of the ATP-induced Ca2+ transient, and the number of 
cells displaying no response to ATP also remained unchanged (Figure 4.11). 
Signal variability (SV) analysis showed that microinjection did not have an effect 
the basal Ca2+ handling of CHO cells (Figure 4.12).
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Figure 4.11 Analysis of the effects of microinjection on the ATP-induced Ca2+ 
transient in CHO cells over a 48 hour time period.
The following parameters of the ATP-induced Ca2+ transients in wild type (WT) CHO cells (black) 
or CHO cells microinjected with KCL Hepes Buffer (B) (white) were analysed at 3, 5, 24 and 48 
hours: A) Amplitude of the Ca2+ release (F-Fo/Fo), B) Rate of the Ca + release, plotted as a 
change in the Ca2+ dependent Fluo 3 fluorescence per second and C) The number of cells 
exhibiting no response. Data are given as mean ± SEM. (n=4, number of cells analysed is shown 
in parentheses).
3 HRS 5 HRS 24 HRS 48 HRS
500 i
n.co ^
>  2 .2 5 0
COco>
U)
(480) (495)
X
(480) (467) (480) (413) (480) (316)
X X
W T  B W T  B W T B W T B
1.0 n
COc
© ^
— o
CD •
£ => 0.5
§ <  o  w
CO
2o3
LL
0.0
(480) (495) (480) (467) (480) (413) (480) (316)
W T B W T  B W T B W T B
Figure 4.12 Microinjection does not have an effect on basal cellular Ca handling
Signal variability (SV), where SV is the sum of point to point differences in Ca + signals over a 30 
second time period remains unchanged in CHO cells microinjected with KCI Hepes Buffer (B, 
white) when compared with wild type (WT) CHO cells (black) at 3, 5, 24 and 48 hours following 
microinjection. Changes in SV are considered alongside mean fluorescence intensities for each 
experimental group due to the linear relationship between these parameters. Data are given as 
mean ± SEM. (n=4, number of cells analysed is shown in parentheses).
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4.3.2 The expression of eYFP-PLC? does not alter the spatio-temporal 
characteristics of the ATP-induced Ca2+ transient.
The data presented in chapter 3 suggests that CHO cells are capable of 
expressing high levels of PLC? without any obvious effect upon Ca2+ handling. 
This raises the question as to how cell types other than the oocyte are capable of 
retaining PLC£ in a seemingly inactive state. Detailed analysis of intracellular 
Ca2+ handling could reveal subtle changes in the Ca2+ signalling machinery that 
may lead to a possible explanation of how cells are capable of expressing this 
protein whilst maintaining an apparently normal phenotype.
The ATP-induced Ca2+ transients of CHO cells expressing eYFP-PLC? were 
analysed using the parameters outlined in figure 4.3. They were compared with 
the agonist responses of CHO cells expressing eYFP alone, the inactive mutant 
eYFP-D210RPLC? and wild type (W T) CHO cells. Transfected cells were 
microinjected with high-purity plasmid DNA as described in Chapter 2 section 
2.2.5.4, and visualised for fluo-3 dependent changes in intracellular Ca2+ at 3, 5, 
24 and 48 hours after injection using CLSM. The average fluorescence 
intensities per pixel were obtained at photomultiplier tube (PMT) settings ranging 
from 800V to 1100V, using a laser power of 20%. Data were acquired from 
regions of interest (ROI) of ~40pm 2 representing global Ca2 environments. 
Analysis revealed that PLC£ expression at 3, 5, 24 and 48 hours did not alter the 
amplitude or temporal characteristics of the ATP-induced Ca2 transient, and the 
number of cells responding to ATP stimulation also remained unchanged 
(Figures 4.13 and 4.14).
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Figure 4.13 The expression of PLC£ has no effect on the ATP-induced Ca2+ 
transient in CHO cells at 3 and 5 hours post microinjection.
The following parameters of the ATP-induced Ca2+ transients in wild type (WT) CHO cells (black), 
and cells expressing eYFP (green), eY FP -D210RPLC£ (blue) or eYFP-PLC^ (red) were analysed at 
3 and 5 hours following transfection: A) Amplitude of the Ca2+ release (F- F0/Fo). B) Rate of the 
Ca2+ release, plotted as a change in the C a2+ dependent Fluo 3 fluorescence per second and C) 
The number of cells exhibiting no response. Data are given as mean ± SEM. (n=4, number of 
cells analysed is shown in parentheses).
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Figure 4.14 The expression of PLC^ has no effect on the ATP-induced Ca2+ 
transient in CHO cells over at 24 and 48 hours post microinjection.
The following parameters of the ATP-induced C a2+ transients in wild type (W T) CHO cells (black), 
and cells expressing eYFP (green), e Y F P -D210RPLC£ (blue) or eYFP-PLC^ (red) were analysed at 
24 and 48 hours following transfection: A) Amplitude of the Ca2+ release (F- Fo/F0), B) Rate of the 
Ca2+ release, plotted as a change in the C a2+ dependent Fluo 3 fluorescence per second and C) 
The number of cells exhibiting no response. Data are given as mean ± SEM. (n=4, number of 
cells analysed is shown in parentheses).
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4.3.3 The expression of eYFP-PLC? does not alter cellular basal Ca2* 
handling
SV was implemented to assess the basal Ca2+ handling in CHO cells expressing 
eYFP-PLC? at 3, 5, 24 and 48 hours following DNA microinjection. Comparisons 
were made with wild type (W T) CHO cells, and cells expressing eYFP or the 
inactive mutant eYFP-D210RPLCC Due to the aforementioned relationship 
between voltage, fluorescence intensity and signal variability (section 4.2.7), data 
were corrected post-acquisition to a PMT setting of 1000V. Data were acquired 
from regions of interest (ROI) of ~40pm2 representing global Ca2+ environments. 
Analysis revealed that the expression of PLC£ in CHO cells had no effect on 
basal cellular Ca2+ handling when compared with eYFP expressing controls 
(Figures 4.15 and 4.16). All cells expressing eYFP tagged constructs have 
significantly higher SV when compared with W T CHO cells; however this 
difference is almost certainly a consequence of eYFP expressing cells exhibiting 
significantly higher fluorescence intensities (Figures 4.15 and 4.16). It is possible 
however; that the subtle changes in Fluo-3 dependent Ca2+ signals may be 
concealed as a result of the higher levels of noise observed with eYFP 
fluorescent signals or indeed the unavoidable use of post-acquisition data 
correction.
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Figure 4.15 PLC^ expression has no effect on basal cellular Ca2+ handling at 3 and 
5 hours post microinjection
Signal variability (SV), where SV is the sum of point to point differences in Ca2+ signals over a 30 
second time period remains unchanged in CHO cells expressing eYFP-PLC^ (red) when 
compared with eYFP expressing control cells (eYFP; green and eYFP- 210RPLC£; blue) at 3 and 5 
hours following transfection. Changes in SV  are considered alongside mean fluorescence 
intensities for each experimental group due to the linear relationship between these parameters. 
Data are given as mean ± SEM. ** represents p<0.01 when compared with wild type (WT) CHO 
cells (n=4, number of cells analysed is shown in parentheses).
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Figure 4.16 PLC£ expression has no effect on basal cellular Ca2+ handling at 24 
and 48 hours post m icroinjection
Signal variability (SV), where SV is the sum of point to point differences in Ca2+ signals over a 30 
second time period remains unchanged in CHO cells expressing eYFP-PLC^ (red) when 
compared with eYFP expressing control cells (eYFP; green and eYFP-D210RPLC£ blue) at 24 and 
48 hours following transfection. Changes in SV are considered alongside mean fluorescence 
intensities for each experimental group due to the linear relationship between these parameters. 
Data are given as mean ± SEM. ** represents p<0.01 when compared with wild type (WT) CHO  
cells (n=4, number of cells analysed is shown in parentheses).
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4.3.4 The use of Fura Red enables the analysis of SV to be made 
independently of eYFP expression.
As a way of addressing the issues raised in section 4.2.4, SV was assessed 
under the same experimental conditions using a Ca2+ indicator that can easily be 
distinguished from the eYFP fluorescence signal (Figure 4.17). This prevented 
the need to adjust PMT voltage settings and consequently avoided any post­
acquisition data correction.
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Figure 4.17 Fluorescence em ission spectra of enhanced yellow fluorescent 
protein (eYFP) and Fura Red.
The green line represents the emission spectra for eYFP and the red line represents the emission 
spectra for Fura Red. The vertical light blue line indicates the position of the 488nm laser line. 
Spectra generated using Molecular Probe’s Fluorescence Spectra Viewer (Invitrogen). 
http://probes.invitrogen.com/servlets/spectraviewer
Transfected cells were microinjected with high-purity plasmid DNA as described 
in section 2.2.5.4, and visualised for Fura Red dependent changes in intracellular 
Ca2+ at 5 and 24 hours after injection using CLSM. The average fluorescence
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intensities per pixel were obtained at photomultiplier tube (PMT) settings of 
1000V, using a laser power of 20%. Data were acquired from regions of interest 
(ROI) of -40pm2 representing global Ca2+ environments. Analysis revealed that 
the expression of PLC? in CHO cells had no effect on basal cellular Ca2+ 
handling when compared with eYFP expressing controls and wild type (WT) 
CHO cells (Figure 4.18), confirming the assertion in section 4.3.4 that any 
significant changes in SV were a consequence of differences in eYFP 
fluorescence intensities between experimental groups.
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Figure 4.18 The use of Fura Red to assess SV confirms that PLC^ expression has 
no effect on basal cellular Ca2+ handling at 5 and 24 hours post microinjection
Signal variability (SV), where SV is the sum of point to point differences in Ca signals over a 30 
second time period remains unchanged in CHO cells expressing eYFP-PLC^ (red) when 
compared with eYFP expressing control cells (eYFP; green and eYFP- PLC£ blue) and wild 
type (WT) CHO cells (black) at 5 and 24 hours following transfection. Data are given as mean ± 
SEM. (n=4, number of cells analysed is shown in parentheses).
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4.4 Discussion
4.4.1 Microinjection does not affect Ca2+ signalling in CHO cells over a 48 
hour time period.
This chapter demonstrates that microinjection does not have an effect on the 
agonist-induced lnsP3R-dependent Ca2+ transient, or on cellular basal Ca2+ 
handling in CHO cells 3-48 hours after DNA delivery. Microinjection did not alter 
the amplitude or rate of Ca2+ release of the transient generated by the addition of 
extracellular ATP. The proportion of cells failing to respond to agonist stimulation 
also remained unchanged. Analysis of signal variability (SV) revealed that 
microinjection also has no effect on Ca2+ cycling in resting (non-stimulated) CHO 
cells. This method of DNA delivery was therefore deemed suitable for the 
assessment of the affects of transient PLC£ expression on Ca2+ signalling in this 
cell type.
4.4.2 The advantages and disadvantages of the use of Fluo 3 as a Ca2+ 
indicator in cells expressing enhanced yellow fluorescent protein (eYFP).
The use of a ratiometric Ca2+ indicator would have been favourable, due to their 
ability of providing Ca2+ measurements that are independent of indicator 
concentration, thereby avoiding issues with uneven indicator distribution. 
However, such indicators require UV excitation which was not achievable with 
the lasers available on the confocal microscope used in this study. This limited us 
to the use of single wavelength indicators, preferably those exhibiting a large 
dynamic range (i.e. the change in intensity upon Ca2 binding is large, giving a
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higher signal-to-noise ratio thus allowing the measurement of small changes in 
Ca2 ) and minimal compartmentalisation. Despite Fluo-3 having an almost 
identical emission profile to eYFP, preventing distinction between their respective 
fluorescences, it was shown that the eYFP fluorescence was independent of ATP 
or the mobilized Ca2+. This indicates that the determination of agonist-induced 
Ca2+ release in this study, calculated by the measurement of relative changes in 
intracellular fluorescence was entirely attributable to Ca2+ dependent changes in 
fluo 3 fluorescent signals. However, eYFP was expressed at levels which 
resulted in significantly higher fluorescence intensities when compared with fluo 
3. This meant that we could not discount the possibility that any subtle changes 
in cellular basal Ca2+ handling were being concealed by the noise of the eYFP 
signal. Fura Red is a visible wavelength excitation fluorescence indicator that 
offers both single wavelength and ratiometric Ca2+ measurement by excitation at 
420nm and 480nm. When used as a single wavelength indicator with excitation 
at 488nm, Fura red exhibits a decrease in emission upon Ca2+ binding. When 
measuring a large Ca2+ transient the signal falls to background levels. This 
property renders Fura Red less suitable as an indicator for measuring the spatio- 
temporal characteristics of the ATP-induced Ca2+ transients in CHO cells. Fura 
Red does however offer certain advantages in the analysis of SV of basal cellular 
Ca2+ handling in cells expressing eYFP, namely due to its red emission profile 
which eliminates interference from the yellow part of the visible spectrum.
This chapter also reports on the issues faced when using a novel method of 
‘noise’ analysis to determine C a2+ signal variability in cells exhibiting a broad
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range of fluorescent intensities, with emphasis on the need to employ an 
experimental set up that utilises a Ca2+ indicator with a fluorescence emission 
that can be easily distinguished from the emission of the reporter protein.
4.4.3 PLC? expression does not alter intracellular Ca2+ handling in CHO 
cells.
Acknowledging the limitations of the present experimental system, the data 
presented in this chapter is consistent with the concept that PLC? does not alter 
agonist-induced Ca2+ responses or basal intracellular Ca2+ signals in CHO cells 
between 3 and 48 hours following DNA microinjection. This finding is confirmed 
by the use of the enzymatically inactive D210R mutant, which is entirely 
comparable to the data derived from full length PLC?. The amplitude and rate of 
Ca2+ release of the agonist-induced transient remained unchanged when 
compared with that of wild type (W T) CHO cells, and cells expressing eYFP or 
the inactive mutant D210R-PLC?. The proportion of cells failing to respond to 
agonist stimulation was also unaffected. Analysis of signal variability (SV) 
revealed that PLC£ expression has no effect on Ca2+ cycling in resting (non­
stimulated) CHO cells. These findings suggest that PLC? expression fails to 
perturb the InsPaR-dependent signalling pathway in CHO cells at the time points 
assessed. The possibility that PLC£ expression stimulates InsPaR-induced Ca2+ 
release in CHO cells at time points other than those examined can not be 
discounted. Additional experiments involving the microinjection of RNA encoding 
PLC£, or indeed PLC£ protein could enable the monitoring of intracellular Ca2+ at 
earlier time points. This could reveal if PLC£ has an initial effect on Ca
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signalling upon its introduction to the intracellular environment of CHO cells that 
is subsequently “switched off’ resembling the cessation of Ca2+ oscillations at 
fertilisation. However, time limitations precluded these interesting further 
investigations.
CHAPTER 5 
STABLE EXPRESSION OF PLC? IN CHO CELLS
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CHAPTER 5 STABLE EXPRESSION OF PLC? IN CHO CELLS 
5.1 Introduction
5.1.1 Mammalian expression systems
The production of protein in mammalian cells is an important tool in which 
recombinant protein function and effects of protein expression on dynamic cell 
signalling pathways can be studied. Cultivated mammalian cells possess the 
appropriate machinery for protein folding and post-translational modification that 
enable the production of fully active proteins with correct conformation. Chinese 
Hamster Ovary (CHO ) cells are widely used for transfection, expression and 
large scale recombinant protein production. Since CHO cells provide precise and 
stable glycosylation, they have the ability to produce a post-translationally 
modified product that is a more accurate in vitro rendition of the natural protein 
(Sheeley et al., 1997; W erner et a i ,  1998). Transfected genetic material can be 
expressed in target cells either temporarily or permanently depending on the 
methods utilized and the experimental questions being investigated.
Transient transfections are used most commonly to analyze the short term (~48 
hours) consequences of protein expression. Genetic material is introduced and 
gene products are expressed in the target cells however the nucleic acids do not 
integrate into the host cell genome. Within a few days most of the foreign DNA is 
degraded by nucleases or diluted by cell division, and after a few weeks its 
presence can no longer be detected. Stably transfected cells produce 
recombinant proteins on a continuous basis (months to years), and therefore
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require the transfected DNA to replicate in synchrony with the cell. This occurs as 
a result of spontaneous and random integration of the transfected DNA into the 
cells genome by recombination (Chisholm, 1995). As integration is a rare 
phenomenon (1 in 104 for mammalian cells), cells exhibiting stable expression 
must be selected and amplified by using selectable markers, for example by 
transfecting a gene of non-mammalian origin that establishes drug resistance in 
cell culture. Frequently, the DNA of interest is transfected with the selectable 
marker on the same plasmid, with a separate transcription unit.
One of the most commonly used selectable markers in mammalian culture is the 
bacterial aminoglycoside phosphotransferase gene (neo). Expression of this 
gene confers resistance to the antibiotic G418 sulphate (Geneticin®, Invitrogen) 
by directing the synthesis of the aminoglycoside phosphotransferase enzyme 
(APH), which renders the antibiotic inactive through phosphorylation. G418 is 
similar in structure to neomycin, kanamycin and gentamycin which kill non- 
resistant eukaryotic cells by blocking protein synthesis through interference with 
the function of the 80S ribosomal subunit. After transfection, cells are grown in a 
medium containing the selective anitibiotic. Selective pressure is applied over a 
period of 2-3 weeks or more, with frequent changes of medium to eliminate dead 
cells and debris, until stable transfectants, which appear as distinct antibiotic- 
resistant clones, can be isolated and subcloned to multiwell plates for further 
propagation in selective medium.
Transient transfection of cells has the advantage of being a rapid process 
particularly useful for monitoring the efficiency of transfection procedures and for
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verifying plasmid expression. Conversely, stably transfected cell lines circumvent 
the need for repeated transient transfection. Despite the time and effort involved 
in the generation and screening of stable cell clones expressing the protein of 
interest, once established, the stably transfected cell population provides a 
source of biological material that is readily available for further experimentation. 
As discussed in chapter 3, transient expression of PLC£ tagged with venus 
(Kuroda et a/., 2006) and eYFP (Coward et a!., 2006) has been previously 
documented in COS-7 cells (a mammalian cell line derived from the kidney cells 
of the African green monkey). These investigations reported on the cellular 
localisation of the protein and its effects on Ca2+ homeostasis during the transient 
expression period. Despite the existence of these expression studies, a 
mammalian cellular system providing stable expression of PLC£ has yet to be 
reported.
5.1.2 Oocyte activation
The sperm factor theory describes a mechanism by which a soluble sperm factor 
is responsible for fertilisation induced Ca2+ oscillations (Swann, 1990; Swann et 
a/., 1994). The identification of the sperm factor has been investigated by 
isolation and purification of sperm extracts. Dale et a/.,(1985) demonstrated that 
injection of a soluble fraction of sea urchin spermatozoa activates unfertilised sea 
urchin eggs and produced signs that a Ca2+ increase had taken place. This result 
was the first to suggest that fertilisation could occur successfully without any 
sperm-egg surface interaction. Since then, the method of injecting sperm extracts
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has been employed to investigate the sperm factor theory across a range of 
species. In the species studied so far including pig (Machaty et a i, 2000), 
hamster (Swann, 1990), mouse (Swann, 1994), human (Homa et a i, 1994) and 
cow (Wu et a i,  1997), sperm extract injections activates oocytes with repetitive 
intracellular Ca2+ oscillations, similar to those that occur during fertilisation. In 
addition to this non-mammalian sperm extracts from xenopus, chicken and fish 
are also able to induce Ca2+ oscillations in mouse eggs (Coward et a i, 2003; 
Dong etal., 2000). Parthenogenetic activation of mammalian oocytes is artificially 
induced by chemical agents including calcium ionophore (Steinhardt et a i, 
1974b), ethanol (Cuthbertson, 1983), strontium (Fraser, 1987) and 
cyclohexamide (Bos-Mikich et a i,  1995). However, unlike sperm extracts the 
majority of the parthenogenetic treatments cause a monotonic increase in 
intracellular Ca2+.
Another indisputable body of evidence in support of the soluble sperm factor 
theory came from intra-cytoplasmic sperm injection (ICSI), in which a single 
sperm is injected directly into an egg. This process, which bypasses the 
interaction of the sperm and egg, gives rise to intracellular Ca2+ oscillations 
(Nakano et a i, 1997) and results in successful egg activation and development 
(Kimura et a i, 1995b). It has been shown that round spermatids (precursor male 
gametes) possess the potential to achieve fertilisation and embryonic 
development when injected into eggs (Kimura et a i, 1995a; Kimura et a i, 
1995c). However, the injection of round spermatids alone in mouse eggs is not 
capable of inducing an increase in intracellular Ca2 and fails to result in egg
activation (Kimura e ta l., 1995a; Kimura et a i,  1995c; Sato eta!., 1998). Methods 
for assisted egg activation for successful fertilisation by round spermatid injection 
include; the application of a high voltage pulse (Kimura et al., 1995a; Kimura et 
a i, 1995c; Sasagawa et al., 1996), and simultaneous injection with the InsPaR 
agonist adenophostin (Sato et a i ,  1998) or sperm extracts (Sakurai et a i, 1999). 
The expression of recombinant PLC? using a mammalian cell expression system 
could provide a means of generating an alternative egg activation agent.
5.1.3 Objective
Chapter 4 describes how the transient expression of PLC? fails to modulate Ca2+ 
signalling in CHO cells, perhaps signifying that this protein is retained in an 
inactive form in this cell type. However, the possibility that this method of 
expression has resulted in the production of a form of PLC? that is not fully 
functional cannot be overlooked. The overall aim of this chapter was to use CHO 
cells as a stable cellular expression system to produce PLC? protein at high 
levels. The Ca2+ mobilizing activity of the PLC£ produced in this somatic cell line 
was subsequently examined in mouse oocytes.
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5.2 Results
5.2.1 Establishing a mammalian system for the stable expression of PLC?
5.2.1.1 G418-mediated selection of cells expressing eYFP tagged 
constructs
Because each eukaryotic cell line demonstrates a different sensitivity to the 
selective antibiotic G418 (with some exhibiting complete resistance to it), the 
optimum concentration required to kill non-transfected cells must be established 
for each new cell line or strain used for stable transfection. This is achieved by 
determining a killing curve for the cell line of interest. Prior to transfection, a 
dose-dependence curve was conducted on CHO cells to determine a suitable 
working concentration of G418 that would eliminate non-resistant cell populations 
(Figure 5.1). Since G418 only kills cells that are actively growing, CHO cells were 
seeded at a low density (1 x 105) in wells of a 6 well plate in order to prevent the 
cells becoming confluent over the duration of the experiment. The cells were 
exposed to increasing concentrations of G418 (0-1 mg/ml, in 100pg/ml 
increments) for 8 days (n=3 per dose). Cells remaining after the 8 day incubation 
were harvested and counted by haemocytometry, shown in Figure 5.1. 
Increasing concentrations of G418 resulted in greater levels of cell death over the 
8 day period. The dose at which G418 kills 50% of cells (Tox50) was ~100pg/ml. 
For this study, the concentration of G418 deemed sufficient to select for stable 
expression was 500pg/ml, as it was the lowest dose that eliminates the majority 
of cells following an 8 day incubation.
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Figure 5.1 G418 dose-dependent elimination of non-resistant cell populations
CHO cell exposure to a range of G418 concentrations (0-1 mg/ml) resulted in a dose dependent 
elimination of cells after 8 days. Tox50 (dose which resulted in the death of 50% of cells) is 
displayed on the graph, (data is presented as mean ± S.E.M. n=3 for each dose).
5.2.1.2 CHO cells express eYFP-PLC? at low fluorescence intensities 
following antibiotic selection
The overall aim within this chapter was to devise a method to produce the PLC? 
protein at levels high enough for assessment of its Ca2+ mobilising activity within 
oocytes. The presence of the neo  gene on the eYFP tagged constructs enabled 
the selection of cells exhibiting stable expression following lipid mediated 
transfection using G418 (500pg/ml). Selective pressure was applied to cells that 
had undergone transfection either with the eYFP or eYFP-PLC? construct for a 
period of two weeks, until distinct antibiotic-resistant clones were evident. eYFP 
facilitated the assessment of the generation of these stably transfected cells by 
flow cytometry. Figure 5.2 (a) is a typical two dimensional dot plot of forward 
scatter (FSC) vs side scatter (SSC), generated from data acquired by flow
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Figure 5.2 Flow cytom etry data
Figure 5.2 (a) is a typical two dimentional dot plot of forward scatter (FSC) vs side scatter (SSC). 
The majority of the cells appear as a dense population of dots; each dot represents one acquired 
event. The isolated subset of cells used for further analysis is indicated by the gate drawn on the 
dot plot; thus excluding small cellular debris and large aggregates from subsequent analysis. The 
percentage of cells typically isolated within this gated region is indicated on the plot. 3 separate 
FSC vs SSC profiles measuring 5000 individual events/cells are acquired for each sample 
analysed by flow cytometry.
Figure 5.2 (b) shows typical overlayed histograms that were derived from two-dimentional dot 
plots as shown in figure 5.2 (a). This data is representative of the distribution of fluorescence 
intensities for the events acquired 2 days following transfection. The red line represents non­
transfected CHO cells (negative control) and serves as a reference point against which all other 
experimental samples are compared. Cells expressing eYFP at fluorescence intensities that are 
higher than CHO cell auto-fluorescence are referred to as being positively labelled. The threshold 
for positively labelled cells is indicated by the horizontal blue line. The proportion of cells to the 
right of this threshold is used to calculate the percentage of positively labelled cells, as indicated 
by the gate drawn on the trace.
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cytometric analysis of a single experimental sample. Dot plots display data from 
each particle/cell as a dot within both coordinate axis; one dot represents one 
acquired event. FSC provides a measure of the size of each event, whilst SSC is 
a measure of the granularity or inner complexity (i.e. shape of the nucleus, the 
amount and type of the cytoplasmic granules or the membrane roughness). The 
positions of the dots reflect the relative intensities of the two measured 
parameters for the event. The majority of cells appear as the most dense 
population of dots. Gates/ regions are a feature of flow cytometry analysis 
software that enables definition of boundaries around populations of interest. It is 
done by graphically drawing the gate/region after the raw data plot has been 
created, as illustrated in figure 5.2 (a). Gates are most often drawn to isolate 
subsets of cells for further analysis. For all flow cytometry experiments in this 
study, gating was used to isolate the majority of cells (typically >95%) which 
appear as the dense population of dots, and to exclude small cellular debris and 
large aggregates from subsequent analysis. The data from this isolated 
population was then used to construct a histogram depicting the number of cells 
and their relative fluorescence intensities as shown in figure 5.2 (b). Histograms 
are useful for flow cytometry data analysis as they allow the visualisation of the 
distribution of a single measured parameter (e.g. fluorescence) for the acquired 
events.
Overlayed histogram plots, as shown in figure 5.2 (b) are a valuable means of 
qualitatively comparing fluorescence intensities of different samples. 
Percentages of positive-expressing cells with fluorescence intensity values above
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a set threshold (e.g. cell autofluorescence) can be determined by drawing a gate 
once the histogram has been generated. Negative control samples (i.e. non­
transfected CHO cells) were acquired at the beginning of each flow cytometric 
analysis in order to establish a baseline reference point. The sensitivity of the 
fluorescent channel photomultiplier tube (PM T) was adjusted so that the negative 
control cells appear with intensities that are near zero but still on scale. This 
sample allows the assessment of the natural or auto-fluorescence of CHO cells, 
and establishes a reference point that can be used when describing the intensity 
of eYFP positive cells in subsequent experimental samples. Fluorescent 
intensities of experimental samples are relative to control samples, and cells 
expressing eYFP above the level of cell background auto-fluorescence are 
^escribed as being positively labelled. Positively labelled cells are gated for as 
illustrated in figure 5.2 (b) and expressed as a percentage of total cells. Following 
lipid mediated transfection, a sample of cells was removed from culture at 5 
hours, and then daily for a period of two weeks in order to assess levels of eYFP 
expression.
The data in Figure 5.3 shows that the typical transfection efficiencies for eYFP  
and eYFP-PLC? transfectants were 3.9 ± 0.1%  and 3.4 ± 0.3% respectively at 5 
hours, with the percentage of positively labelled cells rising to 28.4 ± 0.5% and 
16.6 ± 0.5% at day 2 corresponding to the peak of the transient transfection 
period. Following this, the levels of positively labelled cells fall to 10.6 ± 0.4%  
(eYFP) and 1.1 ± 0.2%  (eYFP-PLC£) which coincides with the period prior to 
complete antibiotic selection when non-transfected cells comprise part of the
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Figure 5.3 Analysing the generation of stable cell populations by flow cytometry
Figure 5.3 shows the proportion of positively labelled cells over a period of 2 weeks following the 
transfection of CHO cells with DNA encoding eYFP (represented by the green line) or eYFP- 
PLC£ (represented by the blue line). The red line represents non-transfected CHO cells (negative 
control) and serves as a reference point against which all other experimental samples are 
compared. Data is expressed as a percentage of the total number of cells (mean ± S.E.M). 
Results are representative of at least 6 separate transfections.
overall population. After 8 days of selective pressure, the point at which the 
majority of non-transfected cells are eliminated, the number of positively labelled 
cells increased gradually, before reaching a plateau of ~ 26% (eYFP) and ~ 4%  
(eYFP-PLCO- After the 14th day, the proportion of positively labelled cells failed 
to increase significantly beyond this level (data not shown). The overlayed 
histogram in figure 5.2 (b) shows that both eYFP and eYFP-PLC? stably 
transfected cell populations contain a large proportion of cells that are not 
positively labelled. It is possible that these cells fail to express the protein of
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interest; however this does not explain their resistance to G418. A more probable 
explanation is that they express eYFP at levels that fall below the limit of positive 
detection, and as a result are not easily distinguishable from CHO cell 
autofluorescence. eYFP-PLC? stables express significantly less positively 
labelled cells when compared with eYFP stables, thus making selection of a 
highly expressing clone by serial dilution more difficult.
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5.2.1.3 Enrichment of the stable eYFP-PLC? cell line
As a means of increasing the total number of positively labelled cells within the 
stably transfected eYFP-PLC? population (i.e. cells with fluorescence intensities 
distinguishable from CHO cell auto-fluorescence), cell suspensions were 
subjected to fluorescence activated cell sorting (FACS). Positively sorted cells 
characterised by fluorescence intensities that are higher than CHO cell 
autofluorescence were selected and cultured in the presence of G418 to maintain 
selection of eYFP-PLC£ expressing cells. A sample of cells was removed from 
the culture 7 days post FACS and analysed by flow cytometry (Figure 5.4 b). 
FACS failed to eliminate all cells expressing below the positively labelled 
threshold. However, the proportion of positively labelled cells increased from 3.8 
± 0.6% to 22.4 ± 0.2%, thus increasing the probability of isolating a highly 
expressing clone by serial dilution. FACS sorted cells were subjected to serial 
dilution, and cells propagated from single clone colonies were screened by flow 
cytometry. Two of the thirty six single clone colonies exhibited a shift in 
fluorescence as depicted in figure 5.4 (c), with 67.2 ± 0.4% of cells displaying 
eYFP fluorescence intensities ~100 fold higher than CHO cell auto-fluorescence, 
whilst the remaining cells within the population continued to express at levels 
below the limit of positive detection.
Repeated propagation of these cells by serial dilution out-cloning, failed to 
increase the proportion of positively labelled cells resulting in a dual expressing 
population. However, an additional round of FACS selecting for the positively 
labelled cells, combined with further propagation by serial dilution out cloning
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Figure 5.4 Enrichm ent of the stable eYFP-PLC^ cell line
This figure shows overlayed histograms representing the distribution of fluorescence intensities of 
non-transfected cells (negative control, red line), and cells exhibiting stable expression of eYFP- 
PLC£ (green line). The horizontal blue line represents the threshold for positive detection. Each 
histogram was generated by flow cytometric analysis, and corresponds to a different stage in the 
process of enrichment of eYFP expression; these stages are indicated to the right of the figure. 
Transfected cells that had been selected by G418 for a period of two weeks (A) were subjected to 
fluorescence activated cell sorting (FACS) (B). Single cell clones were then generated by serial 
dilutions (C), which were subsequently enriched further by an additional round of FACS and out- 
cloning (D).The proportion of positively labelled cells are indicated on each histogram (expressed 
as a percentage of total cells, mean ± SEM  of three acquisitions measuring 5000 events).
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resulted in the isolation of the cell population depicted in figure 5.4 (d). This cell 
line exhibits stable expression of eYFP-PLC? with 97.6 ± 0.1% of cells displaying 
fluorescence intensities ~100 fold higher than CHO cell autofluorescence. This 
pattern of stable expression was maintained for 4 months despite continual cell 
propagation, and is unaffected by cryostorage (as described in Chapter 2, 
section 2.2.4).
In addition to flow cytometric analysis, images were taken of the cells during 
each stage of the enrichment process using CLSM (Figure 5.5). The viability of 
the cells exhibiting stable eYFP-PLC? expression does not appear to be 
compromised. These data suggest that CHO cells are capable of tolerating high 
levels of stable PLC£ expression. The level of eYFP-PLC? expression exhibited 
by this stable cell population should reflect high levels of protein production, 
which will facilitate the assessment of the Ca2+ mobilising activity of this 
mammalian cell line generated PLC? in mouse oocytes.
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Figure 5.5 Images of the stable eYFP-PLC^ cell line
Figure 5.5 shows confocal images of the stable eYFP-PLC£ cell line at each stage of the 
enrichment process. See text for further details. Scale bar represents 50pm.
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5.2.2 Microinjection of eYFP-PLC? cell extracts
One possibility is that CHO cells tolerate high levels of eYFP-PLC? as it is being 
expressed in a form that is not fully functional. The following experiment involving 
the injection of cell extracts into mouse oocytes was carried out in order to 
determine if the PLC£ generated possesses Ca2+ mobilising activity. Cell extract 
injections were peformed in collaboration with Karl Swann. Metaphase ll-arrested 
mouse eggs were collected and loaded with Fura red as described in Chapter 2, 
section 2.2.13. Intracellular Ca2+ was monitored immediately following 
microinjection of cell extracts prepared from non-transfected CHO cells (negative 
control), and cells exhibiting stable expression of eYFP (-73 .4  ± 0.6% positively 
labelled), or eYFP-PLC^ (97.6 ± 0.1% positively labelled) (cell extracts were 
prepared as described in Chapter 2, section 2.2.11). Typically 3-5 eggs were 
injected over a period of 10-20 seconds before being transferred to the 
fluorescence imaging system within 1-2 minutes. Figure 5.6 shows that no 
change in intracellular Ca2+ was observed following microinjection of either the 
negative control (n=4) or eYFP extract (n=6). Microinjection of extracts prepared 
from cells expressing eYFP-PLC? induced a rapid increase in intracellular Ca2+ 
within 1-2 minutes followed by series of repetitive Ca2+ oscillations in 100% of 
oocytes (n=14). The frequency of the Ca2+ oscillations observed was 11.4 ± 1.4 
spikes/hour, which persisted for the duration of the recording (typically 1-1.5 
hours). These data suggests that the stable eYFP-PLC^ cell line is expressing 
some active PLC? that is capable of inducing Ca2+ oscillations in oocytes that are 
comparable to those observed with sperm extract injections (Swann, 1994).
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Figure 5.6 Microinjection of cell extracts into mouse oocytes
This figure shows the intracellular C a2+ responses in mouse oocytes following the microinjection 
of extracts prepared from cells expressing eYFP-PLC^ (A), eYFP (B) or non-transfected CHO  
cells (C). Each trace is a recording from a single oocyte, and is representative of the typical 
observations made in each experimental group. The number of eggs within each group is 
indicated on every trace alongside the Ca2+ oscillation frequencies observed (expressed as mean 
± SEM). The image to the right shows a bright field image of oocytes that have been injected with 
the eYFP-PLC^ extract.
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5.2.3 Microinjection of single CHO cells expressing eYFP-PLC?
It is possible that a large proportion of the PLC? expressed by the eYFP-PLC? 
cell line is inactive and this cannot be assesed by the injection of cell extracts. 
The following experiment involving the microinjection of single CHO cells into 
mouse oocytes was carried out in order to estimate the amount of active PLC£ 
contained within a single CHO cell. Single cell injections were performed in 
collaboration with Yuansong Yu using a technique comparable to that of ISCI. 
Metaphase ll-arrested mouse eggs were collected and loaded with Fura PE3-AM 
as described in Chapter 2. Single CHO cells were drawn into the end of a 
micropipette of internal diameter slightly less than that of the cell, so as to break 
or weaken the cell wall while disturbing as little as possible the cytoplasm that 
surrounds the nucleus, a method devised by (Briggs et al., 1952). This technique 
also resembles a method that is commonly used for cloning experiments 
whereby cell nuclei are transferred into enucleated oocytes (Wakayama et al., 
1999). Intracellular Ca2+ was monitored immediately following microinjection of 
either non-transfected CHO cells (negative control), or cells expressing eYFP- 
PLC? (from the enriched stable cell population). Single cells were injected into 
single mouse eggs before being transferred to the fluorescence imaging system 
within 1-2 minutes. Figure 5.7 shows that no change in intracellular Ca2+ was 
observed following the microinjection of negative control cells (n=14). The 
injection of cells expressing eYFP-PLC? induced a series of repetitive Ca2+ 
oscillations in 15/23 eggs which persisted for the duration of the recording 
(typically 1-6 hours). As observed with the cell extract injections (Figure 5.6) the
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Ca2+ response was rapid, with the initial transient taking place within minutes of 
the cell injection. The frequency of the Ca2+ oscillations observed was 4.3 ± 0.8 
spikes/hour. This data suggests that individual CHO cells are expressing active 
PLC£ at levels capable of inducing Ca2+ oscillations in mouse oocytes that are 
comparable to those observed following sperm extract injections (Swann, 1994).
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Figure 5.7 Microinjection of individual CHO cells into mouse oocytes
This figure shows the intracellular C a2+ responses in mouse oocytes following the microinjection 
of single intact CHO cells either expressing eYFP-PLC^ (A), or non-transfected controls (B). Each 
trace is a recording from a single oocyte, and is representative of the typical observations made 
in each experimental group. The number of eggs within each group is indicated on every trace 
alongside the Ca2+ oscillation frequencies observed (expressed as mean ± SEM).
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5.3 Discussion
5.3.1 Generation and enrichment of the stable eYFP-PLC? cell line
To date, there have been no reports of a stable cell line expressing PLC?. 
Expression of the recombinant PLC£ protein has proven difficult in bacterial 
expression systems, particularly with regards to expressing the more potent 
human form of the protein. Following antibiotic selection of CHO cells transfected 
with eYFP-PLC^, it would have been easy to assume that these mammalian cells 
also had difficulty expressing this protein, as upon microscopic inspection, only a 
very small percentage expressed eYFP above the limit of positive detection. This 
could imply that the cells had somehow managed to downregulate/switch off the 
expression of this protein whilst retaining their resistance to antibiotic selection. 
Upon examination by flow cytometry, it became clear that the majority of the cells 
within this selected population were most likely expressing eYFP-PLC? at very 
low levels that were not easily distinguishable from CHO cell auto-fluorescence. 
The option of enriching the cell population by serial dilution techniques alone was 
considered unsuitable due to the low probability of isolating a clone that would 
express above the limit of positive detection. This chapter demonstrates that the 
combination of fluorescence activated cell sorting (FACS) and serial dilution out 
cloning is a viable method for enrichment of stable cell lines exhibiting low levels 
of expression. This has resulted in the generation of a cell line with high levels of 
stable eYFP-PLC? expression that is clearly distinguishable from cellular 
autofluorecence. The enrichment process has produced the first mammalian 
expression system to offer high levels of PLC£ protein production which could be 
valuable for subsequent experimental analysis of its mechanism of activation.
5.3.2 The PLC? produced in CHO cells causes Ca2+ oscillations in mouse 
oocytes.
One of the main advantages of mammalian expression systems is that they 
possess the appropriate machinery for protein folding and post-translational 
modification that enable the production of fully active proteins with correct 
conformation. The results from previous chapters within this study revealed that 
the expression of eYFP-PLC? had no effect on Ca2+ in CHO cells, and the 
possibility that this expression system had resulted in the production of a form of 
PLC? that was not fully functional could not be disregarded. A suitable means of 
examining the activity of this protein was considered to be its delivery into mouse 
oocytes, a system in which the effects of PLC? have been well characterised. 
Injection of either cytosolic extracts or whole cells from the eYFP-PLC? cell line 
produced Ca2+ oscillations in mouse eggs, confirming that the PLC£ generated by 
this mammalian expression system is fully functional. Interestingly, despite 
individual cells expressing enough PLC£ to trigger Ca2+ oscillations in an oocyte, 
the Ca2+ homeostasis in the somatic cell line remained unperturbed. These 
results imply that the enzymatic activity of PLC£ may be reversibly inhibited in 
somatic cells, or else specifically stimulated by factors in the egg cytoplasm.
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6.1 PLC? and the implications of the current results
In the quest to explain the generation of Ca2+ oscillations at fertilisation, the 
content hypothesis was proposed as an alternative to receptor mediated 
activation of the lnsP3 pathway (Swann, 1990; Swann et a/., 1994). This theory 
describes a mechanism by which a soluble sperm factor is released into the egg, 
capable of activating the lnsP3 signalling pathway and the subsequent Ca2+ 
release from the ER. Microinjection of sperm extracts, or whole sperm in eggs 
produced a series of Ca2+ oscillations in a range of different species much like 
those seen at fertilisation (Kyozuka et al., 1998; Palermo et a/., 1992; Strieker, 
1997; Swann, 1990; Swann et al., 1994; Tang et al., 2000; Wu etal., 1997).
It was proposed that a sperm specific PLC activity could explain the ability of a 
soluble, mammalian sperm extract to cause Ca2+ oscillations (Jones et al., 2000; 
Jones et al., 1998; Parrington et al., 2002). However, microinjection of 
recombinant proteins corresponding to most of the known PLC isoforms 
expressed in sperm, including PLC01, y1, y2 and 51 failed to mimic the Ca2+ 
oscillations observed at fertilisation (Jones et al., 2000; Parrington et al., 2002; 
Runft et al., 2002), or only managed to initiate Ca2+ oscillations at non- 
physiological concentrations (Mehlmann et al., 2001). Analysis of a mouse testis 
expressed sequence tag (EST) database led to the production of a full length 
cDNA encoding a novel sperm specific PLC sequence, termed PLC? (Saunders 
eta l., 2002). Microinjection of cRNA encoding mouse (Saunders et al., 2002), 
human and simian (Cox et al., 2002) PLC? into mouse eggs produced fertilisation
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like Ca2+ responses. Furthermore, these oscillations were abolished when PLC? 
was immunodepleted from native sperm extracts (Saunders et al., 2002; Swann 
et al., 2004). The presence of PLC? has also been demonstrated in boar and 
hamster sperm (Saunders et al., 2002). Microinjecting recombinant PLC? that 
was synthesised using a baculovirus expression system Was able to trigger Ca2+ 
oscillations in mouse eggs (Kouchi et al., 2004). Significantly, the amount of 
PLC? required to initiate Ca2+ transients in eggs correlates with the approximate 
concentration of PLC? in a single sperm (20-50fg) (Saunders et al., 2002). PLC? 
is becoming increasingly accepted as the physiological activator of embryo 
development in mammals and perhaps other vertebrates. The mechanism of 
action of PLC? is still unclear; it is not known how it is regulated or if its effects 
are specific to eggs, and it may be autonomously active when introduced into the 
egg by the sperm during fertilisation.
Relatively little work has focused on examining the activity of PLC? in somatic 
cells. Previous studies have reported on the cellular localisation of PLC? (Coward 
et al., 2006; Ito et al., 2008; Kuroda et al., 2006) and its ability to induce Ca2+ 
oscillations (Kuroda et al., 2006) in mammalian cell lines. The findings of this 
thesis also confirm the nuclear translocation ability of PLC? in somatic cells, 
however the results suggest that this phenomenon is linked to time after 
transfection as apposed to the Ca2+ mobilising activity of PLC? that has been 
suggested previously (Kuroda et al., 2006).
CHO cells were transfected with luciferase or eYFP tagged PLC?. The frequency 
of the spontaneous Ca2+ oscillations observed in these cells was unaffected by
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PLC? expression. Similarly, there was no evident change in resting Ca2+ levels, 
nor any subtle change in the variability in resting Ca2+. There were no differences 
in the response to extracellular ATP when compared with control eYFP 
transfected cells, or to cells transfected with eYFP tagged to a catalytically 
inactive PLC?. Overall, there is no evidence to suggest that PLC? perturbs Ca2+ 
homeostasis in somatic cell lines.
Despite the lack of effect on Ca2+ in CHO cells, either injection of cytosolic 
extracts, or whole cells from a stably transfected eYFP-PLC? cell line were able 
to induce Ca2+ oscillations in mouse eggs. This effect was not seen with 
untransfected CHO cells. These data suggest that PLC? is inactivated when 
expressed in a cell line and yet active when subsequently introduced into an egg. 
Broad ectopic expression of PLC? has been shown to have minimal effects in 
transgenic mice (Yoshida et al., 2007). The authors conclude that the activity of 
PLC? may be restricted to oocytes, and suggest that this is the only tissue that 
possesses the cellular machinery required to transduce PLC? signalling. It is 
important to mention that the low level of ectopic expression observed in the 
transgenic mice was not quantified. The results of this thesis imply that somatic 
cells are capable of tolerating much higher levels of PLC?, which was shown to 
be active upon its introduction into mouse eggs.
6.2 Estimation of protein expression levels
An effective way to measure how much protein is being expressed in living cells 
is to use cDNA constructs tagged with firefly luciferase. Unlike fluorescence
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based methods, luminescence does not suffer from interference from auto­
fluorescence, and as a result provides a highly sensitive technique for the 
qualification of protein levels. When considering that mouse PLC? is active in 
mouse eggs at concentrations as low as 1-1 OnM (Kouchi et al., 2004), this issue 
of sensitivity is particularly significant. One advantage of fluorescent probes is 
that high resolution confocal imaging can be employed, which is better suited to 
studies concerning the cellular localisation of the expressed protein. Photon 
imaging cameras, like the one used in this thesis, enable the identification of 
which individual cells are expressing luciferase allowing the quantitative analysis 
of how much luciferase-tagged protein is being expressed.
Previous work in our laboratory lead to the construction of a calibration curve 
which has enabled users of our photon imaging system to ascertain the amount 
of PLC?-LUC protein that was being expressed in eggs following cRNA injections 
(Campbell, 2007; Nomikos et al., 2005; Swann et al., 2007). To do this, mouse 
eggs had been injected with known amounts of firefly luciferase cRNA or protein. 
After luminescence imaging, eggs from each group were lysed with 1% Triton 
x100 in a PBS buffer containing 1mM MgCI2, 1mM ATP and 100pM luciferin. The 
lysis took place in a custom built luminometer (see Chapter 2, section 2.2.7) and 
the average signal (cps) was taken over 60 seconds. The luminometer was 
calibrated with purified native luciferase protein. A relationship was then obtained 
(Figure 6.1) that can be used to calculate unknown protein content in eggs that 
have been injected with a luciferase tagged construct.
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Figure 6.1 Calibration for quantification of protein expression
Calibration curve constructed to calculate the amount of PLC^-LUC protein being expressed, 
(provided by Karl Swann).
In the experiments presented in this thesis, the average luminescence signal 
recorded in single CHO cells expressing PLC?-LUC ranged from 1-10cps. The 
experimental setup used for recording the expression in cells was estimated to 
be approximately one and a half times more sensitive than the set up used for 
the calibration in eggs. With this in mind, 10cps from a single cell equates to 
~6cps had the same set up have been employed. Using the calibration in figure 
6.1, the amount of PLC? protein expressed in a single CHO cell with an average 
signal of 10cps was estimated to be approximately 130fg. Individual cells are 
expressing within and above the range of PLC? required to initiate Ca2+ 
oscillations in eggs (20-50fg) (Saunders et al., 2002), and are therefore 
considered to be expressing at levels comparable with that of sperm. When 
comparing the relative volume of an average CHO cell (~2pl) to that of an egg
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(~200pl), these cells are clearly capable of tolerating ~200-300 fold more PLC? 
than the amount required to induce Ca2+ release in an egg.
The calibration of eYFP is not as straightforward due to variation in experimental 
factors such as excitation light, focal depth and camera sensitivity; all of which 
would require standardisation with recombinant eYFP. However, with this in 
mind, it is possible to estimate levels of protein expression based on the following 
assumptions. The detection limit of wild type GFP in a typical mammalian cell 
has been determined to be ~1pM over cellular autofluorescence (Niswender et 
al., 1995). Mutant GFPs with improved extinction coefficients decrease this limit 
and allow the detection of lower levels of fluorescence (Cormack et al., 1996; 
Heim et al., 1995). It is reasonable to assume that the cells of the stable eYFP- 
PLC? population which were typically ~10-100 fold brighter than cellular 
autofluorescence contain at least 10pM eYFP-PLC?. Consequently, an estimate 
of the amount of eYFP-PLC? (100,000 Mw) per typical CHO cell of 1-2pL volume 
equates to approximately 1-2pg. This approximate calculation suggests that the 
stably transfected CHO cells generated as part of this thesis have a cytoplasmic 
concentration of PLC? ~1000 fold higher than the amount required to induce 
Ca2+ oscillations in an egg, which is consistent with the PLC?-LUC results. It is 
possible that a proportion of the 1-2pg of protein is inactivated; however the 
single cell injection experiments (Chapter 5) confirm that individual CHO cells 
contain at least the required amount of active PLC? to induce Ca2+ release in an 
egg.
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6.2.1 Cell extract injections
The generation of cell extract enables the isolation of protein from a large 
number of cells. The cytosolic fraction of cells expressing eYFP-PLC? was 
prepared into a 20pl extract as described in Chapter 2, section 2.2.11. The 
number of cells used in all extract preparations was calculated using 
haemocytometry (typically ~2 x 107 cells). Extracts were diluted (1 in 5) in order 
to facilitate injection, and taken together with the estimated injection volume of 
~1-5pl, a calculation was performed in order to determine the number of cells that 
correspond to the amount of extract injected. This revealed that amount of cell 
extract delivered into eggs was equivalent to injecting ~1-5 CHO cells. This data 
also suggests that individual cells expressing eYFP-PLC? are expressing PLC? 
at levels capable of inducing Ca2+ oscillations in eggs; an estimation which is 
supported by experiments involving single cell injections.
6.3 The conundrum of PLC? expression in cells
The data presented in this thesis demonstrates that somatic cells can tolerate 
levels of PLC? 100 -1000 fold higher than the amount required to induce Ca2+ 
release in an egg, without exhibiting any apparent perturbations in Ca2+ 
homeostasis. This suggests that PLC? is completely inactivated when expressed 
in a somatic cell line. However, injections of cytosolic extracts, or whole cells 
from the eYFP-PLC? transfected cell line confirmed that the PLC? expressed 
within these cells is capable of inducing Ca2+ release upon its introduction into 
mouse eggs. The results imply that the enzymatic activity of PLC? may be
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reversibly inhibited in somatic cells, or else specifically stimulated by factors in 
the egg cytoplasm. These hypotheses are considered in the following sections.
6.4 Inhibition of PLC? activity in somatic cells
If the activity of PLC? is inhibited in somatic cells, it is worth considering the 
following possible mechanisms.
6.4.1 Nuclear Translocation
It is possible that nuclear sequestration may be involved in the inhibition of PLC? 
activity. The expression of PLC?-Venus in mouse eggs increases for up to 3 
hours following cRNA injection until a steady level is attained at 4-5 hours (Yoda 
et al., 2004). Expressed PLC? is distributed homogenously throughout the egg 
cytoplasm without membrane association or any localisation. Interestingly, PLC? 
translocates into the pronucleus (PN) formed at 5-6 hours (Yoda et al., 2004), 
which is consistent with an earlier observation that the PN formed after 
fertilisation has Ca2+ releasing activity when introduced into an unfertilized egg 
(Kono et al., 1995). Previous work has shown that Ca2+ oscillations after 
fertilisation (Deguchi et al., 2000; Jones, 1998) or after injection of RNA encoding 
PLC? (Larman et al., 2004) cease around the time of PN formation, suggesting 
that nuclear translocation of PLC? may be responsible for the termination of 
oscillations. Ca2+ oscillations continue over 10 hours when PN formation is 
prevented by injection of a lectin, W GA (Marangos et al., 2003), or when a point 
mutation is added to a putative nuclear translocation signal (NLS) region of PLC? 
(Larman et al., 2004). During early development, Ca2+ oscillations reappear at
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the stage of nuclear envelope breakdown just before the first cell division (15-16 
hours after fertilisation) and cease after the first cleavage (Larman et al., 2004). 
Subsequently, PLC? translocates again to the nuclei of the 2 cell embryo after 
the first cleavage (Larman et al., 2004; Sone et al., 2005). These results have 
lead to the view that the movement of PLC? between the cytoplasm and the 
nucleus may turn on and off a series of lnsP3-dependant Ca2+ rises in a cell cycle 
dependent manner.
However, this is unlikely to explain the lack of PLC? activity observed in the 
current study since no changes in Ca2+ were observed before nuclear 
translocation had taken place (3 and 5 hours following DNA delivery). Nuclear 
sequestration of PLC? may also be limited by capacity, and it is unlikely that all of 
the PLC? is localised to the nucleus at high expression levels, such as in the 
stably transfected eYFP-PLC? cell line. This suggests that there may be other 
mechanisms for inhibiting the activity of PLC? in somatic cells.
6.4.2 Downregulation of I11SP3R
In eggs, lnsP3R downregulation and Ca2+ store depletion have been proposed as 
possible alternative mechanisms for the termination of Ca2+ oscillations following 
fertilisation (Jellerette et al., 2000). Cells also have the ability to adapt to long 
term exposure to an agonist by down regulation of receptors. Chronic stimulation 
of receptors linked to lnsP3 formation has been shown to cause a reduction in the 
number of lnsP3R and a decrease in sensitivity of the intracellular Ca2+ stores to 
lnsP3 (Wojcikiewicz et al., 1991; Wojcikiewicz et al., 1992). Downregulation of 
lnsP3R has been shown to inhibit Ca2+ release in mouse eggs (Brind etal., 2000;
196
Jellerette et al., 2000), and has been proposed to partly explain the cessation of 
Ca2+ oscillations 3-4 hours after fertilisation. It is reasonable to assume therefore 
that lnsP3R downregulation could account for the lack of effect of PLC? on Ca2+ 
in somatic cells.
Results in mouse oocytes have shown that different levels of PLC? protein 
expression alter the pattern of Ca2+ oscillations observed (Yu et al., 2008b). 
Increased expression of PLC? correlates with a quicker onset and higher 
frequency of Ca2+ oscillations. Interestingly, higher levels of PLC? expression 
also cause a gradual decrease in spike amplitude and a more rapid termination 
of Ca2+ transients. The experimental protocol employed during this study made it 
impractical to monitor the intracellular Ca2+ of cells expressing PLC? sooner than 
3 hours following cDNA delivery. It is therefore possible that PLC? does perturb 
the intracellular Ca2+ in somatic cells at earlier time points, which would suggest 
that somatic cells, like eggs, possess an innate ability to limit the duration of Ca2+ 
signals initiated by PLC?. This could involve downregulation of lnsP3Rs.
Sperm extracts have been shown to trigger Ca2+ oscillations in rat hepatocytes 
(Berrie et al., 1996). Two distinct types of oscillations were recorded, either an 
early transient that displayed further secondary oscillations during the falling 
phase, or late transients that were more variable in peak height. Hepatocytes 
displayed between one and 19 early transients, and up to eight of the later 
transients (n= 10 cells). Ca2+ oscillations were initiated within minutes following 
extract injection, and were shown to continue for approximately 1.5 hours. This 
data shows that PLC? is capable of inducing Ca2+ oscillations in hepatocytes
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which appear to be limited in their duration. In order to assess if PLC? is capable 
of inducing a similar Ca2+ response in CHO cells, future experiments could 
involve the injection of RNA encoding PLC? with a prolonged Ca2+ imaging 
period, much like the experiments performed using mouse oocytes. It would also 
be interesting to observe the effects of injecting extracts prepared from the stably 
transfected eYFP-PLC? cell line into CHO cells.
High levels of PLC? promote sustained DAG production in mouse eggs which 
can lead to PKC-mediated Ca2+ influx and subsequent overloading of Ca2+ stores 
(Yu et al., 2008a). The series of secondary Ca2+ oscillations induced by PKC 
overstimulation have been proposed to have a major negative effect on eggs; 
such as failure to develop to blastocyst stages despite having formed pronuclei 
(Berrie et al., 1996; Yu et al., 2008a). Downregulation of InsPaR could account 
for the lack of PLC? activity in CHO cells; however it is possible that cells would 
experience adverse effects of sustained DAG production and subsequent PKC 
activation, such as changes in Ca2+ homeostasis and cell proliferation. The 
results of this thesis do not indicate any marked irregularities in CHO cells 
expressing PLC? that would indicate persistent DAG production, however such 
an effect cannot be ruled out. It would be interesting to assess the levels of DAG 
in cells expressing PLC?. This could be achieved by performing a protein 
phosphorylation assay using a PKC substrate, such as MARCKS (Myristoylated 
Alanine Rich C Kinase Substrate) protein (Arbuzova et al., 1998). Also, DAG 
production in the plasma membrane could be assessed using a fluorescently 
tagged Cl domain of PKC (Yu et al., 2008a).
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In addition to this, CHO cells expressing PLC? have a comparible Ca2+ response 
to extracellular ATP when compared with control eYFP transfected cells and with 
cells transfected with eYFP tagged to a catalytically inactive PLC?. It is 
reasonable to assume that the agonist response would be modified in some way 
had the lnsP3Rs become downregulated. So it seems again unlikely that lnsP3R 
downregulation alone explains the lack of PLC? activity in somatic cells. A more 
precise method of assessing possible lnsP3R downregulation as a result of PLC? 
expression would be to perform an immunoblot for InsPaRs, which could be 
carried out using the stably transfected eYFP-PLC? cell line.
6.4.3 Regulation of PLC? by phosphorylation
One possibility is that PLC? is regulated by phosphorylation. Reversible 
phosphorylation is a highly effective means of switching the activity of target 
proteins. Phosphorylation and dephosphorylation, catalysed by protein kinases 
and protein phosphatases, can modify the function of a protein in many ways; 
such as facilitating or inhibiting movement between subcellular compartments, by 
increasing or decreasing its biological activity, or by initiating or disrupting 
protein-protein interactions (Cohen, 2002). There are a number of bioinformatic 
resources available which allow users to search for motifs within DNA sequences 
of proteins that are likely to be phosphorylated by specific protein kinases. 
Entering the DNA sequence of PLC? into a commonly used world-wide-web 
interfaced bioinformatics computer program (Obenauer et al., 2003) identified 
potential phosphorylation sites for PKC, CamKII and various other kinases.
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Phosphorylation could therefore provide an alternative mechanism for regulating 
the activity of PLC? in somatic cells. Alternatively, it may be that the regulation of 
PLC? requires a specific protein kinase that is only present within the egg. There 
are no previous studies discussing the phosphorylation of PLC?, and there is no 
clear evidence either for or against it as a potential means of regulation.
6.5 Mechanism of action of PLC?
Another means of regulating the activity of PLC? could involve the way in which it 
targets PIP2. The four well characterised isoforms of PLC (p, y, 5, z) interact with 
plasma membranes by different mechanisms (Rebecchi et al., 2000; Rhee, 
2001). The pleckstrin homology (PH) domain functions to target PLC51 with high 
affinity and specificity to the lipid PIP2 (Ferguson et al., 1995; Garcia et al., 1995; 
Lemmon, 2003; Lemmon et al., 2000; Lemmon et al., 1995), whilst PLCs p, y, 
and z bind to specific plasma membrane proteins (Kelley et al., 2006; Kelley et 
al., 2004; Suh et al., 2008; Wang et al., 1999). Membrane interactions are 
important to PLCs as they enhance the catalytic activity of the enzyme by 
exposing them to higher local concentrations of their PIP2 substrate (Rebecchi et 
al., 2000; Rhee, 2001). It remains to be determined whether PLC? is targeted to 
membranes via protein-protein interactions like the P, y, and z isoforms, or via 
protein-lipid interactions like the 51 isoform. It is also unclear which type of 
membrane PLC? targets. It is possible that it interacts with either a distinct 
vesicular PIP2-containing membrane, or a PIP2-containing microdomain within 
the plasma membrane (Rice eta l., 2000; Swann et al., 2001).
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Previous work has shown that the binding of PLC? to PIP2 may involve the X-Y 
linker or the C2 domain (Nomikos et al., 2007). These domains were expressed 
as GST fusion proteins and their binding to phosphoinositides spotted on PIP 
strip membranes was examined. The results were compared to the binding 
capacity of the equivalent domains of PLC61. Both PLC61 and PLC? were shown 
to bind PIP2 , but only the X-Y and C2 domains from PLC? were shown to bind 
PIP, and to a lesser extent to PIP2 (Nomikos et al., 2007). This data suggests that 
the X-Y linker region and C2 domain play an important role in targeting PLC? to 
its substrate.
In addition to this, the unique properties of the different PLC? domains have been 
investigated by generating a series of PLC chimeras involving the substitution of 
the domains of PLC51 (PH, C2, EF hands and X-Y linker) into PLC? (Gonzalez 
Garcia, 2008). These chimeras were tagged with luciferase and their Ca2+ 
oscillation inducing activity was monitored in mouse eggs. The addition of the PH 
domain of PLC51 to PLC? did not alter its activity in eggs. Replacing either the X- 
Y linker or EF hand domain of PLC? with those from PLC51 leads to a reduction 
in the ability of these chimeras to induce Ca2+ oscillations. Interestingly, replacing 
the C2 domain of PLC? with that of PLC51 totally abolished its Ca2+ releasing 
activity in mouse eggs (Gonzalez Garcia, 2008). These results suggest that the 
C2 domain of PLC? is essential for its activity in eggs. It is possible that the 
association of PLC? with its specific plasma membrane target may be mediated 
by the interaction of X-Y linker or C2 domain with another membrane targeting 
protein, thereby compensating for its inherent lack of PH or SH domains.
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6.6 Is there an Egg specific factor?
The work in this thesis suggests a conundrum for understanding how somatic 
cells tolerate high levels of PLC?. The conundrum that exists in nature is that 
sperm cells also show no evidence of abnormal PI signalling despite containing 
~1000 times more PLC? than the amount required to trigger Ca2+ release and PI 
turnover in an egg. This is comparable to the situation observed in somatic cells 
during this study, whereby CHO cells are also capable of tolerating relatively high 
levels of PLC? expression. When PLC? is introduced into an egg by sperm it 
appears to be fully active, and induces a Ca2+ response within minutes. This was 
also the case with injections of either cell extract or single cells from the stably 
transfected eYFP-PLC? cell line. The question remains as to how PLC? is 
seemingly inactive when expressed in sperm and somatic cells and yet active 
when subsequently introduced into an egg. The data presented in this thesis 
does not rule out a specific inhibition of PLC? in somatic cells; however, the 
stimulation of PLC? by egg specific factor not only explains these observations, 
but also offers an interesting explanation for the conundrum that exists in nature. 
As mentioned previously, it is possible that PLC? associates with its specific 
membrane target by interacting with another membrane targeting protein, much 
like the PLC p, y, and £ isoforms. Based on the experimental findings of this 
thesis, one can propose a hypothetical mechanism for PLC? action that involves 
an interaction with an egg specific factor (Figure 6.2). If the interaction involved 
the C2 domain, this would be analogous to the mechanism of action of PLCp 
(Suh et al., 2008). It is likely that this factor is associated with a membrane due to
202
the cellular location of PIP2> however it remains to be determined if this involves 
the plasma membrane or the membrane of an intracellular organelle. Once PLC? 
is associated with this egg specific factor, it could then bind and hydrolyse its 
substrate leading to the generation of lnsP3 and subsequent Ca2+ release from 
intracellular stores. Identification of this egg specific factor interaction could 
involve the use of a pull down assay, whereby PLC? is expressed as a fusion 
protein (e.g. myc tagged) in eggs and then immobilised using an affinity ligand 
specific to the fusion tag. The entire complex could then be eluted from the 
affinity support and evaluated by SDS-PAGE. Having identified the egg specific 
factor, it would be interesting to then introduce this protein into somatic cells 
expressing PLC? in order to examine the effects on Ca2+ signalling.
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Somatic cell
Sperm
Plasma membrane
X = egg 
specific factor
PIP:
PIP;
PIP;
Intracellular vesicle
Figure 6.2 Hypothetical m echanism  of PLC£ action based on the findings of this 
thesis.
(See text for explanation and references)
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